Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	1139047	1139047	C	A	exonic	TNFRSF18	.	nonsynonymous SNV	TNFRSF18:NM_148901:exon4:c.G692T:p.G231V	8.37E-07	0.089996444	0.91000272	.	0.03798	0.16362	.	.	185.06659	2.95295	0.0	0.912	D	0.996	0.670	D	0.907	0.627	P	.	.	.	1	0.090	N	.	.	.	1.4	0.336	T	-0.49	0.156	N	0.039	0.020	-0.993	0.319	T	0.141	0.461	T	0.051	0.647	D	3.838	0.518	23.4	0.983	0.392	0.090	0.147	N	c	-0.379	-0.646	0.337	0.195	0.706	0.609	0	-0.534	0.112	-0.052	0.117	0.068	0.175	0.002	0.151	0.001	0.043	4.128	0.095	.	.	.	0.5	102	511	chr1	1139047	chr1:1139047	C	A	102	PASS	AN=2;DP=511	GT	0/1
chr1	1647893	1647893	-	TTTCTT	exonic	CDK11A;CDK11B	.	nonframeshift insertion	CDK11B:NM_001291345:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11A:NM_001313896:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11A:NM_001313982:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11B:NM_001787:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11A:NM_024011:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11B:NM_033486:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11A:NM_033529:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11B:NM_033489:exon6:c.277_278insAAGAAA:p.E92_R93insKE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	164	chr1	1647893	chr1:1647893	C	CTTTCTT	148	PASS	AN=2;DP=164	GT	0/1
chr1	1670432	1670432	T	C	exonic	SLC35E2	.	synonymous SNV	SLC35E2:NM_182838:exon3:c.A387G:p.L129L,SLC35E2:NM_001199787:exon4:c.A387G:p.L129L	0.374305908	0.578735512	0.04695858	.	0.08723	.	.	.	124.71343	2.42805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	442	chr1	1670432	chr1:1670432	T	C	140	PASS	AN=2;DP=442	GT	0/1
chr1	2409906	2409906	C	T	intronic	PLCH2	.	.	.	1.71E-08	0.841467316	0.158532667	.	0.16736	0.10113	.	.	562.69013	4.81563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	369	chr1	2409906	chr1:2409906	C	T	98	PASS	AN=2;DP=369	GT	0/1
chr1	10754479	10754479	C	G	intronic	CASZ1	.	.	.	0.999938476	6.15E-05	4.86E-13	.	0.71675	0.27528	-2.416721768	1.055673508	1083.53567	6.31123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	154	1172	chr1	10754479	chr1:10754479	C	G	154	PASS	AN=2;DP=1172	GT	0/1
chr1	13353904	13353904	A	C	intronic	PRAMEF18	.	.	.	.	.	.	.	.	.	.	.	287.00244	3.6298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	301	chr1	13353904	chr1:13353904	A	C	95	PASS	AN=2;DP=301	GT	0/1
chr1	16363158	16363158	G	A	intergenic	CLCNKA;CLCNKB	dist=2613;dist=7073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	267	chr1	16363158	chr1:16363158	G	A	139	PASS	AN=2;DP=267	GT	0/1
chr1	16812113	16812113	G	A	ncRNA_exonic	CROCCP3	.	.	.	.	.	.	.	0.06928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	304	chr1	16812113	chr1:16812113	G	A	148	PASS	AN=2;DP=304	GT	0/1
chr1	16945673	16945673	A	G	ncRNA_intronic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	248	chr1	16945673	chr1:16945673	A	G	144	PASS	AN=2;DP=248	GT	0/1
chr1	16955037	16955037	C	G	ncRNA_exonic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	1546	chr1	16955037	chr1:16955037	C	G	116	PASS	AN=2;DP=1546	GT	0/1
chr1	17019445	17019445	G	T	ncRNA_intronic	ESPNP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	621	chr1	17019445	chr1:17019445	G	T	101	PASS	AN=2;DP=621	GT	0/1
chr1	17086941	17086941	C	T	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon4:c.G383A:p.R128H	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	654	chr1	17086941	chr1:17086941	C	T	150	PASS	AN=2;DP=654	GT	0/1
chr1	22913150	22913150	C	T	intronic	EPHA8	.	.	.	1.14E-08	0.983030391	0.016969598	.	0.32535	0.12252	0.130330208	63.21066289	1372.14313	6.94837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	540	chr1	22913150	chr1:22913150	C	T	109	PASS	AN=2;DP=540	GT	0/1
chr1	22922560	22922560	G	A	intronic	EPHA8	.	.	.	1.14E-08	0.983030391	0.016969598	.	0.32535	0.12252	0.130330208	63.21066289	1372.14313	6.94837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	161	148	chr1	22922560	chr1:22922560	G	A	161	PASS	AN=2;DP=148	GT	1/0
chr1	23695969	23695969	G	C	ncRNA_exonic	ZNF436-AS1	.	.	.	.	.	.	.	0.12418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	429	chr1	23695969	chr1:23695969	G	C	104	PASS	AN=2;DP=429	GT	0/1
chr1	24120833	24120833	C	-	intronic	LYPLA2	.	.	.	0.979519145	0.020463866	1.70E-05	.	0.20635	0.10011	-0.295622497	32.61972163	4.69509	0.16866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	543	chr1	24120832	chr1:24120832	AC	A	83	PASS	AN=2;DP=543	GT	0/1
chr1	26663747	26663747	C	A	exonic	CRYBG2	.	synonymous SNV	CRYBG2:NM_001039775:exon10:c.G3768T:p.R1256R	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	240	chr1	26663747	chr1:26663747	C	A	80	PASS	AN=2;DP=240	GT	0/1
chr1	27722052	27722052	G	C	UTR3	GPR3	NM_005281:c.*757G>C	.	.	0.020935797	0.751114613	0.22794959	.	0.64069	0.11438	0.060756528	58.52795471	114.40031	2.33012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	287	chr1	27722052	chr1:27722052	G	C	.	PASS	AN=0;DP=287	GT	0/1
chr1	36203589	36203589	T	A	intronic	CLSPN	.	.	.	0.991559393	0.008440607	5.43E-12	.	0.45114	.	0.744001103	86.37650389	5854.71385	15.86316	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	174	chr1	36203589	chr1:36203589	T	A	58	PASS	AN=2;DP=174	GT	0/1
chr1	36306854	36306854	G	C	exonic	AGO4	.	nonsynonymous SNV	AGO4:NM_017629:exon14:c.G1813C:p.A605P	0.990043812	0.009956187	9.81E-10	.	0.08477	0.14026	-0.890882376	10.30313753	19.9687	0.68036	0.001	0.784	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	4.44	0.988	H	0.99	0.418	T	-4.84	0.810	D	0.975	0.976	0.265	0.870	D	0.473	0.798	T	0.047	0.630	D	6.082	0.838	28.2	0.997	0.839	0.993	0.935	D	c	1.132	1.047	1.000	0.747	0.651	0.465	0	6.01	0.974	7.907	0.867	1.044	0.665	1.000	0.715	0.981	0.494	20.521	0.992	Piwi domain|Ribonuclease H-like domain	.	.	0.5	97	368	chr1	36306854	chr1:36306854	G	C	97	PASS	AN=2;DP=368	GT	0/1
chr1	45267235	45267235	A	T	intronic	PLK3	.	.	.	6.25E-05	0.994577898	0.00535961	.	0.29709	0.18462	-1.109541557	6.782259967	54.52333	1.47654	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	210	chr1	45267235	chr1:45267235	A	T	.	PASS	AN=0;DP=210	GT	0/1
chr1	70385205	70385205	C	G	ncRNA_exonic	PIN1P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	143	789	chr1	70385205	chr1:70385205	C	G	143	PASS	AN=2;DP=789	GT	0/1
chr1	104116937	104116937	G	T	exonic	AMY2B	.	nonsynonymous SNV	AMY2B:NM_020978:exon7:c.G800T:p.R267L	7.65E-09	0.690335158	0.309664835	.	0.12126	0.38738	0.110306132	62.00165133	318.05085	3.78784	0.067	0.359	T	0.968	0.546	D	0.825	0.575	P	0.000	0.843	D	1.000	0.588	D	2.8	0.819	M	-4.78	0.981	D	-4.66	0.794	D	0.559	0.593	0.911	0.958	D	0.923	0.974	D	0.049	0.637	D	4.085	0.548	23.7	0.997	0.816	0.972	0.730	D	c	0.381	0.276	0.002	0.087	0.638	0.428	0	2.6	0.300	5.659	0.675	0.933	0.449	1.000	0.715	0.976	0.476	9.858	0.401	Glycoside hydrolase superfamily|Glycoside hydrolase, catalytic domain|Glycosyl hydrolase, family 13, catalytic domain|Glycosyl hydrolase, family 13, subfamily, catalytic domain	.	.	0.5	137	578	chr1	104116937	chr1:104116937	G	T	137	PASS	AN=2;DP=578	GT	0/1
chr1	110257506	110257506	G	C	intronic	GSTM5	.	.	.	0.000214167	0.736990281	0.262795552	.	0.04393	.	0.905808022	89.4373673	506.91274	4.62021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	169	chr1	110257506	chr1:110257506	G	C	.	PASS	AN=0;DP=169	GT	0/1
chr1	110950493	110950493	G	T	ncRNA_exonic	LAMTOR5-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	665	chr1	110950493	chr1:110950493	G	T	109	PASS	AN=2;DP=665	GT	0/1
chr1	111026677	111026677	C	A	ncRNA_intronic	CYMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	338	chr1	111026677	chr1:111026677	C	A	.	PASS	AN=0;DP=338	GT	0/1
chr1	112281744	112281744	C	A	intronic	FAM212B	.	.	.	0.003590517	0.84159666	0.154812824	.	0.09827	.	-0.60427181	17.74593064	22.74555	0.76057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	348	chr1	112281744	chr1:112281744	C	A	101	PASS	AN=2;DP=348	GT	0/1
chr1	142825055	142825055	C	A	intergenic	ANKRD20A12P;LOC102723769	dist=111450;dist=309548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	512	chr1	142825055	chr1:142825055	C	A	130	PASS	AN=2;DP=512	GT	0/1
chr1	143378854	143378854	G	A	intergenic	LOC102723769;MIR6077	dist=176615;dist=294067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	302	chr1	143378854	chr1:143378854	G	A	134	PASS	AN=2;DP=302	GT	0/1
chr1	144813743	144813743	G	A	exonic	NBPF8;NBPF9	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	c	-0.388	-0.841	0.060	0.152	0.651	0.465	0	-0.38	0.118	-0.295	0.083	-2.386	0.003	0.102	0.226	0.046	0.161	5.299	0.150	.	.	.	0.5	73	105	chr1	144813743	chr1:144813743	G	A	73	PASS	AN=2;DP=105	GT	0/1
chr1	144813824	144813824	G	C	exonic	NBPF8;NBPF9	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	555	chr1	144813824	chr1:144813824	G	C	135	PASS	AN=2;DP=555	GT	0/1
chr1	144854514	144854514	C	A	ncRNA_exonic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	560	chr1	144854514	chr1:144854514	C	A	84	PASS	AN=2;DP=560	GT	0/1
chr1	144856817	144856817	T	C	exonic	PDE4DIP	.	nonsynonymous SNV	PDE4DIP:NM_001350520:exon36:c.A7154G:p.E2385G,PDE4DIP:NM_001198834:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_014644:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_001350522:exon41:c.A6509G:p.E2170G,PDE4DIP:NM_001198832:exon42:c.A6350G:p.E2117G,PDE4DIP:NM_001350521:exon42:c.A6962G:p.E2321G,PDE4DIP:NM_001350523:exon42:c.A6347G:p.E2116G	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	c	0.152	0.039	1.000	0.517	0.598	0.340	0	3.39	0.378	3.846	0.554	0.183	0.247	1.000	0.715	0.636	0.296	8.617	0.328	.	.	.	0.5	137	269	chr1	144856817	chr1:144856817	T	C	137	PASS	AN=2;DP=269	GT	0/1
chr1	144879592	144879592	A	T	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	172	chr1	144879592	chr1:144879592	A	T	123	PASS	AN=2;DP=172	GT	0/1
chr1	144994902	144994902	G	A	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	643	chr1	144994902	chr1:144994902	G	A	142	PASS	AN=2;DP=643	GT	0/1
chr1	145281429	145281429	G	T	exonic	NOTCH2NL	.	nonsynonymous SNV	NOTCH2NL:NM_203458:exon4:c.G359T:p.C120F	0.000100623	0.575070489	0.424828889	.	0.13774	.	0.657836546	84.27105449	3.00594	0.10883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.468	0.946	D	.	.	.	.	.	.	.	.	c	0.726	0.548	1.000	0.747	0.675	0.547	0	2.87	0.324	3.678	0.541	0.613	0.288	1.000	0.715	0.998	0.697	11.536	0.497	EGF-like domain	.	.	0.5	94	862	chr1	145281429	chr1:145281429	G	T	94	PASS	AN=2;DP=862	GT	0/1
chr1	145290398	145290398	G	A	ncRNA_intronic	NBPF25P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	261	chr1	145290398	chr1:145290398	G	A	122	PASS	AN=2;DP=261	GT	0/1
chr1	148882006	148882006	T	C	ncRNA_exonic	LOC101927429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	305	chr1	148882006	chr1:148882006	T	C	70	PASS	AN=2;DP=305	GT	0/1
chr1	149784994	149784994	C	T	exonic	HIST2H3D	.	synonymous SNV	HIST2H3D:NM_001123375:exon1:c.G243A:p.T81T	0.49893728	0.427580174	0.073482546	.	.	.	0.035072054	56.2514744	6.52563	0.24176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	952	chr1	149784994	chr1:149784994	C	T	.	PASS	AN=0;DP=952	GT	0/1
chr1	149859345	149859345	G	A	exonic	HIST2H2AB	.	nonsynonymous SNV	HIST2H2AB:NM_175065:exon1:c.C122T:p.A41V	0.216215034	0.647861978	0.135922988	.	0.94267	0.1705	-0.119252484	44.53880632	2.43929	0.08861	0.0	0.912	D	1.0	0.899	D	0.981	0.736	D	0.000	0.629	D	1	0.810	D	4.095	0.974	H	-0.53	0.708	T	-3.31	0.659	D	0.515	0.558	0.359	0.885	D	0.583	0.850	D	0.049	0.636	D	3.844	0.519	23.4	0.994	0.649	0.910	0.524	D	c	0.944	0.841	1.0	0.983	0.025	0.001	3	5.27	0.737	6.768	0.746	1.036	0.656	1.000	0.715	0.985	0.512	12.482	0.550	Histone H2A/H2B/H3|Histone-fold	.	.	0.5	104	1472	chr1	149859345	chr1:149859345	G	A	104	PASS	AN=2;DP=1472	GT	0/1
chr1	152188563	152188563	G	T	exonic	HRNR	.	nonsynonymous SNV	HRNR:NM_001009931:exon3:c.C5542A:p.H1848N	5.01E-29	0.999822617	0.000177383	.	0.18527	0.10879	-0.141298762	42.87567823	4521.01702	13.5031	0.151	0.245	T	0.898	0.475	P	0.346	0.409	B	.	.	.	1	0.090	N	2.61	0.766	M	3.52	0.049	T	-1.27	0.320	N	0.224	0.275	-0.974	0.364	T	0.005	0.015	T	0.001	0.018	T	-0.810	0.040	0.041	0.563	0.054	0.050	0.107	N	c	-0.928	-1.152	0.000	0.056	0.554	0.246	0	-2.1	0.068	-0.439	0.069	0.048	0.160	0.000	0.063	0.001	0.043	0.938	0.013	.	.	.	0.5	115	980	chr1	152188563	chr1:152188563	G	T	115	PASS	AN=2;DP=980	GT	0/1
chr1	152280796	152280796	G	T	exonic	FLG	.	nonsynonymous SNV	FLG:NM_002016:exon3:c.C6566A:p.A2189E	.	.	.	DISEASE: Ichthyosis vulgaris (VI) [MIM:146700]: The most common form of ichthyosis inherited as an autosomal dominant trait. It is characterized by palmar hyperlinearity, keratosis pilaris and a fine scale that is most prominent over the lower abdomen, arms, and legs. Ichthyosis vulgaris is characterized histologically by absent or reduced keratohyalin granules in the epidermis and mild hyperkeratosis. The disease can be associated with frequent asthma, eczema or hay fever. {ECO:0000269|PubMed:16444271}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dermatitis atopic 2 (ATOD2) [MIM:605803]: Atopic dermatitis is a complex, inflammatory disease with multiple alleles at several loci thought to be involved in the pathogenesis. It commonly begins in infancy or early childhood and is characterized by a chronic relapsing form of skin inflammation, a disturbance of epidermal barrier function that culminates in dry skin, and IgE-mediated sensitization to food and environmental allergens. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. {ECO:0000269|PubMed:16550169, ECO:0000269|PubMed:16815158, ECO:0000269|PubMed:17030239, ECO:0000269|PubMed:17291859}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.08975	.	24.30246465	99.98820477	16458.42079	27.35022	0.31	0.140	T	0.053	0.211	B	0.004	0.093	B	.	.	.	1	0.090	N	2.705	0.794	M	4.62	0.019	T	-0.77	0.214	N	0.099	0.101	-0.848	0.521	T	0.002	0.005	T	0.003	0.071	T	-0.140	0.081	1.450	0.753	0.106	0.015	0.049	N	c	-1.241	-1.406	0.000	0.048	0.554	0.246	0	-3.76	0.041	-1.494	0.024	-0.831	0.030	0.000	0.063	0.000	0.016	0.388	0.004	.	.	.	0.5	112	774	chr1	152280796	chr1:152280796	G	T	112	PASS	AN=2;DP=774	GT	0/1
chr1	152285358	152285358	A	G	exonic	FLG	.	synonymous SNV	FLG:NM_002016:exon3:c.T2004C:p.A668A	.	.	.	DISEASE: Ichthyosis vulgaris (VI) [MIM:146700]: The most common form of ichthyosis inherited as an autosomal dominant trait. It is characterized by palmar hyperlinearity, keratosis pilaris and a fine scale that is most prominent over the lower abdomen, arms, and legs. Ichthyosis vulgaris is characterized histologically by absent or reduced keratohyalin granules in the epidermis and mild hyperkeratosis. The disease can be associated with frequent asthma, eczema or hay fever. {ECO:0000269|PubMed:16444271}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dermatitis atopic 2 (ATOD2) [MIM:605803]: Atopic dermatitis is a complex, inflammatory disease with multiple alleles at several loci thought to be involved in the pathogenesis. It commonly begins in infancy or early childhood and is characterized by a chronic relapsing form of skin inflammation, a disturbance of epidermal barrier function that culminates in dry skin, and IgE-mediated sensitization to food and environmental allergens. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. {ECO:0000269|PubMed:16550169, ECO:0000269|PubMed:16815158, ECO:0000269|PubMed:17030239, ECO:0000269|PubMed:17291859}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.08975	.	24.30246465	99.98820477	16458.42079	27.35022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	445	chr1	152285358	chr1:152285358	A	G	130	PASS	AN=2;DP=445	GT	0/1
chr1	152883550	152883550	A	T	exonic	IVL	.	nonsynonymous SNV	IVL:NM_005547:exon2:c.A1277T:p.Q426L	3.43E-09	0.093504834	0.906495163	.	0.37637	.	0.53464283	81.00967209	386.0752	4.1378	0.002	0.721	D	0.267	0.299	B	0.113	0.301	B	.	.	.	1	0.090	N	1.195	0.303	L	3.0	0.092	T	-2.22	0.498	N	0.373	0.435	-0.924	0.450	T	0.005	0.018	T	0.020	0.433	T	0.972	0.187	10.50	0.895	0.183	0.043	0.098	N	c	-1.179	-1.262	0.997	0.354	0.615	0.372	0	-1.34	0.086	-0.410	0.072	0.765	0.311	0.000	0.063	0.004	0.083	3.557	0.074	.	.	.	0.5	124	401	chr1	152883550	chr1:152883550	A	T	124	PASS	AN=2;DP=401	GT	0/1
chr1	154294499	154294499	G	A	exonic	AQP10	.	nonsynonymous SNV	AQP10:NM_080429:exon2:c.G196A:p.V66I	0.015278293	0.878522243	0.106199464	.	0.1078	0.10375	0.104848986	61.49445624	4035.92542	12.59512	0.036	0.433	D	0.448	0.342	B	0.079	0.292	B	0.001	0.410	N	0.610	0.326	D	1.785	0.466	L	-1.99	0.853	D	-0.81	0.223	N	0.437	0.527	-0.377	0.728	T	0.341	0.707	T	.	.	.	4.244	0.569	23.9	0.995	0.660	0.928	0.563	D	c	-0.135	-0.123	1.000	0.747	0.447	0.083	0	4.34	0.511	4.316	0.587	0.958	0.565	1.000	0.715	0.512	0.273	12.764	0.566	Aquaporin-like	.	.	0.5	114	231	chr1	154294499	chr1:154294499	G	A	114	PASS	AN=2;DP=231	GT	0/1
chr1	155188270	155188270	C	A	ncRNA_exonic	GBAP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	261	chr1	155188270	chr1:155188270	C	A	90	PASS	AN=2;DP=261	GT	0/1
chr1	156499898	156499898	T	A	exonic	IQGAP3	.	nonsynonymous SNV	IQGAP3:NM_178229:exon34:c.A4403T:p.K1468M	6.47E-16	0.999970782	2.92E-05	.	0.22954	0.22033	-0.376786957	28.01958009	7742.20989	18.98627	0.0	0.912	D	0.998	0.715	D	0.924	0.642	D	0.000	0.629	D	1	0.810	D	2.585	0.758	M	0.84	0.475	T	-4.83	0.809	D	0.456	0.508	-0.689	0.610	T	0.194	0.548	T	0.067	0.701	D	6.587	0.906	31	0.995	0.665	0.996	0.975	D	c	0.668	0.621	1.000	0.747	0.707	0.730	0	4.5	0.542	7.661	0.826	0.946	0.533	1.000	0.715	0.898	0.379	12.787	0.567	RasGAP protein, C-terminal	.	.	0.5	100	426	chr1	156499898	chr1:156499898	T	A	100	PASS	AN=2;DP=426	GT	0/1
chr1	156928857	156928857	C	A	exonic	ARHGEF11	.	stopgain	ARHGEF11:NM_014784:exon15:c.G1240T:p.E414X,ARHGEF11:NM_198236:exon16:c.G1360T:p.E454X	0.999945339	5.47E-05	5.06E-18	.	0.31017	0.15072	-1.714337031	2.500589762	1596.56628	7.39387	.	.	.	.	.	.	.	.	.	0.000	0.559	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.294	0.990	41	0.997	0.778	0.974	0.742	D	c	0.976	0.810	1.000	0.747	0.732	0.924	0	4.6	0.564	5.778	0.684	0.807	0.329	1.000	0.715	0.999	0.750	15.344	0.739	RGS domain|Regulator of G protein signalling-like domain	.	.	0.5	84	454	chr1	156928857	chr1:156928857	C	A	84	PASS	AN=2;DP=454	GT	0/1
chr1	159799641	159799641	G	C	intronic	SLAMF8	.	.	.	1.71E-06	0.422014191	0.577984104	.	0.14799	0.10599	-0.001743238	53.85114414	631.46276	5.06279	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	330	chr1	159799641	chr1:159799641	G	C	89	PASS	AN=2;DP=330	GT	0/1
chr1	161192208	161192208	G	T	exonic	APOA2	.	nonsynonymous SNV	APOA2:NM_001643:exon4:c.C290A:p.P97H	0.009437055	0.591169946	0.399392999	.	0.65547	0.43086	-0.031067188	51.03798066	1.71247	0.0561	0.005	0.632	D	0.996	0.670	D	0.923	0.641	D	0.484	0.121	N	1	0.090	N	1.625	0.417	L	.	.	.	-6.27	0.906	D	0.257	0.313	-0.892	0.488	T	0.150	0.478	T	0.008	0.221	T	3.540	0.483	23.1	0.991	0.510	0.204	0.208	N	c	0.006	-0.148	1.000	0.517	0.428	0.059	0	4.01	0.457	2.175	0.419	1.048	0.713	0.021	0.196	0.016	0.126	10.667	0.447	.	.	.	0.5	91	129	chr1	161192208	chr1:161192208	G	T	91	PASS	AN=2;DP=129	GT	0/1
chr1	161645009	161645009	C	G	intronic	FCGR2B	.	.	.	0.047402608	0.855728325	0.096869067	DISEASE: Systemic lupus erythematosus (SLE) [MIM:152700]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. {ECO:0000269|PubMed:12115230, ECO:0000269|PubMed:20385827}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	.	0.12522	0.060756528	58.52795471	1693.68129	7.5857	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	509	chr1	161645009	chr1:161645009	C	G	132	PASS	AN=2;DP=509	GT	0/1
chr1	167190252	167190252	C	-	intronic	POU2F1	.	.	.	0.913950638	0.086048322	1.04E-06	.	0.97789	0.41629	-0.334253673	30.70299599	100.87731	2.1746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	579	chr1	167190251	chr1:167190251	GC	G	92	PASS	AN=2;DP=579	GT	0/1
chr1	169764271	169764271	A	G	exonic	C1orf112	.	nonsynonymous SNV	C1orf112:NM_001320050:exon1:c.A28G:p.S10G	5.98E-08	0.992096257	0.007903683	.	0.45663	.	-0.196519234	39.20736023	683.3862	5.22243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	598	chr1	169764271	chr1:169764271	A	G	134	PASS	AN=2;DP=598	GT	0/1
chr1	171763621	171763621	G	T	exonic	METTL13	.	synonymous SNV	METTL13:NM_001007239:exon7:c.G1311T:p.V437V,METTL13:NM_014955:exon7:c.G1521T:p.V507V,METTL13:NM_015935:exon7:c.G1779T:p.V593V	0.00133198	0.99703939	0.00162863	.	0.24943	0.10191	-0.663133267	15.94715735	3322.76582	11.02115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	75	chr1	171763621	chr1:171763621	G	T	67	PASS	AN=2;DP=75	GT	0/1
chr1	175087853	175087853	G	T	exonic	TNN	.	nonsynonymous SNV	TNN:NM_022093:exon11:c.G2543T:p.S848I	5.19E-15	0.506715096	0.493284904	.	0.17043	.	1.51017302	95.42934654	5625.2664	15.52544	0.039	0.424	D	0.006	0.126	B	0.082	0.276	B	0.050	0.231	N	0.983	0.249	N	2.22	0.631	M	0.37	0.577	T	-2.3	0.511	N	0.25	0.305	-0.836	0.529	T	0.151	0.479	T	0.022	0.452	T	1.409	0.232	12.83	0.985	0.420	0.179	0.198	N	c	-0.755	-0.794	0.997	0.351	0.595	0.332	0	-3.23	0.048	-0.007	0.126	0.908	0.420	0.004	0.165	0.750	0.322	16.174	0.816	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	.	207	chr1	175087853	chr1:175087853	G	T	.	PASS	AN=0;DP=207	GT	0/1
chr1	186089252	186089252	G	T	exonic	HMCN1	.	nonsynonymous SNV	HMCN1:NM_031935:exon80:c.G12204T:p.L4068F	2.19E-18	1	6.42E-24	.	0.11657	0.21661	-3.689691478	0.247699929	8270.20936	19.62945	0.303	0.143	T	1.0	0.899	D	0.998	0.875	D	0.000	0.537	D	1.000	0.537	D	0.36	0.120	N	-0.23	0.667	T	-2.27	0.506	N	0.37	0.431	-0.669	0.619	T	0.238	0.606	T	0.032	0.542	D	4.125	0.553	23.8	0.998	0.882	0.937	0.586	D	c	0.287	0.289	0.001	0.082	0.638	0.428	0	2.97	0.333	2.643	0.460	0.089	0.194	1.000	0.715	0.993	0.574	5.862	0.179	Immunoglobulin I-set|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	52	259	chr1	186089252	chr1:186089252	G	T	52	PASS	AN=2;DP=259	GT	0/1
chr1	205719177	205719177	C	-	UTR5	NUCKS1	NM_022731:c.-76delG	.	.	0.979237658	0.020744772	1.76E-05	.	0.90068	0.13281	-0.119252484	44.53880632	4.59039	0.16497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	662	chr1	205719176	chr1:205719176	AC	A	123	PASS	AN=2;DP=662	GT	0/1
chr1	220964980	220964980	C	A	exonic	MARC1	.	synonymous SNV	MARC1:NM_022746:exon2:c.C423A:p.P141P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	235	chr1	220964980	chr1:220964980	C	A	67	PASS	AN=2;DP=235	GT	0/1
chr1	228335908	228335908	G	T	intronic	GUK1	.	.	.	0.00010002	0.573762218	0.426137762	.	0.61935	0.39826	-0.957024976	9.088228356	85.40721	1.97028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	575	chr1	228335908	chr1:228335908	G	T	85	PASS	AN=2;DP=575	GT	0/1
chr1	228399453	228399453	C	A	ncRNA_intronic	OBSCN-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	300	chr1	228399453	chr1:228399453	C	A	.	PASS	AN=0;DP=300	GT	0/1
chr1	233425136	233425136	C	A	intronic	PCNX2	.	.	.	.	.	.	.	0.09947	.	0.389303812	75.70181647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	299	chr1	233425136	chr1:233425136	C	A	.	PASS	AN=0;DP=299	GT	0/1
chr1	235491824	235491824	G	-	intronic	GGPS1	.	.	.	0.666629559	0.328220145	0.005150296	.	0.22133	0.17306	-0.317668748	31.45789101	27.92768	0.89682	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	714	chr1	235491823	chr1:235491823	CG	C	77	PASS	AN=2;DP=714	GT	0/1
chr1	237167423	237167423	-	A	UTR3	MT1HL1	NM_001276687:c.*63_*64insT	.	.	0.020062126	0.511088562	0.468849312	.	.	.	.	.	93.79969	2.08288	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	362	chr1	237167423	chr1:237167423	G	GA	80	PASS	AN=2;DP=362	GT	0/1
chr1	240775299	240775299	C	A	ncRNA_intronic	MIR1273E	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	225	chr1	240775299	chr1:240775299	C	A	.	PASS	AN=0;DP=225	GT	0/1
chr1	247267209	247267209	C	A	intronic	ZNF669	.	.	.	0.060499399	0.922901133	0.016599468	.	0.05547	.	0.97558591	90.37508846	1414.66175	7.02829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	279	chr1	247267209	chr1:247267209	C	A	.	PASS	AN=0;DP=279	GT	0/1
chr1	247597504	247597504	C	A	exonic	NLRP3	.	synonymous SNV	NLRP3:NM_001127462:exon4:c.C2256A:p.A752A,NLRP3:NM_183395:exon4:c.C2256A:p.A752A,NLRP3:NM_001243133:exon5:c.C2421A:p.A807A,NLRP3:NM_004895:exon5:c.C2427A:p.A809A,NLRP3:NM_001127461:exon6:c.C2427A:p.A809A,NLRP3:NM_001079821:exon7:c.C2427A:p.A809A	0.447262679	0.552726293	1.10E-05	DISEASE: Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100]: A rare autosomal dominant systemic inflammatory disease characterized by recurrent episodes of maculopapular rash associated with arthralgias, myalgias, fever and chills, swelling of the extremities, and conjunctivitis after generalized exposure to cold. Rarely, some patients may also develop late-onset renal amyloidosis. {ECO:0000269|PubMed:11687797, ECO:0000269|PubMed:11992256, ECO:0000269|PubMed:12355493, ECO:0000269|PubMed:12522564, ECO:0000269|PubMed:15593220, ECO:0000269|PubMed:17284928, ECO:0000269|PubMed:24952504}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muckle-Wells syndrome (MWS) [MIM:191900]: A hereditary periodic fever syndrome characterized by fever, chronic recurrent urticaria, arthralgias, progressive sensorineural deafness, and reactive renal amyloidosis. The disease may be severe if generalized reactive amyloidosis occurs. {ECO:0000269|PubMed:11687797, ECO:0000269|PubMed:11992256, ECO:0000269|PubMed:12355493, ECO:0000269|PubMed:15593220, ECO:0000269|PubMed:24952504}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]: Rare congenital inflammatory disorder characterized by a triad of neonatal onset of cutaneous symptoms, chronic meningitis, and joint manifestations with recurrent fever and inflammation. {ECO:0000269|PubMed:12032915, ECO:0000269|PubMed:12483741, ECO:0000269|PubMed:14630794, ECO:0000269|PubMed:15231984, ECO:0000269|PubMed:15334500, ECO:0000269|PubMed:15593220, ECO:0000269|PubMed:24952504}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.41725	0.10512	-0.946125119	9.377211607	78.62534	1.87076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	137	chr1	247597504	chr1:247597504	C	A	.	PASS	AN=0;DP=137	GT	0/1
chr1	248247188	248247188	G	C	intronic	OR2L13	.	.	.	0.014419191	0.679992608	0.305588201	.	0.12185	0.08854	0.595326758	82.66100495	760.16705	5.46484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	208	chr1	248247188	chr1:248247188	G	C	.	PASS	AN=0;DP=208	GT	0/1
chr1	248308521	248308521	C	A	exonic	OR2M5	.	nonsynonymous SNV	OR2M5:NM_001004690:exon1:c.C72A:p.H24Q	0.001566155	0.450104621	0.548329224	.	0.07654	.	2.33165376	98.38405284	958.84659	5.99448	0.1	0.305	T	0.312	0.311	B	0.089	0.282	B	0.005	0.332	U	1	0.090	N	0.165	0.090	N	8.12	0.003	T	-4.96	0.819	D	0.128	0.146	-1.067	0.100	T	0.000	0.001	T	0.002	0.034	T	1.149	0.205	11.48	0.946	0.245	0.001	0.008	N	c	-0.698	-0.627	0.000	0.012	0.487	0.133	0	2.2	0.268	-0.584	0.058	-0.452	0.056	0.000	0.063	0.001	0.043	5.358	0.153	.	.	.	0.5	90	307	chr1	248308521	chr1:248308521	C	A	90	PASS	AN=2;DP=307	GT	0/1
chr2	1983507	1983507	T	C	exonic	MYT1L	.	nonsynonymous SNV	MYT1L:NM_001303052:exon6:c.A43G:p.K15E,MYT1L:NM_001329845:exon6:c.A43G:p.K15E,MYT1L:NM_001329846:exon6:c.A43G:p.K15E,MYT1L:NM_001329847:exon6:c.A43G:p.K15E,MYT1L:NM_001329848:exon6:c.A43G:p.K15E,MYT1L:NM_001329849:exon6:c.A43G:p.K15E,MYT1L:NM_001329851:exon6:c.A43G:p.K15E,MYT1L:NM_001329852:exon6:c.A43G:p.K15E,MYT1L:NM_015025:exon6:c.A43G:p.K15E,MYT1L:NM_001329844:exon7:c.A43G:p.K15E	0.999963989	3.60E-05	6.51E-13	.	0.30683	0.11638	-1.506435464	3.544468035	525.36937	4.67655	0.003	0.682	D	0.956	0.559	P	0.899	0.676	P	0.000	0.843	D	1.000	0.537	D	2.625	0.771	M	0.02	0.623	T	-2.59	0.558	D	0.792	0.782	-0.299	0.750	T	0.360	0.722	T	0.029	0.519	D	4.511	0.604	24.3	0.996	0.723	0.965	0.695	D	c	0.634	0.634	1.000	0.517	0.487	0.133	0	5.1	0.688	6.281	0.725	0.913	0.425	1.000	0.715	1.000	0.888	15.192	0.726	.	.	.	0.5	.	227	chr2	1983507	chr2:1983507	T	C	.	PASS	AN=0;DP=227	GT	0/1
chr2	3488595	3488595	G	C	intergenic	TRAPPC12;ADI1	dist=5253;dist=13095	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	431	chr2	3488595	chr2:3488595	G	C	86	PASS	AN=2;DP=431	GT	0/1
chr2	12164729	12164729	A	T	ncRNA_intronic	MIR3681HG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	326	chr2	12164729	chr2:12164729	A	T	74	PASS	AN=2;DP=326	GT	0/1
chr2	25497908	25497908	G	A	exonic	DNMT3A	.	nonsynonymous SNV	DNMT3A:NM_022552:exon6:c.C541T:p.R181C,DNMT3A:NM_175629:exon6:c.C541T:p.R181C	7.73E-45	8.72E-11	1	DISEASE: Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]: An overgrowth syndrome characterized by a distinctive facial appearance, tall stature and intellectual disability. Facial gestalt is characterized by a round face, heavy horizontal eyebrows and narrow palpebral fissures. Less common features include atrial septal defects, seizures, umbilical hernia, and scoliosis. {ECO:0000269|PubMed:24614070}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.88689	0.41514	-1.131590109	6.481481481	41.83604	1.21826	0.0	0.912	D	1.0	0.899	D	0.973	0.713	D	0.000	0.629	D	1	0.810	D	0.55	0.145	N	-4.25	0.971	D	-3.97	0.736	D	0.825	0.813	1.034	0.978	D	0.895	0.965	D	0.572	0.961	D	6.239	0.861	28.8	0.999	0.967	0.941	0.599	D	c	0.685	0.719	1.000	0.747	0.722	0.854	0	5.24	0.728	9.119	0.936	0.948	0.535	1.000	0.715	1.000	0.888	16.329	0.828	.	.	.	0.5	120	815	chr2	25497908	chr2:25497908	G	A	120	PASS	AN=2;DP=815	GT	0/1
chr2	25551452	25551452	C	-	intronic	DNMT3A	.	.	.	7.73E-45	8.72E-11	1	DISEASE: Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]: An overgrowth syndrome characterized by a distinctive facial appearance, tall stature and intellectual disability. Facial gestalt is characterized by a round face, heavy horizontal eyebrows and narrow palpebral fissures. Less common features include atrial septal defects, seizures, umbilical hernia, and scoliosis. {ECO:0000269|PubMed:24614070}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.88689	0.41514	-1.131590109	6.481481481	41.83604	1.21826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	519	chr2	25551451	chr2:25551451	TC	T	68	PASS	AN=2;DP=519	GT	0/1
chr2	31416096	31416096	G	T	exonic	CAPN14	.	nonsynonymous SNV	CAPN14:NM_001145122:exon10:c.C1015A:p.L339M,CAPN14:NM_001321270:exon10:c.C487A:p.L163M	.	.	.	.	.	.	2.664347924	98.844067	6196.21935	16.44921	0.04	0.421	D	0.993	0.899	D	0.911	0.850	D	0.002	0.368	U	0.694	0.333	D	2.565	0.752	M	-4.48	0.976	D	-0.46	0.150	N	0.226	0.277	1.224	1.000	D	0.941	0.981	D	0.089	0.753	D	3.646	0.495	23.2	0.996	0.710	0.854	0.442	D	c	0.508	0.406	1.000	0.747	0.487	0.133	0	4.53	0.548	2.674	0.463	1.048	0.713	1.000	0.715	0.586	0.286	17.283	0.870	Peptidase C2, calpain, catalytic domain	.	.	0.5	94	260	chr2	31416096	chr2:31416096	G	T	94	PASS	AN=2;DP=260	GT	0/1
chr2	44001334	44001334	T	A	intronic	DYNC2LI1	.	.	.	8.38E-05	0.927454684	0.072461519	.	0.0538	0.0823	1.596607091	95.87166785	1692.77547	7.58315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	541	chr2	44001334	chr2:44001334	T	A	121	PASS	AN=2;DP=541	GT	0/1
chr2	48982646	48982646	T	A	intronic	LHCGR;STON1-GTF2A1L	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	160	chr2	48982646	chr2:48982646	T	A	.	PASS	AN=0;DP=160	GT	0/1
chr2	54895926	54895926	T	-	UTR3	SPTBN1	NM_003128:c.*220delT	.	.	1	5.26E-11	1.63E-28	.	0.27109	0.3714	-3.862151662	0.22410946	285.65309	3.61906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	341	chr2	54895925	chr2:54895925	AT	A	87	PASS	AN=2;DP=341	GT	0/1
chr2	61765418	61765418	G	A	UTR5	XPO1	NM_003400:c.-4386C>T	.	.	0.999999567	4.33E-07	6.76E-17	.	0.99668	0.30319	-0.846787714	11.05803255	10.80842	0.392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	1363	chr2	61765418	chr2:61765418	G	A	106	PASS	AN=2;DP=1363	GT	0/1
chr2	63849547	63849547	G	A	intergenic	MDH1;UGP2	dist=15217;dist=218551	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	304	chr2	63849547	chr2:63849547	G	A	94	PASS	AN=2;DP=304	GT	0/1
chr2	69049478	69049478	G	T	exonic	ARHGAP25	.	nonsynonymous SNV	ARHGAP25:NM_001166276:exon9:c.G1186T:p.D396Y,ARHGAP25:NM_001166277:exon9:c.G1087T:p.D363Y,ARHGAP25:NM_014882:exon9:c.G1183T:p.D395Y,ARHGAP25:NM_001007231:exon10:c.G1207T:p.D403Y	0.438207321	0.561734301	5.84E-05	.	0.82588	0.12015	0.75875178	86.82472281	1845.81859	7.92463	0.031	0.450	D	0.691	0.474	P	0.131	0.511	B	0.355	0.138	N	0.997	0.253	N	2.3	0.659	M	2.73	0.196	T	-2.28	0.524	N	0.395	0.454	-1.105	0.035	T	0.047	0.201	T	0.017	0.382	T	5.039	0.678	25.2	0.987	0.445	0.652	0.324	D	c	-0.329	-0.349	0.941	0.274	0.549	0.223	0	3.56	0.397	0.735	0.256	-0.097	0.117	0.481	0.266	0.011	0.114	5.887	0.180	Rho GTPase-activating protein domain	.	.	0.5	61	240	chr2	69049478	chr2:69049478	G	T	61	PASS	AN=2;DP=240	GT	0/1
chr2	71869711	71869711	C	T	intronic	DYSF	.	.	.	1.00E-15	0.999999362	6.38E-07	DISEASE: Limb-girdle muscular dystrophy 2B (LGMD2B) [MIM:253601]: An autosomal recessive degenerative myopathy characterized by weakness and atrophy starting in the proximal pelvifemoral muscles, with onset in the late teens or later, massive elevation of serum creatine kinase levels and slow progression. Scapular muscle involvement is minor and not present at onset. Upper limb girdle involvement follows some years after the onset in lower limbs. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:14678801, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:16705711, ECO:0000269|PubMed:16996541, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]: A late- onset muscular dystrophy involving the distal lower limb musculature. It is characterized by weakness that initially affects the gastrocnemius muscle during early adulthood. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:11468312, ECO:0000269|PubMed:12796534, ECO:0000269|PubMed:15116377, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:15477515, ECO:0000269|PubMed:15515206, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526, ECO:0000269|Ref.26}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Distal myopathy with anterior tibial onset (DMAT) [MIM:606768]: Onset of the disorder is between 14 and 28 years of age and the anterior tibial muscles are the first muscle group to be involved. Inheritance is autosomal recessive. {ECO:0000269|PubMed:11198284}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18661	0.30664	-1.309065031	4.853739089	1760.18248	7.74393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	291	chr2	71869711	chr2:71869711	C	T	104	PASS	AN=2;DP=291	GT	0/1
chr2	74668346	74668346	T	A	intronic	RTKN	.	.	.	0.000149538	0.992324331	0.007526131	.	0.1644	0.10277	-0.841329384	11.36470866	111.05692	2.29721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	623	chr2	74668346	chr2:74668346	T	A	105	PASS	AN=2;DP=623	GT	0/1
chr2	74687542	74687542	-	C	exonic	WBP1	.	frameshift insertion	WBP1:NM_012477:exon4:c.545dupC:p.H185Sfs*4	0.000303097	0.803000262	0.196696641	.	.	0.10512	-0.26993514	34.59542345	86.33658	1.98463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	643	chr2	74687542	chr2:74687542	G	GC	90	PASS	AN=2;DP=643	GT	0/1
chr2	89278092	89278092	G	C	intergenic	MIR4436A;NONE	dist=166124;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	243	chr2	89278092	chr2:89278092	G	C	.	PASS	AN=0;DP=243	GT	0/1
chr2	90077766	90077766	C	G	intergenic	MIR4436A;LOC654342	dist=965798;dist=1746943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	284	chr2	90077766	chr2:90077766	C	G	.	PASS	AN=0;DP=284	GT	0/1
chr2	90211702	90211702	C	A	intergenic	MIR4436A;LOC654342	dist=1099734;dist=1613007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	607	chr2	90211702	chr2:90211702	C	A	90	PASS	AN=2;DP=607	GT	0/1
chr2	91800687	91800687	C	A	intergenic	NONE;LOC654342	dist=NONE;dist=24022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	1383	chr2	91800687	chr2:91800687	C	A	94	PASS	AN=2;DP=1383	GT	0/1
chr2	96604548	96604548	T	C	intronic	ANKRD36C	.	.	.	.	.	.	.	.	.	.	.	2676.37542	9.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	362	chr2	96604548	chr2:96604548	T	C	112	PASS	AN=2;DP=362	GT	0/1
chr2	96697823	96697823	G	A	exonic	GPAT2	.	synonymous SNV	GPAT2:NM_001321525:exon3:c.C135T:p.P45P,GPAT2:NM_001321526:exon3:c.C135T:p.P45P,GPAT2:NM_001321527:exon3:c.C135T:p.P45P,GPAT2:NM_001321528:exon3:c.C135T:p.P45P,GPAT2:NM_001321529:exon3:c.C135T:p.P45P,GPAT2:NM_001321530:exon3:c.C135T:p.P45P,GPAT2:NM_207328:exon3:c.C135T:p.P45P,GPAT2:NM_001321531:exon4:c.C135T:p.P45P	0.0016123	0.992339401	0.006048299	.	.	.	.	.	151.08322	2.68731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	172	770	chr2	96697823	chr2:96697823	G	A	172	PASS	AN=2;DP=770	GT	0/1
chr2	96780622	96780622	A	C	exonic	ADRA2B	.	nonsynonymous SNV	ADRA2B:NM_000682:exon2:c.T1267G:p.Y423D	0.000244369	0.526369151	0.473386481	DISEASE: Epilepsy, familial adult myoclonic, 2 (FAME2) [MIM:607876]: A form of cortical myoclonic tremor with epilepsy, a syndrome characterized by cortical myoclonus and variable occurrence of epileptic seizures. Usually, myoclonic tremor is the presenting symptom, characterized by tremulous finger movements and myoclonic jerks of the limbs increased by action and posture. In a minority of patients, seizures are the presenting symptom; both complex partial as well as generalized tonic clonic seizures are described. Some patients exhibit mild cognitive impairment. {ECO:0000269|PubMed:24114805}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.11107	-0.247889024	35.98726115	62.69652	1.61925	.	.	.	1.0	0.899	D	1.0	0.971	D	.	.	.	1.000	0.588	D	4.665	0.994	H	.	.	.	.	.	.	0.946	0.941	1.005	0.973	D	0.929	0.977	D	0.294	0.907	D	4.995	0.672	25.1	0.993	0.586	0.989	0.881	D	c	0.963	0.847	1.000	0.747	0.610	0.352	0	4.58	0.559	9.254	0.947	1.073	0.849	1.000	0.715	0.997	0.653	10.424	0.434	GPCR, rhodopsin-like, 7TM	.	.	0.5	.	278	chr2	96780622	chr2:96780622	A	C	.	PASS	AN=0;DP=278	GT	0/1
chr2	109356988	109356988	G	C	exonic	RANBP2	.	nonsynonymous SNV	RANBP2:NM_006267:exon7:c.G826C:p.D276H	0.999999999	1.49E-09	4.67E-27	DISEASE: Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]: A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem. {ECO:0000269|PubMed:19118815}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by themselves are insufficient to make the phenotype fully penetrant; additional genetic and environmental factors are required (PubMed:19118815). {ECO:0000269|PubMed:19118815}.; 	0.93164	0.52169	-1.538551197	3.33215381	1024.97017	6.15454	0.004	0.654	D	0.996	0.670	D	0.831	0.578	P	.	.	.	0.951	0.377	D	2.645	0.776	M	1.53	0.304	T	-3.05	0.629	D	0.485	0.623	-0.912	0.466	T	0.126	0.432	T	0.016	0.378	T	3.831	0.517	23.4	0.994	0.618	0.996	0.976	D	c	0.721	0.716	0.972	0.293	0.707	0.730	0	4.79	0.608	9.401	0.966	1.038	0.658	1.000	0.715	1.000	0.888	11.696	0.506	Tetratricopeptide-like helical domain	.	.	0.5	115	367	chr2	109356988	chr2:109356988	G	C	115	PASS	AN=2;DP=367	GT	0/1
chr2	109960809	109960809	G	T	intronic	SH3RF3	.	.	.	0.981100872	0.018885189	1.39E-05	.	.	.	.	.	1390.76659	6.97706	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.231	0.074	0.945	0.713	0.093	0.095	0.150	N	n	-0.099	-0.182	1.000	0.473	0.054	0.004	0	0.474	0.159	1.163	0.312	0.635	0.291	0.004	0.165	0.015	0.124	5.12	0.141	.	.	.	0.5	81	288	chr2	109960809	chr2:109960809	G	T	81	PASS	AN=2;DP=288	GT	0/1
chr2	112615888	112615888	C	G	exonic	ANAPC1	.	nonsynonymous SNV	ANAPC1:NM_022662:exon11:c.G1353C:p.Q451H	.	.	.	.	0.55585	0.09577	.	.	199.72138	3.0527	0.125	0.273	T	0.006	0.126	B	0.005	0.104	B	0.147	0.181	N	0.993	0.418	D	1.71	0.444	L	.	.	.	-0.9	0.242	N	0.431	0.487	-0.992	0.320	T	0.136	0.452	T	.	.	.	1.479	0.240	13.20	0.969	0.310	0.888	0.487	D	c	-0.624	-0.489	0.002	0.094	0.732	0.924	0	3.2	0.357	1.258	0.323	-0.467	0.054	1.000	0.715	0.973	0.468	7.272	0.253	.	.	.	0.5	127	149	chr2	112615888	chr2:112615888	C	G	127	PASS	AN=2;DP=149	GT	0/1
chr2	113819674	113819674	G	A	intronic	IL36RN	.	.	.	0.00097234	0.584074519	0.414953141	DISEASE: Psoriasis 14, pustular (PSORS14) [MIM:614204]: A life- threatening disease defined by repeated flares of sudden onset consisting of diffuse erythematous skin eruption characterized by rapid coverage with pustules, high-grade fever, asthenia, marked leukocytosis, and elevated serum levels of C-reactive protein. {ECO:0000269|PubMed:21839423, ECO:0000269|PubMed:21848462, ECO:0000269|PubMed:22903787}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15223	0.12775	0.038710339	56.92380278	158.88685	2.75336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	157	chr2	113819674	chr2:113819674	G	A	.	PASS	AN=0;DP=157	GT	0/1
chr2	114257573	114257573	G	T	exonic	FOXD4L1	.	nonsynonymous SNV	FOXD4L1:NM_012184:exon1:c.G740T:p.G247V	.	.	.	.	0.05795	0.07954	1.616843854	95.96013211	3262.81752	10.89654	0.14	0.256	T	1.0	0.899	D	0.994	0.807	D	.	.	.	1	0.090	N	1.545	0.392	L	-3.44	0.944	D	-1.06	0.277	N	0.155	0.185	0.049	0.832	D	0.782	0.926	D	0.038	0.580	D	1.777	0.274	14.85	0.986	0.434	0.120	0.168	N	c	-0.540	-0.763	0.000	0.012	0.598	0.340	0	1.37	0.211	-0.873	0.043	-0.397	0.063	0.000	0.063	0.001	0.043	6.523	0.213	.	.	.	0.5	110	645	chr2	114257573	chr2:114257573	G	T	110	PASS	AN=2;DP=645	GT	0/1
chr2	114415749	114415749	T	A	intergenic	RABL2A;SLC35F5	dist=14774;dist=48549	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	111	chr2	114415749	chr2:114415749	T	A	82	PASS	AN=2;DP=111	GT	0/1
chr2	130832913	130832913	T	G	exonic	POTEF	.	nonsynonymous SNV	POTEF:NM_001099771:exon17:c.A2132C:p.D711A	.	.	.	.	.	.	.	.	1056.59425	6.24058	0.004	0.654	D	0.872	0.459	P	0.895	0.617	P	.	.	.	1	0.810	D	5.575	1.000	H	-4.87	0.983	D	-5.38	0.849	D	0.525	0.568	0.996	0.971	D	0.973	0.991	D	0.012	0.312	T	3.626	0.493	23.2	0.986	0.426	0.401	0.261	N	c	0.095	-0.271	0.000	0.050	0.554	0.246	0	.	.	3.012	0.490	-0.960	0.024	1.000	0.715	0.014	0.122	4.549	0.114	.	.	.	0.5	138	1364	chr2	130832913	chr2:130832913	T	G	138	PASS	AN=2;DP=1364	GT	0/1
chr2	131377636	131377636	C	T	exonic	POTEJ	.	synonymous SNV	POTEJ:NM_001277083:exon4:c.C718T:p.L240L	.	.	.	.	.	.	.	.	1579.22659	7.35384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	209	chr2	131377636	chr2:131377636	C	T	117	PASS	AN=2;DP=209	GT	0/1
chr2	132200282	132200282	C	G	ncRNA_exonic	NOC2LP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	300	chr2	132200282	chr2:132200282	C	G	120	PASS	AN=2;DP=300	GT	0/1
chr2	132366964	132366964	T	C	ncRNA_exonic	POTEKP	.	.	.	.	.	.	.	.	0.43916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	217	chr2	132366964	chr2:132366964	T	C	126	PASS	AN=2;DP=217	GT	0/1
chr2	175199798	175199798	C	T	upstream	SP9	dist=23	.	.	0.498147938	0.428018312	0.07383375	.	.	.	.	.	26.65009	0.86255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	971	chr2	175199798	chr2:175199798	C	T	85	PASS	AN=2;DP=971	GT	0/1
chr2	175200556	175200556	G	T	intronic	SP9	.	.	.	0.498147938	0.428018312	0.07383375	.	.	.	.	.	26.65009	0.86255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	431	chr2	175200556	chr2:175200556	G	T	107	PASS	AN=2;DP=431	GT	0/1
chr2	176973700	176973700	C	A	exonic	HOXD11	.	nonsynonymous SNV	HOXD11:NM_021192:exon2:c.C847A:p.R283S	0.013189848	0.661759099	0.325051053	.	0.23968	.	.	.	52.05051	1.42475	0.0	0.912	D	0.979	0.571	D	0.981	0.736	D	0.003	0.349	U	1	0.810	D	0.925	0.236	L	-3.95	0.962	D	-4.99	0.822	D	0.835	0.822	0.988	0.970	D	0.898	0.966	D	0.161	0.842	D	7.025	0.938	33	0.998	0.852	0.926	0.559	D	c	0.634	0.642	1.000	0.747	0.598	0.340	0	5.42	0.786	3.912	0.559	0.911	0.421	1.000	0.715	1.000	0.888	14.107	0.645	Homeobox domain|Homeodomain-like	.	.	0.5	115	268	chr2	176973700	chr2:176973700	C	A	115	PASS	AN=2;DP=268	GT	0/1
chr2	178081499	178081499	G	T	exonic	HNRNPA3	.	stopgain	HNRNPA3:NM_001330247:exon6:c.G673T:p.G225X,HNRNPA3:NM_001330248:exon6:c.G673T:p.G225X,HNRNPA3:NM_001330249:exon6:c.G739T:p.G247X,HNRNPA3:NM_001330250:exon6:c.G739T:p.G247X,HNRNPA3:NM_001330251:exon6:c.G739T:p.G247X,HNRNPA3:NM_194247:exon6:c.G739T:p.G247X	0.99264494	0.007353682	1.38E-06	.	0.36128	0.0925	-0.273576253	33.97027601	10.21749	0.3726	.	.	.	.	.	.	.	.	.	0.000	0.439	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.756	0.977	38	0.987	0.447	0.924	0.553	D	c	0.695	0.507	1.000	0.747	0.722	0.854	0	3.54	0.395	6.591	0.738	0.067	0.174	1.000	0.715	0.996	0.625	12.837	0.570	Nucleotide-binding alpha-beta plait domain	.	.	0.5	74	97	chr2	178081499	chr2:178081499	G	T	74	PASS	AN=2;DP=97	GT	0/1
chr2	202483804	202483804	C	A	exonic	C2CD6	.	nonsynonymous SNV	C2CD6:NM_001168216:exon1:c.G50T:p.R17L,C2CD6:NM_001168217:exon1:c.G50T:p.R17L,C2CD6:NM_001168221:exon1:c.G50T:p.R17L,C2CD6:NM_152525:exon1:c.G50T:p.R17L	.	.	.	.	.	.	.	.	.	.	0.019	0.518	D	0.892	0.518	P	0.253	0.418	B	0.765	0.066	N	1	0.090	N	0.695	0.181	N	0.16	0.609	T	-2.19	0.545	N	0.233	0.386	-0.916	0.461	T	0.129	0.439	T	0.028	0.508	D	3.667	0.498	23.2	0.942	0.238	0.068	0.127	N	c	-0.961	-1.208	1.000	0.467	0.422	0.057	0	-4.53	0.032	-0.948	0.040	0.069	0.176	0.000	0.063	0.001	0.043	5.306	0.150	.	.	.	0.5	113	492	chr2	202483804	chr2:202483804	C	A	113	PASS	AN=2;DP=492	GT	0/1
chr2	209028006	209028006	C	A	exonic	CRYGA	.	synonymous SNV	CRYGA:NM_014617:exon2:c.G174T:p.L58L	0.000127117	0.626172346	0.373700537	.	0.16773	0.13686	0.016664174	55.21939137	30.09915	0.96006	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	326	chr2	209028006	chr2:209028006	C	A	96	PASS	AN=2;DP=326	GT	0/1
chr2	210737613	210737613	G	T	exonic	UNC80	.	synonymous SNV	UNC80:NM_032504:exon23:c.G3765T:p.R1255R,UNC80:NM_182587:exon23:c.G3750T:p.R1250R	0.139839111	0.85601101	0.00414988	.	0.61288	.	0.992010122	90.49893843	987.20517	6.05851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	340	chr2	210737613	chr2:210737613	G	T	68	PASS	AN=2;DP=340	GT	0/1
chr2	213878595	213878595	G	A	exonic	IKZF2	.	nonsynonymous SNV	IKZF2:NM_016260:exon7:c.C776T:p.P259L,IKZF2:NM_001079526:exon8:c.C698T:p.P233L	0.922956764	0.077024112	1.91E-05	.	0.91208	0.17129	0.020302773	55.60863411	105.57661	2.22656	0.011	0.599	D	0.039	0.384	B	0.051	0.310	B	0.000	0.843	D	1.000	0.810	D	1.7	0.440	L	3.14	0.079	T	-2.77	0.587	D	0.767	0.767	-1.131	0.017	T	0.033	0.140	T	0.019	0.416	T	5.945	0.816	27.6	0.996	0.728	0.979	0.777	D	c	0.267	0.431	1.000	0.747	0.628	0.401	0	5.54	0.828	6.278	0.724	1.048	0.713	1.000	0.715	1.000	0.888	15.345	0.739	.	.	.	0.5	76	212	chr2	213878595	chr2:213878595	G	A	76	PASS	AN=2;DP=212	GT	0/1
chr2	219754817	219754817	G	T	exonic	WNT10A	.	nonsynonymous SNV	WNT10A:NM_025216:exon3:c.G488T:p.R163L	0.010169289	0.943911812	0.045918899	DISEASE: Note=Defects in WNT10A may be a cause of hypohidrotic/anhidrotic ectodermal dysplasia, a disorder characterized by sparse hair (atrichosis or hypotrichosis), abnormal or missing teeth and the inability to sweat due to the absence of sweat glands. Most patients carrying WNT10A mutations present with sweating anomalies. However, comparison with cases harboring mutations in the ectodysplasin pathway identifies some phenotypic differences. Dermatological features (anomalies of hair and sweat glands) are less severe in patients carrying WNT10A mutations and facial dysmorphism can be absent. The dental phenotype consists in microdontia, whereas teeth agenesis is more frequent in patients carrying mutations in the ectodysplasin pathway. {ECO:0000269|PubMed:20979233}.; DISEASE: Odonto-onycho-dermal dysplasia (OODD) [MIM:257980]: A rare autosomal recessive ectodermal dysplasia characterized by dry hair, severe hypodontia, smooth tongue with marked reduction of fungiform and filiform papillae, onychodysplasia, keratoderma and hyperhidrosis of palms and soles, and hyperkeratosis of the skin. {ECO:0000269|PubMed:17847007, ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Schopf-Schulz-Passarge syndrome (SSPS) [MIM:224750]: A rare ectodermal dysplasia, characterized chiefly by cysts of the eyelid margins, palmoplantar keratoderma, hypodontia, hypotrichosis and nail dystrophy. Multiple eyelid apocrine hidrocystomas are the hallmark of this condition, although they usually appear in adulthood. The concomitant presence of eccrine syringofibroadenoma in most patients and of other adnexal skin tumors in some affected subjects indicates that Schopf-Schulz- Passarge syndrome is a genodermatosis with skin appendage neoplasms. {ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tooth agenesis selective 4 (STHAG4) [MIM:150400]: A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). In STHAG4, the upper lateral incisors are absent or peg-shaped. {ECO:0000269|PubMed:21484994, ECO:0000269|PubMed:22581971}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24339	0.20297	.	.	263.26685	3.48077	0.155	0.241	T	0.011	0.147	B	0.03	0.205	B	0.000	0.629	D	1	0.810	D	1.655	0.426	L	-1.02	0.763	T	-2.05	0.470	N	0.491	0.538	-0.455	0.702	T	0.364	0.725	T	0.097	0.767	D	4.530	0.607	24.3	0.993	0.588	0.974	0.742	D	c	-0.012	0.096	1.000	0.747	0.707	0.730	0	4.46	0.534	6.505	0.734	0.953	0.551	1.000	0.715	0.221	0.222	16.205	0.819	.	.	.	0.5	104	566	chr2	219754817	chr2:219754817	G	T	104	PASS	AN=2;DP=566	GT	0/1
chr2	223163291	223163291	C	T	exonic	PAX3	.	nonsynonymous SNV	PAX3:NM_000438:exon1:c.G44A:p.G15D,PAX3:NM_001127366:exon1:c.G44A:p.G15D,PAX3:NM_013942:exon1:c.G44A:p.G15D,PAX3:NM_181457:exon1:c.G44A:p.G15D,PAX3:NM_181458:exon1:c.G44A:p.G15D,PAX3:NM_181459:exon1:c.G44A:p.G15D,PAX3:NM_181460:exon1:c.G44A:p.G15D,PAX3:NM_181461:exon1:c.G44A:p.G15D	0.900856133	0.099136457	7.41E-06	DISEASE: Waardenburg syndrome 1 (WS1) [MIM:193500]: WS1 is an autosomal dominant disorder characterized by non-progressive sensorineural deafness, pigmentary disturbances such as frontal white blaze of hair, heterochromia of irides, white eyelashes, leukoderma, and wide bridge of nose owing to lateral displacement of the inner canthus of each eye (dystopia canthorum). WS1 shows variable clinical expression and some affected individuals do not manifest hearing impairment or iris pigmentation disturbances. Dystopia canthorum is the most consistent sign and is found in 98% of the patients. {ECO:0000269|PubMed:10779847, ECO:0000269|PubMed:12949970, ECO:0000269|PubMed:1303193, ECO:0000269|PubMed:1347148, ECO:0000269|PubMed:1347149, ECO:0000269|PubMed:7825605, ECO:0000269|PubMed:7833953, ECO:0000269|PubMed:7981674, ECO:0000269|PubMed:8447316, ECO:0000269|PubMed:8490648, ECO:0000269|PubMed:8533800, ECO:0000269|PubMed:8589691, ECO:0000269|PubMed:8845842, ECO:0000269|PubMed:9067759, ECO:0000269|PubMed:9452070, ECO:0000269|PubMed:9541113, ECO:0000269|Ref.34}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Waardenburg syndrome 3 (WS3) [MIM:148820]: WS3 is an autosomal dominant disorder characterized by sensorineural deafness, pigmentary disturbances, dystopia canthorum and limb anomalies such as hypoplasia of the musculoskeletal system, flexion contractures, fusion of the carpal bones, syndactylies. {ECO:0000269|PubMed:12949970, ECO:0000269|PubMed:7726174, ECO:0000269|Ref.35}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Craniofacial-deafness-hand syndrome (CDHS) [MIM:122880]: Thought to be an autosomal dominant disease which comprises absence or hypoplasia of the nasal bones, hypoplastic maxilla, small and short nose with thin nares, limited movement of the wrist, short palpebral fissures, ulnar deviation of the fingers, hypertelorism and profound sensory-neural deafness. {ECO:0000269|PubMed:8664898}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Rhabdomyosarcoma 2 (RMS2) [MIM:268220]: A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas. {ECO:0000269|PubMed:8275086}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving PAX3 is found in rhabdomyosarcoma. Translocation (2;13)(q35;q14) with FOXO1. The resulting protein is a transcriptional activator. {ECO:0000269|PubMed:8275086}.; DISEASE: Note=A chromosomal aberration involving PAX3 is a cause of rhabdomyosarcoma. Translocation t(2;2)(q35;p23) with NCOA1 generates the NCOA1-PAX3 oncogene consisting of the N-terminus part of PAX3 and the C-terminus part of NCOA1. The fusion protein acts as a transcriptional activator. Rhabdomyosarcoma is the most common soft tissue carcinoma in childhood, representing 5-8% of all malignancies in children. {ECO:0000269|PubMed:15313887}.; 	0.99336	0.67982	-0.001743238	53.85114414	209.24476	3.12323	0.002	0.721	D	0.136	0.363	B	0.025	0.415	B	0.015	0.283	N	0.840	0.810	N	0.345	0.112	N	-3.42	0.994	D	-1.37	0.364	N	0.338	0.420	0.980	0.969	D	0.917	0.973	D	0.668	0.972	D	3.940	0.530	23.5	0.993	0.575	0.936	0.583	D	c	-0.431	-0.278	1.000	0.747	0.437	0.062	0	3.15	0.351	1.196	0.316	0.768	0.311	0.297	0.251	0.998	0.697	11.550	0.498	.	.	.	0.5	124	594	chr2	223163291	chr2:223163291	C	T	124	PASS	AN=2;DP=594	GT	0/1
chr2	233246153	233246153	C	T	intronic	ALPP	.	.	.	1.69E-06	0.862682097	0.137316218	.	0.11261	0.13673	1.35769336	94.43854683	1957.1571	8.14348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	175	chr2	233246153	chr2:233246153	C	T	.	PASS	AN=0;DP=175	GT	0/1
chr2	235950107	235950107	G	A	exonic	SH3BP4	.	nonsynonymous SNV	SH3BP4:NM_014521:exon4:c.G694A:p.V232I	0.080964436	0.91686014	0.002175424	.	0.16796	0.10864	-0.72020276	14.27813163	283.16989	3.60324	0.209	0.197	T	0.0	0.026	B	0.0	0.013	B	0.018	0.276	N	1.000	0.090	N	0.145	0.088	N	2.92	0.099	T	0.02	0.068	N	0.046	0.026	-1.001	0.297	T	0.018	0.073	T	0.004	0.091	T	0.276	0.121	5.459	0.972	0.325	0.314	0.241	N	c	-0.606	-0.508	1.000	0.747	0.719	0.830	0	4.7	0.586	0.947	0.285	1.048	0.713	0.045	0.210	0.283	0.234	12.621	0.558	.	.	.	0.5	.	248	chr2	235950107	chr2:235950107	G	A	.	PASS	AN=0;DP=248	GT	0/1
chr2	235962622	235962622	G	C	UTR3	SH3BP4	NM_014521:c.*162G>C	.	.	0.080964436	0.91686014	0.002175424	.	0.16796	0.10864	-0.72020276	14.27813163	283.16989	3.60324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	510	chr2	235962622	chr2:235962622	G	C	96	PASS	AN=2;DP=510	GT	0/1
chr2	237074910	237074910	G	T	exonic	GBX2	.	nonsynonymous SNV	GBX2:NM_001485:exon2:c.C694A:p.P232T	0.567961293	0.420206259	0.011832449	.	0.79886	0.23775	-0.229483771	36.86010852	119.9659	2.38746	0.078	0.339	T	0.003	0.102	B	0.002	0.063	B	0.001	0.397	N	1.000	0.810	D	1.525	0.387	L	-3.77	0.956	D	-1.6	0.385	N	0.179	0.227	0.087	0.839	D	0.670	0.886	D	0.131	0.814	D	0.815	0.172	9.553	0.916	0.203	0.906	0.516	D	c	-0.406	-0.242	1.000	0.747	0.685	0.552	0	3.47	0.387	1.164	0.312	0.953	0.551	0.998	0.411	0.986	0.517	13.682	0.618	Homeodomain-like	.	.	0.5	97	328	chr2	237074910	chr2:237074910	G	T	97	PASS	AN=2;DP=328	GT	0/1
chr2	238323052	238323052	-	A	upstream	COL6A3	dist=202	.	.	7.79E-11	1	1.79E-10	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:10399756, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:9536084}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dystonia 27 (DYT27) [MIM:616411]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT27 is an autosomal recessive form characterized by segmental isolated dystonia involving the face, neck, bulbar muscles, and upper limbs. {ECO:0000269|PubMed:26004199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93588	0.40359	-2.550505158	0.861052135	5032.39412	14.4934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	203	chr2	238323050	chr2:238323050	TAA	TAAA,T	87	PASS	AN=2;DP=203	GT	0/1
chr2	238323051	238323052	AA	-	upstream	COL6A3	dist=201	.	.	7.79E-11	1	1.79E-10	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:10399756, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:9536084}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dystonia 27 (DYT27) [MIM:616411]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT27 is an autosomal recessive form characterized by segmental isolated dystonia involving the face, neck, bulbar muscles, and upper limbs. {ECO:0000269|PubMed:26004199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93588	0.40359	-2.550505158	0.861052135	5032.39412	14.4934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	203	chr2	238323050	chr2:238323050	TAA	TAAA,T	87	PASS	AN=2;DP=203	GT	0/1
chr2	239049486	239049486	A	T	exonic	KLHL30	.	stopgain	KLHL30:NM_198582:exon2:c.A91T:p.K31X	8.30E-11	0.039628124	0.960371876	.	0.07834	.	-0.262657925	34.93158764	2561.08705	9.45363	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.049	0.972	37	0.995	0.700	0.956	0.652	D	c	0.856	0.738	1.000	0.747	0.428	0.059	0	5.75	0.904	5.888	0.693	1.199	0.960	1.000	0.715	0.988	0.529	11.093	0.472	BTB/POZ domain|SKP1/BTB/POZ domain	.	.	0.5	110	518	chr2	239049486	chr2:239049486	A	T	110	PASS	AN=2;DP=518	GT	0/1
chr2	240323829	240323829	A	T	ncRNA_exonic	LOC101928111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	620	chr2	240323829	chr2:240323829	A	T	112	PASS	AN=2;DP=620	GT	0/1
chr2	242752382	242752382	C	A	UTR5	NEU4	NM_080741:c.-142C>A;NM_001167602:c.-3300C>A;NM_001167599:c.-142C>A	.	.	0.000277583	0.553721056	0.446001361	.	0.16791	0.22163	.	.	445.2511	4.39211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	505	chr2	242752382	chr2:242752382	C	A	90	PASS	AN=2;DP=505	GT	0/1
chr3	4534940	4534940	G	-	upstream	ITPR1;ITPR1-AS1	dist=92	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	566	chr3	4534939	chr3:4534939	CG	C	62	PASS	AN=2;DP=566	GT	0/1
chr3	48636507	48636507	G	-	UTR3	UQCRC1	NM_003365:c.*54delC	.	.	0.132467103	0.866597704	0.000935193	.	0.19556	0.2411	-0.268115223	34.70747818	259.99619	3.46496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	314	chr3	48636506	chr3:48636506	TG	T	93	PASS	AN=2;DP=314	GT	0/1
chr3	58631240	58631240	G	C	exonic	FAM3D	.	nonsynonymous SNV	FAM3D:NM_138805:exon5:c.C259G:p.R87G	0.004030909	0.959459476	0.036509615	.	0.0529	0.09521	0.262810045	70.43524416	38.8879	1.15175	0.054	0.390	T	0.055	0.213	B	0.039	0.223	B	0.010	0.012	N	1	0.090	N	1.525	0.387	L	1.87	0.241	T	-2.31	0.539	N	0.149	0.560	-1.035	0.188	T	0.049	0.207	T	0.007	0.187	T	0.507	0.143	7.482	0.930	0.220	0.038	0.090	N	c	-1.133	-1.183	0.004	0.105	0.487	0.133	0	-0.736	0.105	-0.543	0.061	-0.493	0.052	0.000	0.063	0.006	0.095	3.787	0.082	.	.	.	0.5	79	339	chr3	58631240	chr3:58631240	G	C	79	PASS	AN=2;DP=339	GT	0/1
chr3	66023660	66023660	C	A	intronic	MAGI1	.	.	.	0.999615675	0.000384325	2.89E-15	.	0.27232	0.12487	-1.383523256	4.358339231	581.76428	4.88893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	383	chr3	66023660	chr3:66023660	C	A	.	PASS	AN=0;DP=383	GT	0/1
chr3	66023661	66023661	C	A	intronic	MAGI1	.	.	.	0.999615675	0.000384325	2.89E-15	.	0.27232	0.12487	-1.383523256	4.358339231	581.76428	4.88893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	379	chr3	66023661	chr3:66023661	C	A	.	PASS	AN=0;DP=379	GT	0/1
chr3	74334562	74334562	T	G	exonic	CNTN3	.	synonymous SNV	CNTN3:NM_020872:exon19:c.A2598C:p.L866L	0.014141786	0.985856032	2.18E-06	.	0.27019	0.43019	0.316000233	72.80018872	1496.00916	7.19616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	325	chr3	74334562	chr3:74334562	T	G	106	PASS	AN=2;DP=325	GT	0/1
chr3	97185055	97185055	C	A	intronic	EPHA6	.	.	.	0.954513147	0.045486811	4.19E-08	.	0.34698	.	-0.771553417	13.15168672	252.47147	3.41934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	81	chr3	97185055	chr3:97185055	C	A	78	PASS	AN=2;DP=81	GT	0/1
chr3	130158343	130158343	C	A	intronic	COL6A5	.	.	.	9.56E-12	0.041150214	0.958849786	DISEASE: Note=Patients affected by atopic dermatitis display an abnormal distribution of COL29A1 mRNA and protein in skin suggesting that COL29A1 may be involved in the pathogenesis of the disease.; 	.	0.06307	.	.	13360.06109	24.98933	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	147	chr3	130158343	chr3:130158343	C	A	82	PASS	AN=2;DP=147	GT	0/1
chr3	145879271	145879271	G	T	UTR5	PLOD2	NM_000935:c.-495C>A;NM_182943:c.-495C>A	.	.	0.00117484	0.998744975	8.02E-05	DISEASE: Note=PLOD2 mutations give rise to a broad variety of phenotypes with variable degrees of severity of bone fragility and joint contractures. Disease-associated mutations have been found in patients with autosomal recessive osteogenesis imperfecta (AR- OI) (PubMed:22689593). {ECO:0000269|PubMed:22689593}.; 	0.65048	0.12778	0.112125503	62.09601321	137.52121	2.55175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	807	chr3	145879271	chr3:145879271	G	T	109	PASS	AN=2;DP=807	GT	0/1
chr3	167745600	167745600	T	A	exonic	GOLIM4	.	nonsynonymous SNV	GOLIM4:NM_001308155:exon11:c.A1455T:p.Q485H,GOLIM4:NM_014498:exon12:c.A1539T:p.Q513H	5.54E-11	0.945879645	0.054120355	.	0.10082	0.09393	-0.33061537	30.82094834	857.93003	5.71496	0.026	0.469	D	0.997	0.689	D	0.918	0.662	D	0.017	0.279	N	0.969	0.387	D	2.25	0.640	M	.	.	.	-2.47	0.539	N	0.345	0.424	-0.539	0.672	T	0.299	0.671	T	0.007	0.180	T	5.811	0.795	27.2	0.997	0.797	0.876	0.469	D	c	0.384	0.340	0.669	0.223	0.732	0.924	0	4.15	0.478	0.695	0.250	1.060	0.767	1.000	0.715	1.000	0.888	6.099	0.191	.	.	.	0.5	92	114	chr3	167745600	chr3:167745600	T	A	92	PASS	AN=2;DP=114	GT	0/1
chr3	184062437	184062437	G	T	exonic	FAM131A	.	synonymous SNV	FAM131A:NM_001171093:exon6:c.G525T:p.L175L,FAM131A:NM_144635:exon6:c.G780T:p.L260L	0.031328424	0.925656059	0.043015517	.	0.38029	0.09699	-0.205617011	38.57631517	64.91238	1.65518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	281	chr3	184062437	chr3:184062437	G	T	.	PASS	AN=0;DP=281	GT	0/1
chr3	195505960	195505960	G	C	exonic	MUC4	.	nonsynonymous SNV	MUC4:NM_018406:exon2:c.C12491G:p.T4164S	.	.	.	.	0.37408	.	6.320387277	99.8643548	14250.21522	26.01128	0.291	0.149	T	0.613	0.378	P	0.213	0.357	B	.	.	.	1.000	0.588	D	.	.	.	1.38	0.358	T	-0.6	0.206	N	0.047	0.028	-1.047	0.153	T	0.046	0.198	T	.	.	.	-0.520	0.054	0.196	0.420	0.030	0.014	0.046	N	c	-1.001	-1.186	0.000	0.029	0.554	0.283	0	.	.	0.464	0.215	0.174	0.246	0.000	0.063	0.005	0.090	5.853	0.178	.	.	.	0.5	126	117	chr3	195505960	chr3:195505960	G	C	126	PASS	AN=2;DP=117	GT	0/1
chr3	195692311	195692311	T	C	ncRNA_exonic	SDHAP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	151	314	chr3	195692311	chr3:195692311	T	C	151	PASS	AN=2;DP=314	GT	0/1
chr4	2460571	2460571	C	T	exonic	CFAP99	.	nonsynonymous SNV	CFAP99:NM_001193282:exon12:c.C1283T:p.A428V	.	.	.	.	.	.	.	.	.	.	0.561	0.063	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.05	0.078	N	0.034	0.014	-0.952	0.406	T	0.000	0.000	T	.	.	.	0.663	0.157	8.585	0.870	0.163	0.031	0.080	N	c	-0.964	-1.035	1.000	0.747	0.581	0.326	0	0.034	0.134	1.083	0.302	-0.858	0.029	0.764	0.290	0.005	0.090	0.910	0.012	.	ENSG00000206113.3|ENSG00000159733.9|ENSG00000159733.9	Colon_Transverse|Lung|Whole_Blood	0.5	165	181	chr4	2460571	chr4:2460571	C	T	165	PASS	AN=2;DP=181	GT	0/1
chr4	2516306	2516306	-	CCA	UTR3	RNF4	NM_001185010:c.*831_*832insCCA;NM_002938:c.*760_*761insCCA;NM_001185009:c.*760_*761insCCA	.	.	0.628950995	0.363852204	0.007196801	.	0.15544	0.12342	0.547599505	81.2160887	26.29011	0.85255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	288	chr4	2516306	chr4:2516306	C	CCCA	107	PASS	AN=2;DP=288	GT	0/1
chr4	3937148	3937148	C	A	intergenic	ADRA2C;FAM86EP	dist=166895;dist=6339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	270	chr4	3937148	chr4:3937148	C	A	75	PASS	AN=2;DP=270	GT	0/1
chr4	8305930	8305930	G	C	exonic	HTRA3	.	nonsynonymous SNV	HTRA3:NM_053044:exon8:c.G1120C:p.A374P	1.72E-05	0.675145167	0.324837634	.	0.16158	0.11489	-0.822919685	11.76574664	170.60666	2.84944	0.272	0.159	T	0.172	0.271	B	0.063	0.256	B	0.091	0.203	N	0.858	0.284	N	0.75	0.191	N	2.43	0.153	T	-0.61	0.181	N	0.291	0.350	-1.044	0.162	T	0.027	0.117	T	0.006	0.163	T	2.478	0.359	19.32	0.976	0.341	0.128	0.173	N	c	-0.352	-0.257	1.000	0.747	0.507	0.198	0	1.61	0.226	2.509	0.449	0.998	0.613	1.000	0.715	0.997	0.653	7.319	0.255	PDZ domain	.	.	0.5	123	195	chr4	8305930	chr4:8305930	G	C	123	PASS	AN=2;DP=195	GT	0/1
chr4	9699761	9699761	A	T	intergenic	MIR548I2;DRD5	dist=141824;dist=83497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	653	chr4	9699761	chr4:9699761	A	T	121	PASS	AN=2;DP=653	GT	0/1
chr4	24833093	24833093	C	A	intronic	CCDC149	.	.	.	0.002049284	0.977529378	0.020421338	.	0.16007	0.098	-0.47017169	23.25430526	5120.65553	14.70466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	417	chr4	24833093	chr4:24833093	C	A	94	PASS	AN=2;DP=417	GT	0/1
chr4	37848746	37848746	G	T	intronic	PGM2	.	.	.	1.06E-12	0.14776252	0.85223748	.	0.13924	0.40444	0.090079492	60.64519934	383.06081	4.12803	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	122	chr4	37848746	chr4:37848746	G	T	.	PASS	AN=0;DP=122	GT	0/1
chr4	47427792	47427792	G	T	exonic	GABRB1	.	nonsynonymous SNV	GABRB1:NM_000812:exon9:c.G1182T:p.M394I	0.977782833	0.022216315	8.52E-07	.	0.31766	0.11156	-0.359940251	28.93371078	31.23713	0.98534	0.416	0.099	T	0.008	0.195	B	0.038	0.252	B	0.011	0.296	N	1.000	0.490	D	1.71	0.444	L	-1.96	0.851	D	-0.97	0.258	N	0.388	0.477	-0.319	0.745	T	0.506	0.814	D	0.034	0.552	D	2.412	0.351	18.90	0.980	0.367	0.933	0.576	D	c	0.020	0.190	0.263	0.188	0.487	0.133	0	5.38	0.772	3.374	0.519	1.048	0.713	1.000	0.715	0.996	0.625	14.526	0.673	Neurotransmitter-gated ion-channel transmembrane domain	.	.	0.5	102	411	chr4	47427792	chr4:47427792	G	T	102	PASS	AN=2;DP=411	GT	0/1
chr4	48485962	48485962	C	T	exonic	SLC10A4	.	synonymous SNV	SLC10A4:NM_152679:exon1:c.C384T:p.H128H	0.167299362	0.771814239	0.060886399	.	0.04161	.	.	.	57.29346	1.52517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	268	chr4	48485962	chr4:48485962	C	T	.	PASS	AN=0;DP=268	GT	0/1
chr4	53525349	53525349	C	A	UTR5	USP46	NM_022832:c.-32G>T;NM_001286768:c.-32952G>T;NM_001286767:c.-32G>T	.	.	0.911054239	0.088809549	0.000136212	.	0.50572	0.11809	-0.229483771	36.86010852	7.68154	0.28352	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	470	chr4	53525349	chr4:53525349	C	A	84	PASS	AN=2;DP=470	GT	0/1
chr4	54439886	54439886	T	A	exonic	LNX1	.	nonsynonymous SNV	LNX1:NM_001126328:exon2:c.A284T:p.N95I	0.007243627	0.992057434	0.00069894	.	0.31424	0.15781	-1.194104514	5.850436424	109.44427	2.27278	0.008	0.586	D	0.612	0.378	P	0.259	0.377	B	0.003	0.358	N	1	0.810	D	1.79	0.469	L	4.49	0.131	T	-1.82	0.760	N	0.22	0.387	-1.057	0.126	T	0.037	0.162	T	0.024	0.473	T	3.757	0.508	23.3	0.983	0.394	0.943	0.604	D	c	-0.038	-0.027	0.994	0.334	0.638	0.428	0	3.34	0.372	3.485	0.527	0.112	0.206	1.000	0.715	0.998	0.697	10.239	0.423	Zinc finger, RING/FYVE/PHD-type	.	.	0.5	80	272	chr4	54439886	chr4:54439886	T	A	80	PASS	AN=2;DP=272	GT	0/1
chr4	56458190	56458190	C	T	intronic	PDCL2	.	.	.	0.041360287	0.844538805	0.114100908	.	0.24036	0.0992	0.014844891	54.94810097	75.77943	1.8232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	151	chr4	56458190	chr4:56458190	C	T	.	PASS	AN=0;DP=151	GT	0/1
chr4	70152475	70152475	G	T	exonic	UGT2B28	.	nonsynonymous SNV	UGT2B28:NM_001207004:exon3:c.G876T:p.M292I,UGT2B28:NM_053039:exon3:c.G876T:p.M292I	6.44E-08	0.434127347	0.565872588	.	0.08008	.	1.534092314	95.56499174	6528.21825	16.98038	0.208	0.206	T	0.036	0.194	B	0.036	0.216	B	0.037	0.245	U	0.994	0.235	N	1.575	0.398	L	0.22	0.599	T	-2.26	0.505	N	0.168	0.203	-1.018	0.242	T	0.112	0.402	T	0.011	0.285	T	0.269	0.120	5.388	0.576	0.057	0.549	0.295	D	c	-0.680	-0.679	0.000	0.012	0.487	0.133	0	0.946	0.186	0.567	0.231	0.792	0.321	1.000	0.715	0.794	0.334	2.507	0.043	.	.	.	0.5	79	399	chr4	70152475	chr4:70152475	G	T	79	PASS	AN=2;DP=399	GT	0/1
chr4	73434535	73434536	CA	-	upstream	ADAMTS3	dist=19	.	.	1.79E-06	0.999985819	1.24E-05	.	0.22292	0.11688	-0.654057602	16.14177872	316.52138	3.77881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	254	chr4	73434534	chr4:73434534	CCA	C	104	PASS	AN=2;DP=254	GT	0/1
chr4	95494467	95494467	-	T	intronic	PDLIM5	.	.	.	0.012278281	0.986126064	0.001595655	.	0.21242	0.85159	1.335644081	94.24982307	220.34888	3.20885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	151	chr4	95494467	chr4:95494467	A	AT	42	PASS	AN=2;DP=151	GT	0/1
chr4	107237814	107237814	C	T	UTR5	TBCK	NM_001163436:c.-7697G>A	.	.	3.22E-06	0.999352989	0.000643795	.	.	.	-0.042196577	50.49539986	1635.40912	7.4738	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	410	chr4	107237814	chr4:107237814	C	T	85	PASS	AN=2;DP=410	GT	0/1
chr4	153864407	153864407	T	C	exonic	FHDC1	.	synonymous SNV	FHDC1:NM_033393:exon1:c.T198C:p.L66L	0.024454127	0.975428958	0.000116915	.	0.39667	0.08948	0.969962249	90.20995518	6091.11428	16.31408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	170	chr4	153864407	chr4:153864407	T	C	120	PASS	AN=2;DP=170	GT	0/1
chr4	161925015	161925015	G	C	intergenic	LINC02233;FSTL5	dist=1226079;dist=380029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	790	chr4	161925015	chr4:161925015	G	C	120	PASS	AN=2;DP=790	GT	0/1
chr4	166326887	166326887	C	A	intronic	CPE	.	.	.	0.997846906	0.002153025	6.86E-08	.	0.71178	0.25258	-0.047654689	50.22410946	45.06523	1.28909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	195	chr4	166326887	chr4:166326887	C	A	60	PASS	AN=2;DP=195	GT	0/1
chr4	174459375	174459375	C	G	ncRNA_exonic	HAND2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	146	772	chr4	174459375	chr4:174459375	C	G	146	PASS	AN=2;DP=772	GT	0/1
chr4	190878577	190878577	A	G	exonic	FRG1	.	nonsynonymous SNV	FRG1:NM_004477:exon6:c.A457G:p.N153D	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	0.004	0.654	D	0.481	0.349	P	0.6	0.489	P	0.000	0.843	D	1.000	0.588	D	2.56	0.750	M	1.75	0.505	T	-4.0	0.769	D	0.204	0.530	-0.731	0.589	T	0.247	0.616	T	.	.	.	4.427	0.593	24.2	0.993	0.572	0.982	0.800	D	c	0.095	0.054	1.000	0.427	0.707	0.730	0	2.99	0.335	7.501	0.803	0.136	0.221	1.000	0.715	0.992	0.562	8.215	0.305	Actin cross-linking	.	.	0.5	112	302	chr4	190878577	chr4:190878577	A	G	112	PASS	AN=2;DP=302	GT	0/1
chr4	190878626	190878626	G	A	exonic	FRG1	.	nonsynonymous SNV	FRG1:NM_004477:exon6:c.G506A:p.S169N	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	0.346	0.200	T	0.531	0.358	P	0.479	0.452	P	0.000	0.629	N	0.999	0.453	D	0.72	0.188	N	1.77	0.485	T	-1.16	0.439	N	0.321	0.516	-1.077	0.080	T	0.097	0.365	T	0.012	0.295	T	1.752	0.272	14.70	0.986	0.430	0.857	0.446	D	c	-0.184	-0.131	0.995	0.337	0.707	0.730	0	2.41	0.285	2.028	0.405	-0.327	0.075	1.000	0.715	0.990	0.544	7.682	0.275	Actin cross-linking	.	.	0.5	88	379	chr4	190878626	chr4:190878626	G	A	88	PASS	AN=2;DP=379	GT	0/1
chr4	190878664	190878664	A	G	intronic	FRG1	.	.	.	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	620	chr4	190878664	chr4:190878664	A	G	133	PASS	AN=2;DP=620	GT	0/1
chr4	190894317	190894317	A	C	intergenic	FRG1;FRG2	dist=9958;dist=51206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	130	chr4	190894317	chr4:190894317	A	C	111	PASS	AN=2;DP=130	GT	0/1
chr5	256514	256514	G	C	exonic	SDHA	.	synonymous SNV	SDHA:NM_001330758:exon13:c.G1731C:p.P577P,SDHA:NM_001294332:exon14:c.G1830C:p.P610P,SDHA:NM_004168:exon15:c.G1974C:p.P658P	9.39E-06	0.996636308	0.003354304	DISEASE: Mitochondrial complex II deficiency (MT-C2D) [MIM:252011]: A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations. Clinical features include psychomotor regression in infants, poor growth with lack of speech development, severe spastic quadriplegia, dystonia, progressive leukoencephalopathy, muscle weakness, exercise intolerance, cardiomyopathy. Some patients manifest Leigh syndrome or Kearns-Sayre syndrome. Note=The disease is caused by mutations affecting the gene represented in this entry. {ECO:0000269|PubMed:12794685}.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:10746566, ECO:0000269|PubMed:24781757, ECO:0000269|PubMed:7550341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1GG (CMD1GG) [MIM:613642]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:20551992}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Paragangliomas 5 (PGL5) [MIM:614165]: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion. Paragangliomas can develop at various body sites, including the head, neck, thorax and abdomen. Most commonly, they are located in the head and neck region, specifically at the carotid bifurcation, the jugular foramen, the vagal nerve, and in the middle ear. {ECO:0000269|PubMed:20484225}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2964	.	-0.857930839	10.95187544	1260.39498	6.69421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	156	300	chr5	256514	chr5:256514	G	C	156	PASS	AN=2;DP=300	GT	0/1
chr5	434847	434847	G	T	exonic	AHRR	.	nonsynonymous SNV	AHRR:NM_001242412:exon11:c.G2004T:p.Q668H,AHRR:NM_020731:exon12:c.G2058T:p.Q686H	6.76E-05	0.977269885	0.022662496	.	.	0.16352	1.004917985	90.78792168	1613.48158	7.43304	0.028	0.469	D	0.5	0.353	P	0.264	0.379	B	0.073	0.213	N	1	0.090	N	0	0.065	N	2.26	0.229	T	-0.52	0.221	N	0.044	0.032	-0.997	0.309	T	0.024	0.103	T	0.004	0.091	T	1.382	0.229	12.69	0.796	0.124	0.147	0.183	N	c	-1.653	-1.816	1.000	0.747	0.672	0.522	0	-9.49	0.005	-2.148	0.014	-1.933	0.005	0.000	0.063	0.000	0.016	9.154	0.360	.	.	.	0.5	.	349	chr5	434847	chr5:434847	G	T	.	PASS	AN=0;DP=349	GT	0/1
chr5	878461	878461	G	A	intronic	BRD9	.	.	.	0.249187874	0.749502264	0.001309862	.	0.12337	0.10817	-0.797234383	12.48525596	290.83161	3.64776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	157	342	chr5	878461	chr5:878461	G	A	157	PASS	AN=2;DP=342	GT	0/1
chr5	1004352	1004352	C	T	intergenic	LOC100506688;NKD2	dist=6897;dist=4725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	1015	chr5	1004352	chr5:1004352	C	T	90	PASS	AN=2;DP=1015	GT	0/1
chr5	1065611	1065611	G	A	intronic	SLC12A7	.	.	.	8.45E-11	0.968735953	0.031264047	.	0.09754	.	-2.793650711	0.654635527	209.87901	3.12733	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	332	chr5	1065611	chr5:1065611	G	A	85	PASS	AN=2;DP=332	GT	0/1
chr5	9119250	9119250	G	T	exonic	SEMA5A	.	nonsynonymous SNV	SEMA5A:NM_003966:exon15:c.C1785A:p.N595K	0.000979594	0.999016141	4.26E-06	.	0.23092	0.10687	-2.892521092	0.583864119	185.92785	2.96172	0.007	0.599	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	0.999	0.451	D	2.23	0.633	M	2.18	0.189	T	-4.08	0.747	D	0.321	0.382	-0.431	0.710	T	0.082	0.322	T	0.016	0.372	T	1.065	0.196	11.03	0.960	0.280	0.360	0.252	N	c	-1.060	-1.367	1.000	0.747	0.539	0.216	0	-10.7	0.002	-0.272	0.085	-2.161	0.004	0.200	0.241	0.680	0.305	10.557	0.441	.	.	.	0.5	98	620	chr5	9119250	chr5:9119250	G	T	98	PASS	AN=2;DP=620	GT	0/1
chr5	10618641	10618641	C	A	intronic	ANKRD33B	.	.	.	.	.	.	.	.	.	.	.	245.21895	3.37855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	697	chr5	10618641	chr5:10618641	C	A	99	PASS	AN=2;DP=697	GT	0/1
chr5	17273722	17273722	A	C	intronic	BASP1	.	.	.	0.539222353	0.403650733	0.057126915	.	0.20195	0.13818	.	.	157.19188	2.73957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	218	chr5	17273722	chr5:17273722	A	C	90	PASS	AN=2;DP=218	GT	0/1
chr5	17486848	17486848	G	T	intergenic	LINC02218;LINC02223	dist=2793;dist=320535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	517	chr5	17486848	chr5:17486848	G	T	97	PASS	AN=2;DP=517	GT	0/1
chr5	41904406	41904406	G	T	upstream	C5orf51	dist=40	.	.	0.0038889	0.957830834	0.038280267	.	.	.	0.104848986	61.49445624	180.03222	2.91542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	794	chr5	41904406	chr5:41904406	G	T	120	PASS	AN=2;DP=794	GT	0/1
chr5	53606347	53606347	-	A	UTR5	ARL15	NM_019087:c.-39_-38insT	.	.	0.008866422	0.804130998	0.18700258	.	0.61156	0.1051	-0.163345027	41.24793583	6.04468	0.22863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	659	chr5	53606347	chr5:53606347	G	GA	92	PASS	AN=2;DP=659	GT	0/1
chr5	85582748	85582748	A	G	ncRNA_exonic	NBPF22P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	137	chr5	85582748	chr5:85582748	A	G	82	PASS	AN=2;DP=137	GT	0/1
chr5	92923754	92923754	C	A	exonic	NR2F1	.	nonsynonymous SNV	NR2F1:NM_005654:exon2:c.C595A:p.P199T	.	.	.	DISEASE: Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722]: An autosomal dominant disorder characterized by optic atrophy associated with developmental delay and intellectual disability. Most patients also have evidence of cerebral visual impairment. {ECO:0000269|PubMed:24462372}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.7496	0.11262	-0.339715008	30.06605331	3.34161	0.12228	0.03	0.453	D	0.997	0.689	D	0.975	0.717	D	0.000	0.843	D	1	0.810	D	1.57	0.397	L	0.72	0.510	T	-5.94	0.891	D	0.644	0.660	-0.669	0.619	T	0.274	0.646	T	0.045	0.621	D	2.325	0.341	18.33	0.997	0.823	0.996	0.981	D	c	0.524	0.446	1.000	0.747	0.707	0.730	0	4.5	0.542	7.879	0.856	0.932	0.445	1.000	0.715	0.971	0.463	17.383	0.872	Nuclear hormone receptor, ligand-binding domain	.	.	0.5	.	228	chr5	92923754	chr5:92923754	C	A	.	PASS	AN=0;DP=228	GT	0/1
chr5	127593605	127593605	C	A	UTR3	FBN2	NM_001999:c.*1542G>T	.	.	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	98	chr5	127593605	chr5:127593605	C	A	59	PASS	AN=2;DP=98	GT	0/1
chr5	140165915	140165915	C	T	exonic	PCDHA1	.	synonymous SNV	PCDHA1:NM_018900:exon1:c.C40T:p.L14L,PCDHA1:NM_031410:exon1:c.C40T:p.L14L,PCDHA1:NM_031411:exon1:c.C40T:p.L14L	0.000559475	0.973083018	0.026357507	.	0.08763	.	0.213053688	67.54541165	435.99793	4.35381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	280	chr5	140165915	chr5:140165915	C	T	89	PASS	AN=2;DP=280	GT	0/1
chr5	140616226	140616226	C	A	ncRNA_exonic	PCDHB18P	.	.	.	.	.	.	.	0.0684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	424	chr5	140616226	chr5:140616226	C	A	.	PASS	AN=0;DP=424	GT	0/1
chr5	140755476	140755476	T	A	exonic	PCDHGA6	.	nonsynonymous SNV	PCDHGA6:NM_018919:exon1:c.T1826A:p.L609H,PCDHGA6:NM_032086:exon1:c.T1826A:p.L609H	8.20E-07	0.736871867	0.263127313	.	0.20048	.	-0.079012906	47.25760793	336.38673	3.89594	0.035	0.437	D	0.999	0.764	D	0.978	0.725	D	0.223	0.161	U	1	0.810	D	3.395	0.918	M	0.35	0.580	T	-5.61	0.867	D	0.312	0.373	-0.685	0.612	T	0.299	0.671	T	0.026	0.494	D	4.802	0.644	24.8	0.985	0.418	0.265	0.228	N	c	0.344	0.230	0.156	0.175	0.646	0.450	0	4.85	0.622	0.010	0.130	1.061	0.807	0.000	0.063	1.000	0.888	4.751	0.123	Cadherin|Cadherin-like	.	.	0.5	125	906	chr5	140755476	chr5:140755476	T	A	125	PASS	AN=2;DP=906	GT	0/1
chr5	140764446	140764446	C	A	exonic	PCDHGA7	.	synonymous SNV	PCDHGA7:NM_018920:exon1:c.C1980A:p.L660L,PCDHGA7:NM_032087:exon1:c.C1980A:p.L660L	5.28E-06	0.660312893	0.33968183	.	.	.	0.143271594	63.67067705	862.76559	5.72657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	179	chr5	140764446	chr5:140764446	C	A	.	PASS	AN=0;DP=179	GT	0/1
chr5	171424015	171424015	C	A	intronic	FBXW11	.	.	.	0.997161484	0.002838511	5.51E-09	.	0.6328	0.16023	-0.471992905	23.03609342	11.11765	0.40246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	81	chr5	171424015	chr5:171424015	C	A	83	PASS	AN=2;DP=81	GT	0/1
chr5	171849555	171849555	T	C	intronic	SH3PXD2B	.	.	.	0.018536793	0.981286619	0.000176588	DISEASE: Frank-Ter Haar syndrome (FTHS) [MIM:249420]: A syndrome characterized by brachycephaly, wide fontanels, prominent forehead, hypertelorism, prominent eyes, macrocornea with or without glaucoma, full cheeks, small chin, bowing of the long bones and flexion deformity of the fingers. {ECO:0000269|PubMed:20137777}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26216	0.10532	-0.279250919	33.56923803	389.35486	4.15627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	158	chr5	171849555	chr5:171849555	T	C	107	PASS	AN=2;DP=158	GT	0/1
chr5	175717357	175717357	G	T	exonic	SIMC1	.	nonsynonymous SNV	SIMC1:NM_001308195:exon2:c.G830T:p.G277V,SIMC1:NM_001308196:exon4:c.G773T:p.G258V	0.000207487	0.907420866	0.092371647	.	0.11144	0.08199	-0.580403979	18.58928993	498.88864	4.58624	0.015	0.524	D	0.016	0.261	B	0.015	0.190	B	0.000	0.006	N	1.000	0.189	N	1.445	0.365	L	2.28	0.307	T	-1.02	0.301	N	0.073	0.062	-1.046	0.155	T	0.051	0.219	T	0.003	0.054	T	-0.518	0.054	0.199	0.461	0.036	0.143	0.181	N	c	-1.079	-1.151	0.002	0.087	0.706	0.609	0	0.422	0.156	-0.094	0.110	-0.470	0.054	0.182	0.239	0.000	0.016	6.185	0.196	.	.	.	0.5	.	151	chr5	175717357	chr5:175717357	G	T	.	PASS	AN=0;DP=151	GT	0/1
chr5	176930231	176930231	C	G	exonic	DOK3	.	nonsynonymous SNV	DOK3:NM_001144876:exon5:c.G502C:p.E168Q,DOK3:NM_001144875:exon6:c.G808C:p.E270Q	7.28E-05	0.743816689	0.256110523	.	0.16443	0.09799	-0.08265057	47.20452937	503.42172	4.60415	0.0	0.912	D	0.914	0.518	P	0.483	0.517	P	.	.	.	1	0.090	N	.	.	.	0.63	0.542	T	-0.4	0.138	N	0.022	0.005	-1.059	0.120	T	0.099	0.369	T	0.010	0.268	T	0.367	0.129	6.323	0.993	0.574	0.067	0.126	N	c	-0.725	-0.837	1.000	0.747	0.722	0.854	0	2.4	0.284	-0.378	0.074	0.461	0.278	0.000	0.063	0.005	0.090	8.393	0.315	IRS-type PTB domain|PH domain-like;PH domain-like|Pleckstrin homology domain	.	.	0.5	68	180	chr5	176930231	chr5:176930231	C	G	68	PASS	AN=2;DP=180	GT	0/1
chr6	16761565	16761565	G	-	ncRNA_intronic	LOC101928433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	387	chr6	16761564	chr6:16761564	AG	A	68	PASS	AN=2;DP=387	GT	0/1
chr6	34495048	34495048	G	A	intronic	PACSIN1	.	.	.	0.991339222	0.008658723	2.06E-06	.	0.29818	0.20704	-0.137658575	43.57159707	108.56082	2.26081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	387	chr6	34495048	chr6:34495048	G	A	105	PASS	AN=2;DP=387	GT	0/1
chr6	35436822	35436822	C	A	intronic	RPL10A	.	.	.	0.302378831	0.678598653	0.019022516	.	0.89137	.	-0.185391282	39.67916962	2.4123	0.08544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	198	chr6	35436822	chr6:35436822	C	A	.	PASS	AN=0;DP=198	GT	0/1
chr6	43098306	43098306	A	T	exonic	PTK7	.	nonsynonymous SNV	PTK7:NM_001270398:exon5:c.A743T:p.E248V,PTK7:NM_002821:exon5:c.A719T:p.E240V,PTK7:NM_152880:exon5:c.A719T:p.E240V,PTK7:NM_152881:exon5:c.A719T:p.E240V,PTK7:NM_152882:exon5:c.A719T:p.E240V	0.975879481	0.02412051	8.65E-09	.	0.64562	0.13964	-0.766111714	13.17527719	636.95125	5.07778	0.005	0.654	D	0.599	0.764	P	0.633	0.774	P	0.000	0.843	D	1.000	0.810	D	3.16	0.888	M	4.57	0.767	T	-3.59	0.755	D	0.66	0.696	0.256	0.868	D	0.571	0.845	D	0.241	0.887	D	5.908	0.810	27.5	0.993	0.580	0.942	0.601	D	c	0.576	0.514	1.000	0.747	0.737	0.974	0	4.62	0.568	4.835	0.622	1.194	0.916	1.000	0.715	0.953	0.430	11.583	0.500	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	74	264	chr6	43098306	chr6:43098306	A	T	74	PASS	AN=2;DP=264	GT	0/1
chr6	72186673	72186673	G	C	intergenic	LINC01626;RIMS1	dist=18098;dist=409733	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	233	chr6	72186673	chr6:72186673	G	C	107	PASS	AN=2;DP=233	GT	0/1
chr6	74230807	74230807	A	-	upstream	EEF1A1	dist=52	.	.	0.984461027	0.015530359	8.61E-06	.	0.98787	0.6963	-0.273576253	33.97027601	10.98489	0.39784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	1016	chr6	74230806	chr6:74230806	GA	G	98	PASS	AN=2;DP=1016	GT	0/1
chr6	80775100	80775100	A	T	intergenic	TTK;BCKDHB	dist=22856;dist=41227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	388	chr6	80775100	chr6:80775100	A	T	.	PASS	AN=0;DP=388	GT	0/1
chr6	83877682	83877682	G	A	exonic	DOPEY1	.	synonymous SNV	DOPEY1:NM_015018:exon39:c.G7194A:p.P2398P,DOPEY1:NM_001199942:exon40:c.G7227A:p.P2409P	0.999995778	4.22E-06	4.05E-22	.	0.3292	0.09427	-1.052752328	7.619721632	1415.32398	7.03165	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	205	chr6	83877682	chr6:83877682	G	A	51	PASS	AN=2;DP=205	GT	0/1
chr6	133135715	133135715	C	A	UTR5	RPS12	NM_001016:c.-193C>A	.	.	0.827435142	0.168866928	0.00369793	.	0.26171	0.19444	0.035072054	56.2514744	9.87588	0.36197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	206	chr6	133135715	chr6:133135715	C	A	.	PASS	AN=0;DP=206	GT	0/1
chr6	157150537	157150537	G	C	exonic	ARID1B	.	nonsynonymous SNV	ARID1B:NM_001346813:exon2:c.G1719C:p.M573I,ARID1B:NM_017519:exon2:c.G1719C:p.M573I,ARID1B:NM_020732:exon2:c.G1719C:p.M573I	0.99994993	5.01E-05	4.93E-16	DISEASE: Mental retardation, autosomal dominant 12 (MRD12) [MIM:614562]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD12 patients present with moderate to severe psychomotor retardation, and most show evidence of muscular hypotonia. In many patients, expressive speech is more severely affected than receptive function. Additional common findings include short stature, abnormal head shape and low-set, posteriorly rotated, and abnormally shaped ears, downslanting palpebral fissures, a bulbous nasal tip, a thin upper lip, minor teeth anomalies, and brachydactyly or single palmar creases. Autistic features are uncommon. {ECO:0000269|PubMed:22405089, ECO:0000269|PubMed:22426308, ECO:0000269|PubMed:22426309}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15152	0.12645	-2.622392448	0.802075961	623.55868	5.03581	0.116	0.371	T	0.0	0.026	B	0.001	0.063	B	0.001	0.426	D	0.627	0.327	D	1.385	0.346	L	4.69	0.022	T	-1.83	0.441	N	0.294	0.354	-0.890	0.489	T	0.003	0.010	T	0.007	0.194	T	2.186	0.324	17.42	0.970	0.312	0.982	0.804	D	c	-0.350	-0.161	1.000	0.747	0.707	0.730	0	4.22	0.490	4.549	0.602	0.124	0.212	1.000	0.715	0.993	0.574	15.343	0.739	.	.	.	0.5	124	310	chr6	157150537	chr6:157150537	G	C	124	PASS	AN=2;DP=310	GT	0/1
chr6	159655276	159655276	C	T	exonic	FNDC1	.	synonymous SNV	FNDC1:NM_032532:exon11:c.C3732T:p.L1244L	3.07E-07	0.999968249	3.14E-05	.	0.1324	0.09503	2.671889479	98.84996461	6512.79761	16.93629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	431	chr6	159655276	chr6:159655276	C	T	94	PASS	AN=2;DP=431	GT	0/1
chr6	167622276	167622276	C	A	intergenic	TCP10L2;UNC93A	dist=25880;dist=82527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	233	chr6	167622276	chr6:167622276	C	A	.	PASS	AN=0;DP=233	GT	0/1
chr7	959589	959589	A	C	intronic	ADAP1	.	.	.	0.657926854	0.341835895	0.000237251	.	0.17754	0.12827	-0.933156985	9.54824251	48.02044	1.34684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	303	chr7	959589	chr7:959589	A	C	109	PASS	AN=2;DP=303	GT	0/1
chr7	2296436	2296436	C	A	intronic	SNX8	.	.	.	0.165170969	0.831782233	0.003046798	.	0.16684	0.11365	0.376678994	75.50719509	357.15648	4.00401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	416	chr7	2296436	chr7:2296436	C	A	95	PASS	AN=2;DP=416	GT	0/1
chr7	4722356	4722356	C	A	exonic	FOXK1	.	synonymous SNV	FOXK1:NM_001037165:exon1:c.C417A:p.G139G	0.962670921	0.037313855	1.52E-05	.	0.15597	0.12005	-1.107723888	6.829440906	888.10645	5.80361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	595	chr7	4722356	chr7:4722356	C	A	112	PASS	AN=2;DP=595	GT	0/1
chr7	5959485	5959485	G	A	exonic	CCZ1	.	nonsynonymous SNV	CCZ1:NM_015622:exon12:c.G994A:p.V332I	0.994694688	0.005304692	6.20E-07	.	0.2029	.	-0.159704656	41.90846898	84.72538	1.9605	0.44	0.092	T	0.001	0.067	B	0.004	0.093	B	0.045	0.236	N	1	0.090	P	.	.	.	.	.	.	-0.17	0.096	N	0.043	0.023	-1.016	0.249	T	0.000	0.000	T	.	.	.	-1.013	0.031	0.015	0.631	0.069	0.021	0.061	N	c	-1.612	-1.668	0.000	0.057	0.706	0.609	0	-5.07	0.027	0.961	0.287	-0.569	0.046	0.134	0.232	0.001	0.043	9.832	0.399	.	ENSG00000122674.8	Colon_Transverse	0.5	147	576	chr7	5959485	chr7:5959485	G	A	147	PASS	AN=2;DP=576	GT	0/1
chr7	6899511	6899511	C	A	intergenic	CCZ1B;MIR3683	dist=33585;dist=207084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	475	chr7	6899511	chr7:6899511	C	A	98	PASS	AN=2;DP=475	GT	0/1
chr7	6977554	6977554	C	A	intergenic	CCZ1B;MIR3683	dist=111628;dist=129041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	551	chr7	6977554	chr7:6977554	C	A	.	PASS	AN=0;DP=551	GT	0/1
chr7	23625204	23625204	C	T	ncRNA_exonic	CLK2P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	278	chr7	23625204	chr7:23625204	C	T	92	PASS	AN=2;DP=278	GT	0/1
chr7	28547355	28547355	G	T	exonic	CREB5	.	synonymous SNV	CREB5:NM_182899:exon3:c.G192T:p.R64R,CREB5:NM_004904:exon4:c.G270T:p.R90R,CREB5:NM_182898:exon4:c.G291T:p.R97R	0.989844565	0.010154821	6.14E-07	.	0.7763	.	-0.670411825	15.61689078	30.64753	0.97477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	256	chr7	28547355	chr7:28547355	G	T	77	PASS	AN=2;DP=256	GT	0/1
chr7	45108047	45108047	G	T	exonic	CCM2	.	nonsynonymous SNV	CCM2:NM_001167934:exon4:c.G304T:p.D102Y,CCM2:NM_001029835:exon5:c.G541T:p.D181Y,CCM2:NM_031443:exon5:c.G478T:p.D160Y	0.483088351	0.515904177	0.001007472	DISEASE: Cerebral cavernous malformations 2 (CCM2) [MIM:603284]: A congenital vascular anomaly of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters. {ECO:0000269|PubMed:14624391, ECO:0000269|PubMed:14740320, ECO:0000269|PubMed:22415356}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17979	0.11593	-0.376526807	28.10804435	1216.01154	6.59576	0.005	0.654	D	0.983	0.637	D	0.736	0.614	P	0.000	0.466	D	1.000	0.810	D	1.79	0.469	L	1.05	0.400	T	-2.96	0.617	D	0.612	0.690	-0.672	0.617	T	0.205	0.564	T	0.052	0.652	D	6.036	0.831	28.0	0.995	0.697	0.996	0.982	D	c	0.653	0.624	1.000	0.747	0.706	0.609	0	4.2	0.486	9.077	0.934	1.048	0.713	1.000	0.715	1.000	0.888	15.476	0.751	PH domain-like|PTB/PI domain	.	.	0.5	80	410	chr7	45108047	chr7:45108047	G	T	80	PASS	AN=2;DP=410	GT	0/1
chr7	48965281	48965281	G	T	ncRNA_exonic	CDC14C	.	.	.	.	.	.	.	.	0.09972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	392	chr7	48965281	chr7:48965281	G	T	105	PASS	AN=2;DP=392	GT	0/1
chr7	57247689	57247689	C	A	ncRNA_exonic	GUSBP10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	761	chr7	57247689	chr7:57247689	C	A	132	PASS	AN=2;DP=761	GT	0/1
chr7	63020525	63020525	C	A	intergenic	LOC100287834;MIR4283-1	dist=161106;dist=60943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	959	chr7	63020525	chr7:63020525	C	A	121	PASS	AN=2;DP=959	GT	0/1
chr7	63020733	63020733	C	G	intergenic	LOC100287834;MIR4283-1	dist=161314;dist=60735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	501	chr7	63020733	chr7:63020733	C	G	134	PASS	AN=2;DP=501	GT	0/1
chr7	63033363	63033363	G	T	intergenic	LOC100287834;MIR4283-1	dist=173944;dist=48105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	511	chr7	63033363	chr7:63033363	G	T	121	PASS	AN=2;DP=511	GT	0/1
chr7	63033371	63033371	C	T	intergenic	LOC100287834;MIR4283-1	dist=173952;dist=48097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	503	chr7	63033371	chr7:63033371	C	T	122	PASS	AN=2;DP=503	GT	0/1
chr7	63232336	63232336	G	T	intergenic	MIR4283-1;ZNF722P	dist=150789;dist=226848	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	471	chr7	63232336	chr7:63232336	G	T	103	PASS	AN=2;DP=471	GT	0/1
chr7	72341068	72341068	C	A	intergenic	SPDYE7P;POM121	dist=1412;dist=8838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	168	chr7	72341068	chr7:72341068	C	A	.	PASS	AN=0;DP=168	GT	0/1
chr7	72341070	72341070	T	C	intergenic	SPDYE7P;POM121	dist=1414;dist=8836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	162	chr7	72341070	chr7:72341070	T	C	.	PASS	AN=0;DP=162	GT	0/1
chr7	72361246	72361246	A	T	UTR5	POM121	NM_001257190:c.-35705A>T;NM_172020:c.-35705A>T	.	.	.	.	.	.	0.2255	0.08649	-0.33061537	30.82094834	663.23352	5.16151	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	484	chr7	72361246	chr7:72361246	A	T	116	PASS	AN=2;DP=484	GT	0/1
chr7	73814774	73814774	G	A	exonic	CLIP2	.	synonymous SNV	CLIP2:NM_032421:exon14:c.G2850A:p.R950R,CLIP2:NM_003388:exon15:c.G2955A:p.R985R	0.999881647	0.000118353	1.18E-11	DISEASE: Note=CLIP2 is located in the Williams-Beuren syndrome (WBS) critical region (PubMed:9799601). WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region. Haploinsufficiency of CLIP2 may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in the disease. However, it has been demonstrated that haploinsufficiency of this gene alone is not sufficient to cause any of the cognitive or facial features of WBS (PubMed:22608712). {ECO:0000305|PubMed:22608712, ECO:0000305|PubMed:9799601}.; 	0.13125	.	-1.186862251	5.90351498	632.85889	5.0685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	703	chr7	73814774	chr7:73814774	G	A	122	PASS	AN=2;DP=703	GT	0/1
chr7	74573036	74573036	C	G	ncRNA_intronic	NCF1C	.	.	.	.	.	.	.	0.17774	0.11639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	442	chr7	74573036	chr7:74573036	C	G	118	PASS	AN=2;DP=442	GT	0/1
chr7	74573061	74573061	G	-	ncRNA_exonic	NCF1C	.	.	.	.	.	.	.	0.17774	0.11639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	570	chr7	74573060	chr7:74573060	CG	C	120	PASS	AN=2;DP=570	GT	0/1
chr7	76681186	76681186	G	T	ncRNA_exonic	PMS2P9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	325	chr7	76681186	chr7:76681186	G	T	.	PASS	AN=0;DP=325	GT	0/1
chr7	90226055	90226055	C	-	intronic	CDK14	.	.	.	0.476260128	0.52352424	0.000215631	.	0.45755	0.11073	-0.514264485	21.41424864	102.95947	2.19295	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	1125	chr7	90226054	chr7:90226054	GC	G	94	PASS	AN=2;DP=1125	GT	0/1
chr7	94054477	94054477	C	A	exonic	COL1A2	.	nonsynonymous SNV	COL1A2:NM_000089:exon42:c.C2722A:p.P908T	0.999754944	0.000245056	9.66E-16	DISEASE: Ehlers-Danlos syndrome 7B (EDS7B) [MIM:130060]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations. {ECO:0000269|PubMed:1577745, ECO:0000269|PubMed:2394758, ECO:0000269|PubMed:3680255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. {ECO:0000269|PubMed:16705691, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. {ECO:0000269|PubMed:10627137, ECO:0000269|PubMed:1284475, ECO:0000269|PubMed:1339453, ECO:0000269|PubMed:1385413, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1874719, ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:2777764, ECO:0000269|PubMed:2914942, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:7891382, ECO:0000269|PubMed:7906591, ECO:0000269|PubMed:7959683, ECO:0000269|PubMed:8182080, ECO:0000269|Ref.33}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form (EDSCV) [MIM:225320]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. In addition to joint laxity, skin hyperextensibility and friability, and abnormal scar formation, patients have mitral valve prolapse and insufficiency, mitral regurgitation, and aortic insufficiency. {ECO:0000269|PubMed:16816023}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:10408781, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:7520724, ECO:0000269|PubMed:7720740, ECO:0000269|PubMed:7749416, ECO:0000269|PubMed:7860070, ECO:0000269|PubMed:7881420, ECO:0000269|PubMed:8081394, ECO:0000269|PubMed:8444468, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:8800927, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:1642148, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:2052622, ECO:0000269|PubMed:2064612, ECO:0000269|PubMed:2897363, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8401517, ECO:0000269|PubMed:8800927}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving COL1A2 may be a cause of lipoblastomas, which are benign tumors resulting from transformation of adipocytes, usually diagnosed in children. Translocation t(7;8)(p22;q13) with PLAG1.; 	0.99859	.	-1.144569759	6.363529134	161.91131	2.78024	0.001	0.784	D	0.997	0.689	D	0.939	0.657	D	0.000	0.559	D	1.000	0.588	D	2.51	0.734	M	-4.22	0.970	D	-5.39	0.850	D	0.645	0.660	1.085	0.991	D	0.945	0.982	D	0.293	0.906	D	4.592	0.615	24.4	0.992	0.562	0.931	0.570	D	c	0.699	0.657	1.000	0.747	0.707	0.730	0	5.25	0.731	3.245	0.509	0.892	0.403	1.000	0.715	0.980	0.490	19.231	0.938	.	.	.	0.5	113	567	chr7	94054477	chr7:94054477	C	A	113	PASS	AN=2;DP=567	GT	0/1
chr7	99905688	99905688	C	A	intronic	SPDYE3	.	.	.	0.825434138	0.173760887	0.000804975	.	.	.	.	.	7.34499	0.27357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	353	chr7	99905688	chr7:99905688	C	A	65	PASS	AN=2;DP=353	GT	0/1
chr7	100636196	100636196	C	A	exonic	MUC12	.	synonymous SNV	MUC12:NM_001164462:exon2:c.C2352A:p.A784A	.	.	.	.	0.09711	.	.	.	8273.45926	19.64989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	1143	chr7	100636196	chr7:100636196	C	A	107	PASS	AN=2;DP=1143	GT	0/1
chr7	100677557	100677557	C	G	exonic	MUC17	.	nonsynonymous SNV	MUC17:NM_001040105:exon3:c.C2860G:p.P954A	.	.	.	.	0.01571	.	16.94869906	99.98230715	4366.26914	13.19122	0.012	0.546	D	0.718	0.403	P	0.126	0.311	B	.	.	.	1	0.090	N	1.265	0.321	L	4.04	0.032	T	-0.69	0.197	N	0.068	0.055	-0.935	0.434	T	0.005	0.018	T	0.002	0.037	T	-1.287	0.022	0.005	0.155	0.004	0.002	0.010	N	c	-1.305	-1.480	0.000	0.058	0.516	0.203	0	-2.38	0.062	-3.328	0.006	-0.692	0.038	0.000	0.063	0.000	0.016	7.728	0.278	.	.	.	0.5	100	498	chr7	100677557	chr7:100677557	C	G	100	PASS	AN=2;DP=498	GT	0/1
chr7	100678405	100678405	T	C	exonic	MUC17	.	synonymous SNV	MUC17:NM_001040105:exon3:c.T3708C:p.A1236A	.	.	.	.	0.01571	.	16.94869906	99.98230715	4366.26914	13.19122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	157	chr7	100678405	chr7:100678405	T	C	95	PASS	AN=2;DP=157	GT	0/1
chr7	100773732	100773732	T	A	exonic	SERPINE1	.	nonsynonymous SNV	SERPINE1:NM_000602:exon3:c.T302A:p.L101Q	0.219519977	0.772130789	0.008349234	DISEASE: Plasminogen activator inhibitor-1 deficiency (PAI-1D) [MIM:613329]: A hematologic disorder characterized by increased bleeding after trauma, injury, or surgery. Affected females have menorrhagia. The bleeding defect is due to increased fibrinolysis of fibrin blood clots due to deficiency of plasminogen activator inhibitor-1, which inhibits tissue and urinary activators of plasminogen. {ECO:0000269|PubMed:9207454}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=High concentrations of SERPINE1 seem to contribute to the development of venous but not arterial occlusions.; 	0.42306	0.86891	-0.268115223	34.70747818	478.10918	4.51469	0.051	0.393	T	0.999	0.899	D	0.922	0.697	D	0.000	0.523	D	0.999	0.456	D	3.355	0.913	M	-2.44	0.888	D	-3.76	0.712	D	0.921	0.913	0.864	0.952	D	0.832	0.944	D	0.173	0.850	D	4.402	0.589	24.1	0.992	0.550	0.943	0.604	D	c	0.466	0.301	1.000	0.747	0.696	0.573	0	5.44	0.793	4.762	0.617	1.061	0.807	0.981	0.351	0.007	0.100	13.445	0.604	Serpin domain	.	.	0.5	95	296	chr7	100773732	chr7:100773732	T	A	95	PASS	AN=2;DP=296	GT	0/1
chr7	101194452	101194452	G	-	intronic	COL26A1	.	.	.	0.000191086	0.974764546	0.025044368	.	0.19198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	632	chr7	101194451	chr7:101194451	TG	T	125	PASS	AN=2;DP=632	GT	0/1
chr7	117188750	117188750	C	T	exonic	CFTR	.	nonsynonymous SNV	CFTR:NM_000492:exon10:c.C1265T:p.S422F	2.96E-36	5.19E-06	0.999994809	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.76593	0.87681	-0.50727808	21.73271998	637.50803	5.08064	0.09	0.329	T	0.675	0.393	P	0.246	0.371	B	0.024	0.264	N	0.909	0.317	N	2.3	0.659	M	-3.12	0.931	D	-1.39	0.344	N	0.255	0.524	0.455	0.899	D	0.707	0.899	D	0.117	0.798	D	1.454	0.237	13.07	0.886	0.176	0.731	0.355	D	c	-0.081	-0.132	0.009	0.119	0.554	0.246	0	3.01	0.337	3.118	0.499	0.852	0.362	0.992	0.373	0.155	0.206	10.332	0.428	.	.	.	0.5	.	111	chr7	117188750	chr7:117188750	C	T	.	PASS	AN=0;DP=111	GT	0/1
chr7	123334697	123334697	T	-	intronic	WASL	.	.	.	0.961960487	0.038036282	3.23E-06	.	0.89386	0.35187	-0.692458599	14.96815287	24.64068	0.80952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	75	chr7	123334696	chr7:123334696	GT	G	148	PASS	AN=2;DP=75	GT	0/1
chr7	142448556	142448556	C	G	intergenic	MTRNR2L6;PRSS1	dist=73031;dist=8763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	212	chr7	142448556	chr7:142448556	C	G	96	PASS	AN=2;DP=212	GT	0/1
chr7	142459679	142459679	G	A	exonic	PRSS1	.	synonymous SNV	PRSS1:NM_002769:exon3:c.G255A:p.E85E	0.001220295	0.848354593	0.150425112	DISEASE: Pancreatitis, hereditary (PCTT) [MIM:167800]: A disease characterized by pancreas inflammation, permanent destruction of the pancreatic parenchyma, maldigestion, and severe abdominal pain attacks. {ECO:0000269|PubMed:10204851, ECO:0000269|PubMed:10381903, ECO:0000269|PubMed:10930381, ECO:0000269|PubMed:11073545, ECO:0000269|PubMed:11788572, ECO:0000269|PubMed:11866271, ECO:0000269|PubMed:14695529, ECO:0000269|PubMed:15776435, ECO:0000269|PubMed:8841182, ECO:0000269|PubMed:9322498, ECO:0000269|PubMed:9633818}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.47806	0.78094	-0.117432389	44.89266336	35.65715	1.07286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	237	chr7	142459679	chr7:142459679	G	A	100	PASS	AN=2;DP=237	GT	0/1
chr7	143453661	143453661	T	G	exonic	CTAGE6	.	nonsynonymous SNV	CTAGE6:NM_178561:exon1:c.A1091C:p.E364A	0.366836245	0.621526849	0.011636907	.	.	.	.	.	126.17664	2.44439	.	.	.	0.0	0.026	B	0.0	0.013	B	.	.	.	.	.	.	-3	0.000	N	3.5	0.050	T	.	.	.	0.041	0.021	.	.	.	.	.	.	.	.	.	-1.880	0.010	0.002	0.508	0.044	0.000	0.003	N	n	-0.640	-0.258	0.000	0.012	0.075	0.013	0	0.109	0.138	-0.293	0.083	-0.934	0.025	0.493	0.267	0.028	0.145	.	.	.	.	.	0.5	98	367	chr7	143453661	chr7:143453661	T	G	98	PASS	AN=2;DP=367	GT	0/1
chr7	149430875	149430875	G	C	exonic	KRBA1	.	unknown	UNKNOWN	1.47E-12	0.095501601	0.904498399	.	0.07786	.	.	.	814.97375	5.61027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	209	chr7	149430875	chr7:149430875	G	C	101	PASS	AN=2;DP=209	GT	0/1
chr7	149495134	149495134	G	C	intronic	SSPO	.	.	.	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	505	chr7	149495134	chr7:149495134	G	C	126	PASS	AN=2;DP=505	GT	0/1
chr7	149497462	149497462	C	A	exonic	SSPO	.	nonsynonymous SNV	SSPO:NM_198455:exon49:c.C7220A:p.A2407E	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	0.0	0.026	B	0.002	0.063	B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.115	0.126	.	.	.	.	.	.	.	.	.	1.592	0.253	13.81	0.879	0.170	0.023	0.066	N	n	0.827	2.765	0.857	0.251	0.070	0.012	0	-4.21	0.035	-1.105	0.034	-1.465	0.011	0.000	0.063	0.933	0.406	1.166	0.017	Low-density lipoprotein (LDL) receptor class A, conserved site	.	.	0.5	130	492	chr7	149497462	chr7:149497462	C	A	130	PASS	AN=2;DP=492	GT	0/1
chr7	151932916	151932916	C	G	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon16:c.G2755C:p.V919L	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.465	0.086	T	0.005	0.119	B	0.006	0.112	B	0.001	0.407	D	0.910	0.275	N	1.04	0.263	L	-1.76	0.836	D	-0.87	0.236	N	0.106	0.208	-0.782	0.562	T	0.290	0.662	T	.	.	.	1.682	0.263	14.31	0.935	0.226	0.885	0.481	D	c	-0.471	-0.289	0.000	0.060	0.737	0.974	0	3.05	0.341	0.914	0.280	0.892	0.403	0.989	0.365	1.000	0.888	9.075	0.355	.	.	.	0.5	151	493	chr7	151932916	chr7:151932916	C	G	151	PASS	AN=2;DP=493	GT	0/1
chr7	151935853	151935853	T	C	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon15:c.A2591G:p.E864G	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.077	0.346	T	0.986	0.596	D	0.655	0.508	P	0.010	0.301	N	1.000	0.488	D	1.95	0.526	M	-2.06	0.860	D	-1.73	0.410	N	0.593	0.620	-0.013	0.820	T	0.585	0.851	D	.	.	.	4.196	0.562	23.9	0.998	0.907	0.978	0.770	D	c	0.478	0.540	1.000	0.747	0.651	0.465	0	5.53	0.825	7.411	0.791	1.061	0.807	1.000	0.715	1.000	0.888	15.955	0.796	.	.	.	0.5	.	172	chr7	151935853	chr7:151935853	T	C	.	PASS	AN=0;DP=172	GT	0/1
chr7	151936975	151936975	A	G	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	73	chr7	151936975	chr7:151936975	A	G	97	PASS	AN=2;DP=73	GT	0/1
chr7	151962265	151962265	C	T	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon8:c.G1042A:p.D348N	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.027	0.465	D	1.0	0.899	D	0.99	0.774	D	0.001	0.437	U	1.000	0.495	D	2.62	0.769	M	-5.15	0.988	D	-3.29	0.677	D	0.144	0.169	1.060	0.984	D	0.951	0.984	D	.	.	.	4.868	0.654	24.9	0.993	0.581	0.995	0.972	D	c	0.470	0.415	1.000	0.747	0.707	0.730	0	4.65	0.575	7.902	0.860	0.847	0.346	1.000	0.715	0.995	0.604	17.916	0.888	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING-type|Zinc finger, RING/FYVE/PHD-type	.	.	0.5	129	302	chr7	151962265	chr7:151962265	C	T	129	PASS	AN=2;DP=302	GT	0/1
chr7	157931119	157931119	A	G	exonic	PTPRN2	.	synonymous SNV	PTPRN2:NM_001308267:exon6:c.T885C:p.A295A,PTPRN2:NM_130842:exon6:c.T948C:p.A316A,PTPRN2:NM_001308268:exon7:c.T1068C:p.A356A,PTPRN2:NM_002847:exon7:c.T999C:p.A333A,PTPRN2:NM_130843:exon7:c.T999C:p.A333A	0.016557153	0.983434299	8.55E-06	DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus (IDDM). {ECO:0000269|PubMed:8637868, ECO:0000269|PubMed:8798755, ECO:0000269|PubMed:8878534}.; 	0.18753	0.09983	0.889106693	89.19556499	4454.24566	13.37565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	183	211	chr7	157931119	chr7:157931119	A	G	183	PASS	AN=2;DP=211	GT	0/1
chr8	608055	608055	C	A	intronic	ERICH1	.	.	.	1.39E-10	0.027971373	0.972028627	.	0.06769	0.07517	0.07167258	59.15899976	140.672	2.58786	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	406	chr8	608055	chr8:608055	C	A	.	PASS	AN=0;DP=406	GT	0/1
chr8	1626429	1626429	G	C	exonic	DLGAP2	.	nonsynonymous SNV	DLGAP2:NM_001346810:exon12:c.G2338C:p.D780H	0.950397326	0.049601404	1.27E-06	.	0.18261	0.10991	-1.609459583	3.001887238	.	.	0.0	0.912	D	1.0	0.899	D	0.996	0.971	D	0.000	0.843	D	1.000	0.588	D	3.325	0.910	M	1.99	0.217	T	-6.03	0.897	D	0.939	0.933	-0.692	0.608	T	0.177	0.522	T	0.068	0.705	D	6.198	0.855	28.7	0.996	0.734	0.982	0.799	D	c	0.821	0.756	1.000	0.747	0.554	0.283	0	4.95	0.648	7.421	0.792	1.048	0.713	1.000	0.715	0.990	0.544	18.187	0.897	.	.	.	0.5	106	468	chr8	1626429	chr8:1626429	G	C	106	PASS	AN=2;DP=468	GT	0/1
chr8	7189853	7189853	C	A	ncRNA_intronic	FAM66B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	628	chr8	7189853	chr8:7189853	C	A	108	PASS	AN=2;DP=628	GT	0/1
chr8	10480541	10480541	G	T	exonic	RP1L1	.	synonymous SNV	RP1L1:NM_178857:exon2:c.C171A:p.A57A	.	.	.	DISEASE: Occult macular dystrophy (OCMD) [MIM:613587]: An inherited macular dystrophy characterized by progressive loss of macular function but normal ophthalmoscopic appearance. It is typically characterized by a central cone dysfunction leading to a loss of vision despite normal ophthalmoscopic appearance, normal fluorescein angiography, and normal full-field electroretinogram (ERGs), but the amplitudes of the focal macular ERGs and multifocal ERGs are significantly reduced at the central retina. {ECO:0000269|PubMed:20826268, ECO:0000269|PubMed:22605915}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09178	.	7.246646544	99.8997405	19576.13196	29.90294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	274	chr8	10480541	chr8:10480541	G	T	.	PASS	AN=0;DP=274	GT	0/1
chr8	21903695	21903695	G	T	exonic	FGF17	.	nonsynonymous SNV	FGF17:NM_001304478:exon3:c.G110T:p.S37I,FGF17:NM_003867:exon3:c.G143T:p.S48I	0.86533156	0.132739231	0.00192921	DISEASE: Hypogonadotropic hypogonadism 20 with or without anosmia (HH20) [MIM:615270]: A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic- pituitary axis. In some cases, it is associated with non- reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). {ECO:0000269|PubMed:23643382}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Some patients carrying mutations in FGF17 also have a mutation in another HH-associated gene including FGFR1, HS6ST1 and FLRT3 (PubMed:23643382). {ECO:0000269|PubMed:23643382}.; 	0.9799	0.11262	-0.229483771	36.86010852	5.5877	0.20855	0.001	0.912	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1.000	0.588	D	2.645	0.776	M	-2.3	0.877	D	-4.36	0.769	D	0.88	0.891	0.686	0.930	D	0.765	0.920	D	0.211	0.873	D	6.401	0.884	29.6	0.997	0.787	0.971	0.724	D	c	0.816	0.776	1.000	0.747	0.598	0.340	0	4.75	0.598	9.541	0.972	0.953	0.551	1.000	0.715	1.000	0.888	15.252	0.731	.	.	.	0.5	110	506	chr8	21903695	chr8:21903695	G	T	110	PASS	AN=2;DP=506	GT	0/1
chr8	30210458	30210458	C	A	intergenic	DCTN6;RBPMS-AS1	dist=169303;dist=29177	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	189	chr8	30210458	chr8:30210458	C	A	.	PASS	AN=0;DP=189	GT	0/1
chr8	38239293	38239293	T	C	intronic	NSD3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	1387	chr8	38239293	chr8:38239293	T	C	144	PASS	AN=2;DP=1387	GT	0/1
chr8	98787959	98787959	C	A	UTR5	LAPTM4B	NM_018407:c.-6C>A	.	.	3.43E-05	0.583037321	0.416928384	.	0.48759	0.10563	-0.381986487	27.68931352	162.96113	2.78656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	174	chr8	98787959	chr8:98787959	C	A	124	PASS	AN=2;DP=174	GT	0/1
chr8	101908345	101908345	G	A	intergenic	PABPC1;YWHAZ	dist=174030;dist=22459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	164	chr8	101908345	chr8:101908345	G	A	100	PASS	AN=2;DP=164	GT	0/1
chr8	101960934	101960934	C	A	exonic	YWHAZ	.	nonsynonymous SNV	YWHAZ:NM_001135699:exon2:c.G184T:p.V62F,YWHAZ:NM_001135700:exon2:c.G184T:p.V62F,YWHAZ:NM_001135701:exon2:c.G184T:p.V62F,YWHAZ:NM_001135702:exon2:c.G184T:p.V62F,YWHAZ:NM_003406:exon2:c.G184T:p.V62F,YWHAZ:NM_145690:exon2:c.G184T:p.V62F	0.817170005	0.181916765	0.00091323	.	0.99976	0.58572	0.079165051	59.43029016	1.06384	0.02718	0.0	0.912	D	0.987	0.600	D	0.748	0.541	P	0.000	0.629	D	1.000	0.810	D	2.105	0.586	M	0.83	0.478	T	-2.39	0.623	N	0.82	0.821	-0.773	0.567	T	0.189	0.541	T	0.050	0.642	D	6.470	0.892	29.9	0.997	0.785	0.960	0.667	D	c	0.461	0.497	1.000	0.747	0.672	0.522	0	5.51	0.817	0.788	0.263	0.935	0.490	0.858	0.303	1.000	0.888	19.492	0.950	14-3-3 domain	.	.	0.5	76	444	chr8	101960934	chr8:101960934	C	A	76	PASS	AN=2;DP=444	GT	0/1
chr8	110499005	110499005	C	A	exonic	PKHD1L1	.	nonsynonymous SNV	PKHD1L1:NM_177531:exon59:c.C9835A:p.R3279S	9.13E-65	1.02E-07	0.999999898	.	0.38442	0.10513	5.453048233	99.84666195	12241.38174	23.72246	0.004	0.682	D	0.942	0.510	P	0.809	0.568	P	0.000	0.537	D	0.989	0.244	N	2.9	0.842	M	-1.29	0.795	T	-4.98	0.867	D	0.523	0.763	-0.013	0.820	T	0.642	0.875	D	0.043	0.608	D	4.720	0.633	24.6	0.996	0.753	0.761	0.370	D	c	0.477	0.409	0.849	0.250	0.554	0.246	0	5.42	0.786	1.543	0.355	0.935	0.490	0.999	0.424	0.676	0.304	17.071	0.864	Pectin lyase fold/virulence factor	.	.	0.5	63	78	chr8	110499005	chr8:110499005	C	A	63	PASS	AN=2;DP=78	GT	0/1
chr8	128428862	128428862	C	T	exonic	POU5F1B	.	stopgain	POU5F1B:NM_001159542:exon1:c.C751T:p.Q251X	7.27E-07	0.154902824	0.845096449	.	0.06534	.	.	.	6077.10056	16.28567	.	.	.	.	.	.	.	.	.	0.000	0.537	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8.918	0.960	35	0.986	0.430	0.241	0.221	N	c	0.201	-0.139	0.002	0.089	0.706	0.609	0	0.197	0.144	2.119	0.413	0.439	0.276	0.960	0.334	0.082	0.182	1.798	0.029	Homeobox domain|Homeodomain-like	.	.	0.5	79	396	chr8	128428862	chr8:128428862	C	T	79	PASS	AN=2;DP=396	GT	0/1
chr8	128806836	128806836	G	T	ncRNA_exonic	PVT1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	705	chr8	128806836	chr8:128806836	G	T	89	PASS	AN=2;DP=705	GT	0/1
chr8	134488107	134488107	A	G	exonic	ST3GAL1	.	nonsynonymous SNV	ST3GAL1:NM_003033:exon4:c.T161C:p.I54T,ST3GAL1:NM_173344:exon5:c.T161C:p.I54T	0.593559246	0.404393836	0.002046918	.	0.12911	0.14444	0.286674996	71.49681529	215.8106	3.17089	0.301	0.564	T	0.02	0.170	B	0.021	0.181	B	0.333	0.141	N	1.000	0.186	N	1.525	0.387	L	2.28	0.173	T	-0.22	0.679	N	0.111	0.126	-1.048	0.150	T	0.039	0.167	T	0.008	0.213	T	0.349	0.128	6.153	0.957	0.270	0.763	0.371	D	c	-0.316	-0.222	1.000	0.500	0.707	0.730	0	5.55	0.832	4.746	0.616	1.112	0.879	1.000	0.715	0.012	0.117	14.887	0.701	.	.	.	0.5	109	191	chr8	134488107	chr8:134488107	A	G	109	PASS	AN=2;DP=191	GT	0/1
chr8	142437186	142437186	G	T	intronic	PTP4A3	.	.	.	0.127669884	0.780179392	0.092150724	.	0.21928	0.22085	-0.317668748	31.45789101	12.49227	0.45442	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	622	chr8	142437186	chr8:142437186	G	T	123	PASS	AN=2;DP=622	GT	0/1
chr8	143603494	143603494	C	T	intronic	ADGRB1	.	.	.	.	.	.	.	0.12027	0.1959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	144	chr8	143603494	chr8:143603494	C	T	.	PASS	AN=0;DP=144	GT	0/1
chr8	145638078	145638078	C	A	intronic	SLC39A4	.	.	.	0.005737361	0.971586525	0.022676115	.	0.09914	0.12725	1.208829905	93.05260675	6782.66145	17.50995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	570	chr8	145638078	chr8:145638078	C	A	127	PASS	AN=2;DP=570	GT	0/1
chr8	145948629	145948629	C	A	exonic	ZNF251	.	nonsynonymous SNV	ZNF251:NM_138367:exon5:c.G416T:p.R139L	3.06E-06	0.77679478	0.22320216	.	0.06873	.	-0.510624372	21.65015334	82.4269	1.92785	0.648	0.049	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	0.55	0.145	N	3.31	0.063	T	0.73	0.021	N	0.186	0.227	-0.919	0.457	T	0.007	0.022	T	0.001	0.006	T	-0.712	0.044	0.067	0.207	0.008	0.033	0.082	N	c	-2.046	-2.108	0.005	0.109	0.651	0.465	0	-3.14	0.049	-4.047	0.003	-2.334	0.003	0.000	0.063	0.000	0.016	0.460	0.005	.	.	.	0.5	76	165	chr8	145948629	chr8:145948629	C	A	76	PASS	AN=2;DP=165	GT	0/1
chr8	145979746	145979746	G	A	intronic	ZNF251	.	.	.	3.06E-06	0.77679478	0.22320216	.	0.06873	.	-0.510624372	21.65015334	82.4269	1.92785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	230	chr8	145979746	chr8:145979746	G	A	112	PASS	AN=2;DP=230	GT	0/1
chr9	52577	52577	G	A	intergenic	FAM138C;PGM5P3-AS1	dist=16713;dist=20113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	193	chr9	52577	chr9:52577	G	A	.	PASS	AN=0;DP=193	GT	0/1
chr9	146221	146221	G	A	intronic	CBWD1	.	.	.	0.642141452	0.356513512	0.001345035	.	0.1465	0.09079	.	.	228.50043	3.26546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	314	chr9	146221	chr9:146221	G	A	61	PASS	AN=2;DP=314	GT	0/1
chr9	6413120	6413120	C	A	upstream	UHRF2	dist=31	.	.	0.999646144	0.000353856	3.45E-11	DISEASE: Note=Associated with various cancers. DNA copy number loss is found in multiple kinds of malignancies originating from the brain, breast, stomach, kidney, hematopoietic tissue and lung.; 	0.26264	0.13812	-0.380166007	27.88393489	43.75397	1.25932	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	548	chr9	6413120	chr9:6413120	C	A	.	PASS	AN=0;DP=548	GT	0/1
chr9	8449690	8449690	G	C	intronic	PTPRD	.	.	.	0.999999982	1.80E-08	4.88E-23	.	0.89661	0.17382	-3.078871465	0.483604624	1565.5627	7.32256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	269	chr9	8449690	chr9:8449690	G	C	103	PASS	AN=2;DP=269	GT	0/1
chr9	21974695	21974695	G	T	exonic	CDKN2A	.	stopgain	CDKN2A:NM_000077:exon1:c.C132A:p.Y44X,CDKN2A:NM_001195132:exon1:c.C132A:p.Y44X,CDKN2A:NM_058197:exon1:c.C132A:p.Y44X	0.357648776	0.58984451	0.052506714	DISEASE: Note=The association between cutaneous and uveal melanomas in some families suggests that mutations in CDKN2A may account for a proportion of uveal melanomas. However, CDKN2A mutations are rarely found in uveal melanoma patients.; DISEASE: Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]: A malignant neoplasm of melanocytes, arising de novo or from a pre- existing benign nevus, which occurs most often in the skin but also may involve other sites. {ECO:0000269|PubMed:10651484, ECO:0000269|PubMed:10874641, ECO:0000269|PubMed:11506491, ECO:0000269|PubMed:12019208, ECO:0000269|PubMed:14646619, ECO:0000269|PubMed:19260062, ECO:0000269|PubMed:7987387, ECO:0000269|PubMed:8595405, ECO:0000269|PubMed:8653684, ECO:0000269|PubMed:8710906, ECO:0000269|PubMed:9328469, ECO:0000269|PubMed:9425228}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome (FAMMMPC) [MIM:606719]: An inherited cancer predisposition syndrome characterized by an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Li-Fraumeni syndrome (LFS) [MIM:151623]: Autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:10484981}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Melanoma-astrocytoma syndrome (MASTS) [MIM:155755]: Characterized by a dual predisposition to melanoma and neural system tumors, commonly astrocytoma. {ECO:0000269|PubMed:11136714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.03037	0.06846	0.725794416	85.98136353	20.60127	0.70067	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7.848	0.956	35	0.984	0.403	0.199	0.206	N	c	-0.369	-0.750	1.000	0.747	0.658	0.486	0	-2.57	0.059	-1.027	0.037	0.108	0.203	0.000	0.063	0.004	0.083	3.596	0.075	Ankyrin repeat-containing domain	.	.	0.5	97	405	chr9	21974695	chr9:21974695	G	T	97	PASS	AN=2;DP=405	GT	0/1
chr9	30690073	30690073	G	C	intergenic	LINC01242;LINC01243	dist=281621;dist=681536	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	418	chr9	30690073	chr9:30690073	G	C	100	PASS	AN=2;DP=418	GT	0/1
chr9	40332652	40332652	G	T	intergenic	FAM74A1;LOC105379450	dist=426433;dist=351167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	416	chr9	40332652	chr9:40332652	G	T	114	PASS	AN=2;DP=416	GT	0/1
chr9	67284054	67284054	G	T	ncRNA_intronic	AQP7P1	.	.	.	.	.	.	.	0.02901	0.081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	301	chr9	67284054	chr9:67284054	G	T	130	PASS	AN=2;DP=301	GT	0/1
chr9	67293607	67293607	T	C	ncRNA_exonic	LOC102724580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	164	274	chr9	67293607	chr9:67293607	T	C	164	PASS	AN=2;DP=274	GT	0/1
chr9	69847082	69847082	C	T	intergenic	LOC101928381;FOXD4L5	dist=89298;dist=328625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	431	chr9	69847082	chr9:69847082	C	T	71	PASS	AN=2;DP=431	GT	0/1
chr9	70177139	70177139	G	C	exonic	FOXD4L5	.	nonsynonymous SNV	FOXD4L5:NM_001126334:exon1:c.C845G:p.P282R	.	.	.	.	.	.	.	.	79.92726	1.89028	0.004	0.654	D	0.998	0.715	D	0.965	0.695	D	0.055	0.227	U	0.999	0.215	N	0.945	0.238	L	-3.23	0.934	D	-1.92	0.446	N	0.178	0.217	-0.033	0.816	T	0.729	0.907	D	0.075	0.722	D	3.024	0.424	22.3	0.995	0.665	0.006	0.026	N	c	-0.490	-0.739	0.000	0.012	0.487	0.133	0	1.07	0.193	-0.797	0.046	0.576	0.285	0.000	0.063	0.008	0.104	5.494	0.160	.	.	.	0.5	.	437	chr9	70177139	chr9:70177139	G	C	.	PASS	AN=0;DP=437	GT	0/1
chr9	82242418	82242418	G	T	intronic	TLE4	.	.	.	0.99992164	7.84E-05	4.33E-12	.	0.94973	0.14686	-0.556537043	19.72753008	90.91723	2.05178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	368	chr9	82242418	chr9:82242418	G	T	67	PASS	AN=2;DP=368	GT	0/1
chr9	84530614	84530614	C	G	ncRNA_exonic	SPATA31D5P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	306	chr9	84530614	chr9:84530614	C	G	95	PASS	AN=2;DP=306	GT	0/1
chr9	90473388	90473388	A	T	ncRNA_exonic	LOC392364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	318	chr9	90473388	chr9:90473388	A	T	.	PASS	AN=0;DP=318	GT	0/1
chr9	90535825	90535825	C	T	exonic	SPATA31C1	.	synonymous SNV	SPATA31C1:NM_001145124:exon4:c.C1003T:p.L335L	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	361	chr9	90535825	chr9:90535825	C	T	.	PASS	AN=0;DP=361	GT	0/1
chr9	101068579	101068579	C	T	exonic	GABBR2	.	nonsynonymous SNV	GABBR2:NM_005458:exon15:c.G2053A:p.A685T	0.999790263	0.000209737	9.64E-12	.	0.72097	0.15588	-1.285933373	5.083746167	1340.48679	6.87315	0.012	0.546	D	0.999	0.764	D	0.996	0.832	D	0.000	0.843	D	1	0.810	D	1.01	0.254	L	-2.26	0.874	D	-3.06	0.630	D	0.739	0.736	0.767	0.940	D	0.799	0.932	D	0.171	0.849	D	4.022	0.540	23.6	0.999	0.995	0.994	0.954	D	c	0.706	0.605	1.000	0.747	0.706	0.609	0	5.15	0.702	7.676	0.832	0.935	0.490	1.000	0.715	0.969	0.458	16.142	0.813	GPCR family 3, C-terminal	.	.	0.5	79	354	chr9	101068579	chr9:101068579	C	T	79	PASS	AN=2;DP=354	GT	0/1
chr9	102588038	102588038	G	T	UTR5	NR4A3	NM_006981:c.-2287G>T;NM_173200:c.-1015G>T;NM_173199:c.-2287G>T	.	.	.	.	.	DISEASE: Ewing sarcoma (ES) [MIM:612219]: A highly malignant, metastatic, primitive small round cell tumor of bone and soft tissue that affects children and adolescents. It belongs to the Ewing sarcoma family of tumors, a group of morphologically heterogeneous neoplasms that share the same cytogenetic features. They are considered neural tumors derived from cells of the neural crest. Ewing sarcoma represents the less differentiated form of the tumors. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving NR4A3 is found in patients with Erwing sarcoma. Translocation t(9;22)(q22- 31;q11-12) with EWSR1.; DISEASE: Note=A chromosomal aberration involving NR4A3 is a cause of a form of extraskeletal myxoid chondrosarcomas (EMC). Translocation t(9;17)(q22;q11) with TAF2N.; 	0.71461	0.18411	-0.339715008	30.06605331	1958.05838	8.14638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	309	chr9	102588038	chr9:102588038	G	T	95	PASS	AN=2;DP=309	GT	0/1
chr9	115818958	115818958	G	A	exonic	ZFP37	.	nonsynonymous SNV	ZFP37:NM_001282515:exon1:c.C11T:p.S4F,ZFP37:NM_001282518:exon1:c.C11T:p.S4F,ZFP37:NM_003408:exon1:c.C11T:p.S4F	4.11E-09	0.103496806	0.89650319	.	0.07258	0.06248	0.264628794	70.5178108	1185.08476	6.53135	0.001	0.784	D	0.005	0.119	B	0.005	0.104	B	.	.	.	1	0.090	N	0	0.065	N	3.37	0.062	T	0.19	0.119	N	0.163	0.284	-0.950	0.411	T	0.010	0.035	T	0.010	0.271	T	4.237	0.568	23.9	0.995	0.652	0.006	0.026	N	c	-0.866	-0.849	1.000	0.747	0.524	0.211	1	1.26	0.204	0.678	0.248	0.951	0.538	0.295	0.251	0.415	0.257	4.528	0.113	.	.	.	0.5	130	618	chr9	115818958	chr9:115818958	G	A	130	PASS	AN=2;DP=618	GT	0/1
chr9	124534970	124534970	C	T	exonic	DAB2IP	.	synonymous SNV	DAB2IP:NM_138709:exon10:c.C1791T:p.P597P,DAB2IP:NM_032552:exon12:c.C2079T:p.P693P	0.999652088	0.000347912	1.63E-10	DISEASE: Note=A chromosomal aberration involving DAB2IP is found in a patient with acute myeloid leukemia (AML). Translocation t(9;11)(q34;q23) with KMT2A/MLL1. May give rise to a KMT2A/MLL1- DAB2IP fusion protein lacking the PH domain (PubMed:14978793). {ECO:0000269|PubMed:14978793}.; 	0.49661	0.13993	-1.517642441	3.467799009	1179.95825	6.52137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	348	chr9	124534970	chr9:124534970	C	T	101	PASS	AN=2;DP=348	GT	0/1
chr9	127620830	127620830	C	G	intronic	RPL35	.	.	.	0.527875069	0.456078589	0.016046342	.	0.92515	.	0.125076652	62.7388535	10.99298	0.39832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	306	chr9	127620830	chr9:127620830	C	G	103	PASS	AN=2;DP=306	GT	0/1
chr9	127623857	127623857	C	G	intronic	RPL35	.	.	.	0.527875069	0.456078589	0.016046342	.	0.92515	.	0.125076652	62.7388535	10.99298	0.39832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	521	chr9	127623857	chr9:127623857	C	G	78	PASS	AN=2;DP=521	GT	0/1
chr9	130279245	130279245	C	A	exonic	FAM129B	.	nonsynonymous SNV	FAM129B:NM_001035534:exon8:c.G825T:p.E275D,FAM129B:NM_022833:exon8:c.G864T:p.E288D	0.096703214	0.903283319	1.35E-05	.	0.24632	0.10776	-1.346642726	4.62962963	224.45345	3.23964	0.223	0.188	T	0.122	0.252	B	0.056	0.247	B	0.000	0.504	D	0.933	0.370	D	0.61	0.157	N	1.87	0.241	T	-0.87	0.236	N	0.08	0.072	-1.069	0.096	T	0.042	0.182	T	0.010	0.257	T	1.657	0.260	14.17	0.986	0.433	0.078	0.136	N	c	-0.549	-0.502	1.000	0.517	0.672	0.522	0	3.9	0.441	-0.708	0.051	0.016	0.142	0.063	0.217	0.021	0.135	7.542	0.268	.	.	.	0.5	.	207	chr9	130279245	chr9:130279245	C	A	.	PASS	AN=0;DP=207	GT	0/1
chr9	133269139	133269139	C	A	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	238	chr9	133269139	chr9:133269139	C	A	.	PASS	AN=0;DP=238	GT	0/1
chr9	133280335	133280335	G	T	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	0.005	0.119	B	0.002	0.063	B	.	.	.	.	.	.	-1.075	0.010	N	.	.	.	.	.	.	0.168	0.203	-0.993	0.317	T	0.075	0.301	T	0.003	0.073	T	1.953	0.296	15.92	0.981	0.374	0.185	0.201	N	c	-0.892	-0.739	0.040	0.144	0.646	0.450	0	1.18	0.200	-0.101	0.109	0.095	0.197	0.028	0.201	0.974	0.471	6.172	0.195	Immunoglobulin I-set|Immunoglobulin V-set domain|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	121	475	chr9	133280335	chr9:133280335	G	T	121	PASS	AN=2;DP=475	GT	0/1
chr9	134184484	134184484	C	A	UTR3	PLPP7	NM_032728:c.*810C>A	.	.	.	.	.	.	0.13175	.	-0.291981272	33.20358575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	435	chr9	134184484	chr9:134184484	C	A	92	PASS	AN=2;DP=435	GT	0/1
chr9	136403431	136403431	C	G	intronic	ADAMTSL2	.	.	.	0.071058667	0.916004048	0.012937285	DISEASE: Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]: An autosomal recessive disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone- shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues. {ECO:0000269|PubMed:18677313, ECO:0000269|PubMed:21415077}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26032	0.11516	.	.	74.41925	1.80297	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	510	chr9	136403431	chr9:136403431	C	G	123	PASS	AN=2;DP=510	GT	0/1
chr9	136412300	136412300	G	T	exonic	ADAMTSL2	.	nonsynonymous SNV	ADAMTSL2:NM_001145320:exon9:c.G904T:p.A302S,ADAMTSL2:NM_014694:exon9:c.G904T:p.A302S	0.071058667	0.916004048	0.012937285	DISEASE: Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]: An autosomal recessive disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone- shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues. {ECO:0000269|PubMed:18677313, ECO:0000269|PubMed:21415077}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26032	0.11516	.	.	74.41925	1.80297	0.0	0.912	D	1.0	0.899	D	0.984	0.745	D	0.002	0.372	N	1	0.810	D	1.455	0.369	L	0.56	0.546	T	-2.4	0.527	N	0.606	0.764	-0.625	0.638	T	0.310	0.681	T	0.024	0.468	T	4.603	0.617	24.4	0.998	0.850	0.989	0.883	D	c	0.695	0.670	1.000	0.747	0.646	0.450	0	5.16	0.704	9.847	0.984	1.048	0.713	1.000	0.715	0.997	0.653	18.645	0.913	ADAM-TS Spacer 1	.	.	0.5	76	496	chr9	136412300	chr9:136412300	G	T	76	PASS	AN=2;DP=496	GT	0/1
chr9	138648974	138648974	C	T	intronic	KCNT1	.	.	.	0.005348738	0.994649439	1.82E-06	DISEASE: Epileptic encephalopathy, early infantile, 14 (EIEE14) [MIM:614959]: A rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay. This severe neurologic disorder is characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another. {ECO:0000269|PubMed:23086397}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, nocturnal frontal lobe, 5 (ENFL5) [MIM:615005]: An autosomal dominant focal epilepsy syndrome characterized by childhood onset of clusters of motor seizures during sleep. Some patients may develop behavioral or psychiatric manifestations and/or intellectual disability. The phenotype is more severe than observed in other genetic forms of nocturnal frontal lobe epilepsy. {ECO:0000269|PubMed:23086396}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10242	0.10521	-2.070835943	1.615947157	121.99362	2.40558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	505	chr9	138648974	chr9:138648974	C	T	74	PASS	AN=2;DP=505	GT	0/1
chr9	139298595	139298595	C	A	exonic	SDCCAG3	.	nonsynonymous SNV	SDCCAG3:NM_001039708:exon7:c.G901T:p.G301C,SDCCAG3:NM_006643:exon8:c.G1051T:p.G351C,SDCCAG3:NM_001039707:exon9:c.G1120T:p.G374C	1.38E-07	0.368767768	0.631232094	.	0.13869	0.10313	0.468503535	78.79806558	1803.84196	7.83738	0.067	0.359	T	0.13	0.278	B	0.077	0.311	B	0.148	0.180	N	0.599	0.309	N	1.59	0.404	L	1.49	0.315	T	-2.55	0.558	D	0.275	0.483	-1.049	0.148	T	0.053	0.226	T	0.014	0.345	T	2.394	0.349	18.78	0.971	0.319	0.467	0.276	N	c	-0.057	-0.035	1.000	0.747	0.672	0.522	0	2.67	0.306	1.072	0.301	0.852	0.362	0.982	0.353	0.290	0.235	2.448	0.042	.	.	.	0.5	88	441	chr9	139298595	chr9:139298595	C	A	88	PASS	AN=2;DP=441	GT	0/1
chr9	139840877	139840877	G	C	intronic	C8G	.	.	.	1.63E-09	0.032163822	0.967836176	.	0.04668	.	0.196671391	67.19155461	801.2629	5.57646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	600	chr9	139840877	chr9:139840877	G	C	132	PASS	AN=2;DP=600	GT	0/1
chr9	140356813	140356813	T	A	intronic	PNPLA7	.	.	.	6.23E-27	0.002298147	0.997701853	.	0.10273	0.0978	0.163315215	64.96815287	2633.02271	9.62537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	649	chr9	140356813	chr9:140356813	T	A	124	PASS	AN=2;DP=649	GT	0/1
chr9	140357105	140357105	G	A	intronic	PNPLA7	.	.	.	6.23E-27	0.002298147	0.997701853	.	0.10273	0.0978	0.163315215	64.96815287	2633.02271	9.62537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	423	chr9	140357105	chr9:140357105	G	A	104	PASS	AN=2;DP=423	GT	0/1
chr10	1779236	1779236	G	A	intronic	ADARB2	.	.	.	0.738168861	0.261726193	0.000104945	.	0.18882	0.14637	-0.505170032	21.79759377	584.19726	4.90127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	608	chr10	1779236	chr10:1779236	G	A	126	PASS	AN=2;DP=608	GT	0/1
chr10	15761714	15761714	G	T	exonic	ITGA8	.	synonymous SNV	ITGA8:NM_001291494:exon1:c.C57A:p.P19P,ITGA8:NM_003638:exon1:c.C57A:p.P19P	5.02E-08	0.999982572	1.74E-05	.	0.19255	0.19038	-0.786348947	12.63269639	602.10061	4.96627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	213	chr10	15761714	chr10:15761714	G	T	90	PASS	AN=2;DP=213	GT	0/1
chr10	24834880	24834880	G	T	exonic	KIAA1217	.	nonsynonymous SNV	KIAA1217:NM_001321681:exon14:c.G2813T:p.G938V,KIAA1217:NM_001282768:exon18:c.G3677T:p.G1226V,KIAA1217:NM_001098500:exon19:c.G3422T:p.G1141V,KIAA1217:NM_001282767:exon19:c.G3752T:p.G1251V,KIAA1217:NM_019590:exon21:c.G5459T:p.G1820V	0.014167894	0.985832017	8.91E-08	.	0.22162	0.09445	-3.009169053	0.524887945	2127.12642	8.49315	0.009	0.912	D	0.879	0.588	P	0.426	0.500	B	0.014	0.286	N	0.998	0.810	D	1.795	0.474	L	1.42	0.344	T	-2.69	0.574	D	0.358	0.551	-1.018	0.245	T	0.124	0.428	T	0.016	0.368	T	5.390	0.730	26.0	0.996	0.732	0.815	0.406	D	c	0.437	0.470	0.987	0.311	0.706	0.609	0	4.62	0.568	2.364	0.436	1.048	0.713	1.000	0.715	0.999	0.750	13.765	0.623	.	.	.	0.5	102	127	chr10	24834880	chr10:24834880	G	T	102	PASS	AN=2;DP=127	GT	0/1
chr10	27793246	27793246	G	A	UTR5	RAB18	NM_021252:c.-53G>A;NM_001256412:c.-53G>A;NM_001256411:c.-53G>A;NM_001256410:c.-53G>A;NM_001256415:c.-53G>A	.	.	0.955008595	0.044872127	0.000119278	.	0.19227	0.1096	0.103030231	61.2762444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	454	chr10	27793246	chr10:27793246	G	A	108	PASS	AN=2;DP=454	GT	0/1
chr10	30316534	30316534	C	A	exonic	JCAD	.	nonsynonymous SNV	JCAD:NM_020848:exon3:c.G2543T:p.S848I,JCAD:NM_001350001:exon4:c.G2129T:p.S710I,JCAD:NM_001350021:exon4:c.G2129T:p.S710I,JCAD:NM_001350022:exon4:c.G2543T:p.S848I	.	.	.	.	.	.	.	.	.	.	0.01	0.564	D	1.0	0.899	D	0.971	0.708	D	.	.	.	0.951	0.265	N	1.87	0.498	L	2.25	0.178	T	-1.91	0.444	N	0.392	0.452	-1.077	0.080	T	0.083	0.325	T	0.019	0.409	T	5.862	0.803	27.3	0.996	0.729	0.938	0.590	D	c	0.239	0.136	1.000	0.747	0.714	0.819	0	4.61	0.566	2.624	0.459	0.935	0.490	0.995	0.385	0.017	0.128	11.758	0.510	.	.	.	0.5	102	334	chr10	30316534	chr10:30316534	C	A	102	PASS	AN=2;DP=334	GT	0/1
chr10	30638190	30638190	G	T	exonic	MTPAP	.	synonymous SNV	MTPAP:NM_018109:exon1:c.C15A:p.G5G	0.910575497	0.089418828	5.67E-06	.	0.0821	0.07339	-0.179930907	40.35739561	83.82931	1.94936	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	417	chr10	30638190	chr10:30638190	G	T	.	PASS	AN=0;DP=417	GT	0/1
chr10	42833142	42833142	A	T	ncRNA_exonic	LOC441666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	123	chr10	42833142	chr10:42833142	A	T	131	PASS	AN=2;DP=123	GT	0/1
chr10	42833154	42833154	T	C	ncRNA_exonic	LOC441666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	131	chr10	42833154	chr10:42833154	T	C	152	PASS	AN=2;DP=131	GT	0/1
chr10	42924593	42924593	G	-	ncRNA_exonic	CCNYL2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	287	chr10	42924592	chr10:42924592	AG	A	80	PASS	AN=2;DP=287	GT	0/1
chr10	45938895	45938895	G	C	exonic	ALOX5	.	nonsynonymous SNV	ALOX5:NM_000698:exon11:c.G1483C:p.E495Q,ALOX5:NM_001256153:exon11:c.G1387C:p.E463Q,ALOX5:NM_001256154:exon11:c.G1483C:p.E495Q,ALOX5:NM_001320861:exon11:c.G1396C:p.E466Q,ALOX5:NM_001320862:exon11:c.G1048C:p.E350Q	0.001644393	0.998111454	0.000244152	.	0.58302	0.38768	-0.953385901	9.206180703	89.21156	2.03011	0.068	0.357	T	0.01	0.271	B	0.014	0.347	B	0.012	0.292	N	1	0.090	N	.	.	.	-2.55	0.896	D	-0.28	0.116	N	0.108	0.132	-0.484	0.692	T	0.481	0.802	T	0.026	0.487	D	1.601	0.254	13.86	0.959	0.276	0.668	0.329	D	c	-0.323	-0.180	0.903	0.261	0.635	0.413	0	3.54	0.395	1.459	0.346	0.135	0.219	0.813	0.296	0.964	0.448	9.299	0.368	Lipoxygenase, C-terminal	.	.	0.5	130	592	chr10	45938895	chr10:45938895	G	C	130	PASS	AN=2;DP=592	GT	0/1
chr10	49791107	49791107	C	G	exonic	ARHGAP22	.	nonsynonymous SNV	ARHGAP22:NM_001256024:exon2:c.G125C:p.G42A,ARHGAP22:NM_001256025:exon2:c.G143C:p.G48A,ARHGAP22:NM_001347735:exon2:c.G125C:p.G42A,ARHGAP22:NM_001347737:exon2:c.G125C:p.G42A,ARHGAP22:NM_021226:exon2:c.G125C:p.G42A,ARHGAP22:NM_001347736:exon3:c.G143C:p.G48A,ARHGAP22:NM_001347738:exon3:c.G143C:p.G48A	0.000724652	0.980744858	0.01853049	.	0.12203	0.13515	-0.396754488	26.97570182	185.07105	2.95338	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1.000	0.588	D	3.81	0.956	H	-1.36	0.801	T	-4.73	0.800	D	0.464	0.732	0.820	0.947	D	0.781	0.926	D	0.206	0.871	D	5.863	0.803	27.3	0.998	0.928	0.993	0.936	D	c	0.987	0.894	1.000	0.747	0.707	0.730	0	5.28	0.740	7.531	0.807	0.935	0.490	1.000	0.715	0.916	0.392	17.462	0.875	PH domain-like|Pleckstrin homology domain	.	.	0.5	67	290	chr10	49791107	chr10:49791107	C	G	67	PASS	AN=2;DP=290	GT	0/1
chr10	50339798	50339798	C	A	exonic	FAM170B	.	stopgain	FAM170B:NM_001164484:exon2:c.G712T:p.E238X	.	.	.	.	0.14419	.	1.436808095	95.04600142	2513.30848	9.33771	.	.	.	.	.	.	.	.	.	0.002	0.383	N	1.000	0.520	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.868	0.964	36	0.994	0.614	0.403	0.262	N	c	0.451	0.247	1.000	0.517	0.497	0.185	0	2.64	0.304	2.607	0.457	0.935	0.490	0.942	0.325	0.990	0.544	7.549	0.268	.	.	.	0.5	61	232	chr10	50339798	chr10:50339798	C	A	61	PASS	AN=2;DP=232	GT	0/1
chr10	71658520	71658520	T	C	splicing	COL13A1	NM_080798:exon10:c.609+2T>C;NM_080800:exon13:c.723+2T>C;NM_001320951:exon14:c.750+2T>C;NM_001130103:exon14:c.780+2T>C	.	.	0.003928968	0.996068184	2.85E-06	.	0.28276	0.14899	-0.440847477	24.59896202	250.76638	3.41203	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.763	0.639	24.7	0.993	0.589	0.918	0.541	D	c	1.056	0.900	1.000	0.747	0.060	0.007	0	5.38	0.772	5.327	0.654	1.061	0.807	1.000	0.715	0.996	0.625	13.899	0.631	.	.	.	0.5	122	309	chr10	71658520	chr10:71658520	T	C	122	PASS	AN=2;DP=309	GT	0/1
chr10	72520775	72520775	G	T	UTR3	ADAMTS14	NM_139155:c.*166G>T;NM_080722:c.*166G>T	.	.	2.33E-06	0.999989194	8.47E-06	.	0.21639	0.12333	-0.5513802	19.86907289	5123.0958	14.71781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	194	chr10	72520775	chr10:72520775	G	T	69	PASS	AN=2;DP=194	GT	0/1
chr10	81465992	81465992	T	A	exonic	NUTM2B	.	nonsynonymous SNV	NUTM2B:NM_001278495:exon2:c.T577A:p.C193S	0.841786847	0.155272462	0.002940691	.	.	.	.	.	421.0619	4.28418	0.471	0.084	T	.	.	.	.	.	.	.	.	.	1	0.090	N	0.345	0.112	N	2.01	0.213	T	0.45	0.043	N	0.093	0.092	-0.965	0.382	T	0.017	0.070	T	0.001	0.018	T	-1.849	0.010	0.002	0.285	0.015	0.003	0.016	N	c	-1.202	-1.417	0.000	0.012	0.554	0.246	0	-1.44	0.083	-1.628	0.021	-2.511	0.003	0.000	0.063	0.000	0.016	5.635	0.167	Nuclear Testis  protein, N-terminal	.	.	0.5	107	1375	chr10	81465992	chr10:81465992	T	A	107	PASS	AN=2;DP=1375	GT	0/1
chr10	83635665	83635665	C	T	exonic	NRG3	.	nonsynonymous SNV	NRG3:NM_001010848:exon1:c.C569T:p.P190L,NRG3:NM_001165972:exon1:c.C569T:p.P190L	0.21033799	0.789584348	7.77E-05	.	0.1568	0.1028	-0.464712395	23.5727766	868.61501	5.74237	0.001	0.784	D	0.99	0.615	D	0.792	0.560	P	0.001	0.395	U	0.993	0.418	D	0.345	0.112	N	1.33	0.350	T	-1.42	0.350	N	0.118	0.130	-0.978	0.355	T	0.090	0.346	T	0.164	0.844	D	5.556	0.756	26.4	0.999	0.946	0.625	0.315	D	c	0.109	0.059	1.000	0.747	0.658	0.486	0	3.41	0.380	6.372	0.729	0.802	0.324	0.954	0.330	0.567	0.282	12.737	0.564	.	.	.	0.5	145	829	chr10	83635665	chr10:83635665	C	T	145	PASS	AN=2;DP=829	GT	0/1
chr10	89127071	89127071	A	T	intronic	NUTM2D	.	.	.	0.227557524	0.646694336	0.12574814	.	0.01294	.	.	.	4268.05044	12.98771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	560	chr10	89127071	chr10:89127071	A	T	117	PASS	AN=2;DP=560	GT	0/1
chr10	95123715	95123715	C	A	intronic	MYOF	.	.	.	2.08E-36	0.259659118	0.740340882	.	0.19502	0.13376	-0.435697896	24.68152866	2094.22471	8.43082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	505	chr10	95123715	chr10:95123715	C	A	116	PASS	AN=2;DP=505	GT	0/1
chr10	104161672	104161672	G	T	exonic	NFKB2	.	stopgain	NFKB2:NM_001261403:exon20:c.G2464T:p.E822X,NFKB2:NM_001322935:exon20:c.G2338T:p.E780X,NFKB2:NM_001077494:exon21:c.G2464T:p.E822X,NFKB2:NM_001288724:exon21:c.G2464T:p.E822X,NFKB2:NM_001322934:exon21:c.G2464T:p.E822X,NFKB2:NM_002502:exon21:c.G2464T:p.E822X	0.999696458	0.000303542	4.80E-12	DISEASE: Note=A chromosomal aberration involving NFKB2 is found in a case of B-cell non Hodgkin lymphoma (B-NHL). Translocation t(10;14)(q24;q32) with IGHA1. The resulting oncogene is also called Lyt-10C alpha variant.; DISEASE: Note=A chromosomal aberration involving NFKB2 is found in a cutaneous T-cell leukemia (C-TCL) cell line. This rearrangement produces the p80HT gene which codes for a truncated 80 kDa protein (p80HT).; DISEASE: Note=In B-cell leukemia (B-CLL) cell line, LB40 and EB308, can be found after heterogeneous chromosomal aberrations, such as internal deletions.; DISEASE: Immunodeficiency, common variable, 10 (CVID10) [MIM:615577]: A primary immunodeficiency characterized by childhood-onset of recurrent infections, hypogammaglobulinemia, and decreased numbers of memory and marginal zone B-cells. Some patients may develop autoimmune features and have circulating autoantibodies. An unusual feature is central adrenal insufficiency. {ECO:0000269|PubMed:24140114, ECO:0000269|PubMed:25524009}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.82248	0.47581	-0.778825328	12.88039632	68.14775	1.70783	.	.	.	.	.	.	.	.	.	0.036	0.246	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.738	0.970	36	0.981	0.378	0.484	0.279	N	c	0.076	-0.286	1.000	0.747	0.632	0.406	0	-1.9	0.072	0.312	0.190	-0.104	0.116	0.073	0.219	0.191	0.215	5.762	0.174	Death domain|Death-like domain	.	.	0.5	111	224	chr10	104161672	chr10:104161672	G	T	111	PASS	AN=2;DP=224	GT	0/1
chr10	118927199	118927276	GGTCCCGGCGCCCGGCCTGTGTGGTGCTCAGATCAGACTTATCCACCCGAGCACCACGCAGACCAGCGCCTGGACCAA	-	ncRNA_exonic	MIR3663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	754	chr10	118927198	chr10:118927198	TGGTCCCGGCGCCCGGCCTGTGTGGTGCTCAGATCAGACTTATCCACCCGAGCACCACGCAGACCAGCGCCTGGACCAA	T	91	PASS	AN=2;DP=754	GT	0/1
chr10	123260325	123260325	C	A	intronic	FGFR2	.	.	.	0.999752493	0.000247507	1.44E-11	DISEASE: Crouzon syndrome (CS) [MIM:123500]: An autosomal dominant syndrome characterized by craniosynostosis, hypertelorism, exophthalmos and external strabismus, parrot-beaked nose, short upper lip, hypoplastic maxilla, and a relative mandibular prognathism. {ECO:0000269|PubMed:10574673, ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11380921, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7581378, ECO:0000269|PubMed:7655462, ECO:0000269|PubMed:7874170, ECO:0000269|PubMed:7987400, ECO:0000269|PubMed:8528214, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:8946174, ECO:0000269|PubMed:8956050, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9152842, ECO:0000269|PubMed:9521581, ECO:0000269|PubMed:9677057, ECO:0000269|Ref.10}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Jackson-Weiss syndrome (JWS) [MIM:123150]: An autosomal dominant craniosynostosis syndrome characterized by craniofacial abnormalities and abnormality of the feet: broad great toes with medial deviation and tarsal-metatarsal coalescence. {ECO:0000269|PubMed:7874170, ECO:0000269|PubMed:8528214, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9385368, ECO:0000269|PubMed:9677057}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Apert syndrome (APRS) [MIM:101200]: A syndrome characterized by facio-cranio-synostosis, osseous and membranous syndactyly of the four extremities, and midface hypoplasia. The craniosynostosis is bicoronal and results in acrocephaly of brachysphenocephalic type. Syndactyly of the fingers and toes may be total (mitten hands and sock feet) or partial affecting the second, third, and fourth digits. Intellectual deficit is frequent and often severe, usually being associated with cerebral malformations. {ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7668257, ECO:0000269|PubMed:7719344, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9452027, ECO:0000269|PubMed:9677057}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pfeiffer syndrome (PS) [MIM:101600]: A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3). {ECO:0000269|PubMed:10394936, ECO:0000269|PubMed:10945669, ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7719333, ECO:0000269|PubMed:7719345, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9150725, ECO:0000269|PubMed:9693549, ECO:0000269|PubMed:9719378}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Beare-Stevenson cutis gyrata syndrome (BSTVS) [MIM:123790]: An autosomal dominant disease characterized by craniofacial anomalies, particularly craniosynostosis, and ear defects, cutis gyrata, acanthosis nigricans, anogenital anomalies, skin tags, and prominent umbilical stump. The skin furrows have a corrugated appearance and are widespread. Cutis gyrata variably affects the scalp, forehead, face, preauricular area, neck, trunk, hands, and feet. {ECO:0000269|PubMed:12000365, ECO:0000269|PubMed:8696350}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial scaphocephaly syndrome (FSPC) [MIM:609579]: An autosomal dominant craniosynostosis syndrome characterized by scaphocephaly, macrocephaly, hypertelorism, maxillary retrusion, and mild intellectual disability. Scaphocephaly is the most common of the craniosynostosis conditions and is characterized by a long, narrow head. It is due to premature fusion of the sagittal suture or from external deformation. {ECO:0000269|PubMed:16061565}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730]: An autosomal dominant ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Lacrimo-auriculo-dento-digital syndrome is characterized by aplastic/hypoplastic lacrimal and salivary glands and ducts, cup-shaped ears, hearing loss, hypodontia and enamel hypoplasia, and distal limb segments anomalies. In addition to these cardinal features, facial dysmorphism, malformations of the kidney and respiratory system and abnormal genitalia have been reported. Craniosynostosis and severe syndactyly are not observed. {ECO:0000269|PubMed:16501574}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410]: A rare syndrome characterized by craniosynostosis, radiohumeral synostosis present from the perinatal period, midface hypoplasia, choanal stenosis or atresia, femoral bowing and multiple joint contractures. Arachnodactyly and/or camptodactyly have also been reported. {ECO:0000269|PubMed:10633130}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bent bone dysplasia syndrome (BBDS) [MIM:614592]: A perinatal lethal skeletal dysplasia characterized by poor mineralization of the calvarium, craniosynostosis, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones. Dysmorphic facial features included low-set ears, hypertelorism, midface hypoplasia, prematurely erupted fetal teeth, and micrognathia. {ECO:0000269|PubMed:22387015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.96396	0.7628	-1.50462206	3.568058504	593.43974	4.93642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	359	chr10	123260325	chr10:123260325	C	A	77	PASS	AN=2;DP=359	GT	0/1
chr10	135142432	135142432	C	A	exonic	CALY	.	nonsynonymous SNV	CALY:NM_015722:exon2:c.G62T:p.G21V	0.706613402	0.277792655	0.015593942	.	0.1537	0.13077	.	.	177.87988	2.8985	0.0	0.912	D	1.0	0.899	D	0.985	0.749	D	0.000	0.629	D	1.000	0.810	D	2.915	0.845	M	.	.	.	-5.47	0.904	D	0.651	0.771	-0.458	0.702	T	0.326	0.695	T	0.192	0.863	D	5.028	0.677	25.2	0.995	0.678	0.227	0.216	N	c	0.132	-0.057	0.997	0.354	0.598	0.340	0	2.62	0.302	0.230	0.175	0.047	0.160	0.010	0.182	0.020	0.134	6.860	0.231	.	.	.	0.5	67	393	chr10	135142432	chr10:135142432	C	A	67	PASS	AN=2;DP=393	GT	0/1
chr10	135372870	135372870	C	G	intronic	SYCE1	.	.	.	0.000763635	0.981995413	0.017240952	.	.	0.08486	1.374284246	94.51521585	1749.70499	7.72284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	173	436	chr10	135372870	chr10:135372870	C	G	173	PASS	AN=2;DP=436	GT	0/1
chr10	135379064	135379064	G	T	UTR5	SYCE1	NM_001143763:c.-31C>A	.	.	0.000763635	0.981995413	0.017240952	.	.	0.08486	1.374284246	94.51521585	1749.70499	7.72284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	1015	chr10	135379064	chr10:135379064	G	T	129	PASS	AN=2;DP=1015	GT	0/1
chr11	199467	199467	C	A	exonic	ODF3	.	nonsynonymous SNV	ODF3:NM_053280:exon6:c.C633A:p.D211E	0.586974862	0.402841641	0.010183496	.	0.18037	0.1095	0.174625237	65.9648502	456.66332	4.43875	0.06	0.373	T	0.634	0.384	P	0.281	0.386	B	0.000	0.486	D	1	0.810	D	2.005	0.547	M	1.41	0.334	T	-2.98	0.620	D	0.301	0.361	-1.099	0.041	T	0.058	0.244	T	0.009	0.227	T	2.785	0.396	21.3	0.991	0.519	0.230	0.217	N	c	-0.179	-0.167	0.962	0.285	0.403	0.052	0	2.23	0.271	-0.189	0.095	0.077	0.185	0.742	0.288	0.999	0.750	4.226	0.100	.	.	.	0.5	100	421	chr11	199467	chr11:199467	C	A	100	PASS	AN=2;DP=421	GT	0/1
chr11	1016630	1016630	G	A	exonic	MUC6	.	synonymous SNV	MUC6:NM_005961:exon31:c.C6171T:p.S2057S	1.09E-32	4.75E-05	0.999952489	.	0.16113	0.17704	1.26225728	93.56569946	5602.29835	15.48599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	849	chr11	1016630	chr11:1016630	G	A	145	PASS	AN=2;DP=849	GT	0/1
chr11	1221758	1221758	G	A	exonic	MUC5AC	.	unknown	UNKNOWN	.	.	.	.	0.15646	.	.	.	993.41134	6.07467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.23	0.897	M	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.865	0.177	9.861	0.799	0.125	0.913	0.531	D	n	1.251	1.181	1.000	0.747	0.078	0.016	0	4.48	0.538	3.067	0.495	0.951	0.538	1.000	0.715	0.049	0.163	14.439	0.667	Cystine knot, C-terminal	.	.	0.5	115	285	chr11	1221758	chr11:1221758	G	A	115	PASS	AN=2;DP=285	GT	0/1
chr11	1271009	1271009	C	A	exonic	MUC5B	.	nonsynonymous SNV	MUC5B:NM_002458:exon31:c.C12899A:p.S4300Y	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	0.008	0.586	D	0.464	0.346	P	0.086	0.280	B	.	.	.	1	0.090	N	2.005	0.547	M	2.05	0.207	T	-1.0	0.264	N	0.157	0.189	-1.034	0.190	T	0.043	0.186	T	0.003	0.070	T	-0.383	0.063	0.424	0.608	0.064	0.016	0.051	N	c	-0.834	-1.010	0.000	0.038	0.554	0.246	0	0.016	0.134	1.089	0.303	-0.152	0.108	0.003	0.159	0.005	0.090	5.720	0.171	.	.	.	0.5	.	305	chr11	1271009	chr11:1271009	C	A	.	PASS	AN=0;DP=305	GT	0/1
chr11	1271010	1271010	C	A	exonic	MUC5B	.	synonymous SNV	MUC5B:NM_002458:exon31:c.C12900A:p.S4300S	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	297	chr11	1271010	chr11:1271010	C	A	.	PASS	AN=0;DP=297	GT	0/1
chr11	1464604	1464604	T	A	exonic	BRSK2	.	nonsynonymous SNV	BRSK2:NM_001256627:exon7:c.T604A:p.C202S,BRSK2:NM_001256629:exon7:c.T604A:p.C202S,BRSK2:NM_001256630:exon7:c.T742A:p.C248S,BRSK2:NM_001282218:exon7:c.T424A:p.C142S,BRSK2:NM_003957:exon7:c.T604A:p.C202S	0.779570081	0.220416998	1.29E-05	.	0.16676	0.10676	-1.506435464	3.544468035	64.45039	1.64641	0.003	0.784	D	0.58	0.615	P	0.557	0.670	P	0.000	0.843	U	1.000	0.810	D	0.67	0.164	N	1.86	0.243	T	-8.64	0.975	D	0.69	0.813	-0.978	0.354	T	0.117	0.413	T	0.253	0.892	D	4.816	0.646	24.8	0.993	0.589	0.851	0.439	D	c	0.187	0.142	0.999	0.398	0.696	0.567	0	3.55	0.396	4.389	0.592	0.831	0.339	1.000	0.715	0.964	0.448	12.312	0.541	Protein kinase domain|Protein kinase-like domain|Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	0.5	114	578	chr11	1464604	chr11:1464604	T	A	114	PASS	AN=2;DP=578	GT	0/1
chr11	1629400	1629400	G	T	exonic	KRTAP5-3	.	synonymous SNV	KRTAP5-3:NM_001012708:exon1:c.C216A:p.G72G	0.262910457	0.638148141	0.098941402	.	0.11645	.	0.637604436	83.77565464	285.15099	3.61497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	204	chr11	1629400	chr11:1629400	G	T	.	PASS	AN=0;DP=204	GT	0/1
chr11	2018440	2018440	G	A	ncRNA_exonic	H19	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	437	chr11	2018440	chr11:2018440	G	A	89	PASS	AN=2;DP=437	GT	0/1
chr11	2356603	2356603	T	C	ncRNA_intronic	CD81-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	148	chr11	2356603	chr11:2356603	T	C	145	PASS	AN=2;DP=148	GT	0/1
chr11	2591883	2591883	G	T	exonic	KCNQ1	.	nonsynonymous SNV	KCNQ1:NM_000218:exon3:c.G503T:p.G168V,KCNQ1:NM_181798:exon3:c.G122T:p.G41V	2.45E-05	0.980167927	0.019807543	DISEASE: Long QT syndrome 1 (LQT1) [MIM:192500]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:10024302, ECO:0000269|PubMed:10220144, ECO:0000269|PubMed:10220146, ECO:0000269|PubMed:10367071, ECO:0000269|PubMed:10409658, ECO:0000269|PubMed:10482963, ECO:0000269|PubMed:10728423, ECO:0000269|PubMed:10973849, ECO:0000269|PubMed:11799244, ECO:0000269|PubMed:12442276, ECO:0000269|PubMed:15840476, ECO:0000269|PubMed:16414944, ECO:0000269|PubMed:16922724, ECO:0000269|PubMed:18165683, ECO:0000269|PubMed:18400097, ECO:0000269|PubMed:19540844, ECO:0000269|PubMed:19716085, ECO:0000269|PubMed:21241800, ECO:0000269|PubMed:24184248, ECO:0000269|PubMed:24269949, ECO:0000269|PubMed:24713462, ECO:0000269|PubMed:25037568, ECO:0000269|PubMed:25139741, ECO:0000269|PubMed:25705178, ECO:0000269|PubMed:8528244, ECO:0000269|PubMed:8818942, ECO:0000269|PubMed:8872472, ECO:0000269|PubMed:9024139, ECO:0000269|PubMed:9272155, ECO:0000269|PubMed:9302275, ECO:0000269|PubMed:9312006, ECO:0000269|PubMed:9323054, ECO:0000269|PubMed:9386136, ECO:0000269|PubMed:9482580, ECO:0000269|PubMed:9570196, ECO:0000269|PubMed:9641694, ECO:0000269|PubMed:9693036, ECO:0000269|PubMed:9702906, ECO:0000269|PubMed:9799083, ECO:0000269|PubMed:9927399, ECO:0000269|Ref.31}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400]: An autosomal recessive disorder characterized by congenital deafness, prolongation of the QT interval, syncopal attacks due to ventricular arrhythmias, and a high risk of sudden death. {ECO:0000269|PubMed:10090886, ECO:0000269|PubMed:10728423, ECO:0000269|PubMed:18400097, ECO:0000269|PubMed:18441444, ECO:0000269|PubMed:25705178, ECO:0000269|PubMed:9781056}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrial fibrillation, familial, 3 (ATFB3) [MIM:607554]: An autosomal dominant form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:12522251}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short QT syndrome 2 (SQT2) [MIM:609621]: A heart disorder characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. It causes syncope and sudden death. {ECO:0000269|PubMed:15159330}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:18711366, ECO:0000269|PubMed:18711367, ECO:0000269|PubMed:24390345}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.32219	0.33671	-0.685180376	15.32200991	131.10283	2.49419	0.004	0.784	D	0.999	0.764	D	0.993	0.797	D	0.000	0.843	D	1	0.810	D	0.96	0.240	L	-4.84	0.982	D	-6.79	0.928	D	0.937	0.931	1.084	0.990	D	0.930	0.977	D	0.823	0.986	D	6.022	0.828	27.9	0.998	0.882	0.997	0.987	D	c	0.616	0.615	1.000	0.747	0.701	0.575	0	4.41	0.524	7.615	0.821	0.998	0.613	1.000	0.715	0.992	0.562	16.105	0.809	Ion transport domain	.	.	0.5	116	289	chr11	2591883	chr11:2591883	G	T	116	PASS	AN=2;DP=289	GT	0/1
chr11	3657347	3657347	G	T	ncRNA_exonic	TRPC2	.	.	.	.	.	.	.	0.54481	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	335	chr11	3657347	chr11:3657347	G	T	79	PASS	AN=2;DP=335	GT	0/1
chr11	4263954	4263954	C	A	intergenic	LOC100506082;OR52B4	dist=40071;dist=124539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	221	chr11	4263954	chr11:4263954	C	A	78	PASS	AN=2;DP=221	GT	0/1
chr11	6470696	6470696	G	C	intronic	TRIM3	.	.	.	0.952560875	0.047437989	1.14E-06	.	0.41195	0.15175	-1.199555187	5.761972163	44.30437	1.27061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	133	chr11	6470696	chr11:6470696	G	C	.	PASS	AN=0;DP=133	GT	0/1
chr11	15134112	15134112	G	T	splicing	INSC	NM_001031853:exon1:c.96+1G>T	.	.	1.34E-09	0.338205484	0.661794515	.	0.24334	0.13495	0.892856963	89.28992687	1315.35282	6.81837	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.322	0.579	24.0	0.988	0.454	0.898	0.502	D	c	0.899	0.678	0.343	0.196	0.054	0.004	0	3.54	0.395	3.841	0.553	1.048	0.713	0.994	0.380	0.730	0.316	10.919	0.462	.	.	.	0.5	116	728	chr11	15134112	chr11:15134112	G	T	116	PASS	AN=2;DP=728	GT	0/1
chr11	17426154	17426154	G	T	exonic	ABCC8	.	synonymous SNV	ABCC8:NM_000352:exon28:c.C3462A:p.A1154A,ABCC8:NM_001287174:exon28:c.C3465A:p.A1155A,ABCC8:NM_001351295:exon28:c.C3528A:p.A1176A,ABCC8:NM_001351296:exon28:c.C3462A:p.A1154A,ABCC8:NM_001351297:exon28:c.C3459A:p.A1153A	3.94E-15	0.998700876	0.001299124	DISEASE: Leucine-induced hypoglycemia (LIH) [MIM:240800]: Rare cause of hypoglycemia and is described as a condition in which symptomatic hypoglycemia is provoked by high protein feedings. Hypoglycemia is also elicited by administration of oral or intravenous infusions of a single amino acid, leucine. {ECO:0000269|PubMed:15356046}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]: Most common cause of persistent hypoglycemia in infancy. Unless early and aggressive intervention is undertaken, brain damage from recurrent episodes of hypoglycemia may occur. {ECO:0000269|PubMed:10202168, ECO:0000269|PubMed:10334322, ECO:0000269|PubMed:12364426, ECO:0000269|PubMed:12941782, ECO:0000269|PubMed:15562009, ECO:0000269|PubMed:15579781, ECO:0000269|PubMed:15807877, ECO:0000269|PubMed:16357843, ECO:0000269|PubMed:16429405, ECO:0000269|PubMed:24814349, ECO:0000269|PubMed:25720052, ECO:0000269|PubMed:8751851, ECO:0000269|PubMed:8923011, ECO:0000269|PubMed:9618169, ECO:0000269|PubMed:9769320}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, permanent neonatal (PNDM) [MIM:606176]: A rare form of diabetes distinct from childhood- onset autoimmune diabetes mellitus type 1. It is characterized by insulin-requiring hyperglycemia that is diagnosed within the first months of life. Permanent neonatal diabetes requires lifelong therapy. {ECO:0000269|PubMed:16613899, ECO:0000269|PubMed:16885549, ECO:0000269|PubMed:17213273, ECO:0000269|PubMed:17668386}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Transient neonatal diabetes mellitus 2 (TNDM2) [MIM:610374]: Neonatal diabetes is a form of diabetes mellitus defined by the onset of mild-to-severe hyperglycemia within the first months of life. Transient neonatal diabetes remits early, with a possible relapse during adolescence. {ECO:0000269|PubMed:16885549}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15041	0.43468	-2.091107194	1.568766218	407.27264	4.2315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	323	chr11	17426154	chr11:17426154	G	T	84	PASS	AN=2;DP=323	GT	0/1
chr11	19853946	19853946	A	T	intronic	NAV2	.	.	.	0.997517125	0.002482875	4.58E-16	.	0.41631	0.11088	-1.555318186	3.22009908	8281.16376	19.67042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	196	chr11	19853946	chr11:19853946	A	T	103	PASS	AN=2;DP=196	GT	0/1
chr11	43702296	43702296	C	T	UTR5	HSD17B12	NM_016142:c.-82C>T	.	.	0.005554478	0.970740124	0.023705398	.	0.11055	0.19829	0.060756528	58.52795471	416.42358	4.2711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	519	chr11	43702296	chr11:43702296	C	T	.	PASS	AN=0;DP=519	GT	0/1
chr11	47371399	47371399	C	A	exonic	MYBPC3	.	nonsynonymous SNV	MYBPC3:NM_000256:exon5:c.G580T:p.G194C	1.35E-06	0.999906933	9.17E-05	DISEASE: Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:11499718, ECO:0000269|PubMed:11499719, ECO:0000269|PubMed:11815426, ECO:0000269|PubMed:12379228, ECO:0000269|PubMed:12628722, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:12818575, ECO:0000269|PubMed:12951062, ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:14563344, ECO:0000269|PubMed:15114369, ECO:0000269|PubMed:15519027, ECO:0000269|PubMed:15563892, ECO:0000269|PubMed:16004897, ECO:0000269|PubMed:16199542, ECO:0000269|PubMed:18403758, ECO:0000269|PubMed:18929575, ECO:0000269|PubMed:18957093, ECO:0000269|PubMed:23840593, ECO:0000269|PubMed:7744002, ECO:0000269|PubMed:9048664, ECO:0000269|PubMed:9541104, ECO:0000269|PubMed:9541115, ECO:0000269|PubMed:9562578}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1MM (CMD1MM) [MIM:615396]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:20215591}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=MYBPC3 mutations may be involved in restrictive cardiomyopathy (RCM), a rare non-ischemic myocardial disease. RCM is characterized by restrictive ventricular-filling physiology in the presence of normal or reduced diastolic and/or systolic volumes (of 1 or both ventricles), biatrial enlargement, and normal ventricular wall thickness. {ECO:0000269|PubMed:26163040}.; DISEASE: Left ventricular non-compaction 10 (LVNC10) [MIM:615396]: A disease due to an arrest of myocardial morphogenesis. It is characterized by a hypertrophic left ventricle with deep trabeculations and with poor systolic function, with or without associated left ventricular dilation. In some cases, it is associated with other congenital heart anomalies. {ECO:0000269|PubMed:21551322}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.49203	0.21433	-0.534756622	20.54140127	1069.38163	6.26965	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	.	.	.	1	0.810	D	2.635	0.774	M	-0.6	0.717	T	-8.13	0.967	D	0.897	0.886	0.392	0.890	D	0.604	0.859	D	0.294	0.907	D	7.019	0.938	33	0.998	0.885	0.987	0.851	D	c	0.854	0.785	1.000	0.747	0.403	0.052	0	4.8	0.610	7.899	0.859	0.935	0.490	1.000	0.715	1.000	0.888	18.212	0.898	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	188	chr11	47371399	chr11:47371399	C	A	.	PASS	AN=0;DP=188	GT	0/1
chr11	47371400	47371400	C	T	exonic	MYBPC3	.	synonymous SNV	MYBPC3:NM_000256:exon5:c.G579A:p.K193K	1.35E-06	0.999906933	9.17E-05	DISEASE: Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:11499718, ECO:0000269|PubMed:11499719, ECO:0000269|PubMed:11815426, ECO:0000269|PubMed:12379228, ECO:0000269|PubMed:12628722, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:12818575, ECO:0000269|PubMed:12951062, ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:14563344, ECO:0000269|PubMed:15114369, ECO:0000269|PubMed:15519027, ECO:0000269|PubMed:15563892, ECO:0000269|PubMed:16004897, ECO:0000269|PubMed:16199542, ECO:0000269|PubMed:18403758, ECO:0000269|PubMed:18929575, ECO:0000269|PubMed:18957093, ECO:0000269|PubMed:23840593, ECO:0000269|PubMed:7744002, ECO:0000269|PubMed:9048664, ECO:0000269|PubMed:9541104, ECO:0000269|PubMed:9541115, ECO:0000269|PubMed:9562578}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1MM (CMD1MM) [MIM:615396]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:20215591}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=MYBPC3 mutations may be involved in restrictive cardiomyopathy (RCM), a rare non-ischemic myocardial disease. RCM is characterized by restrictive ventricular-filling physiology in the presence of normal or reduced diastolic and/or systolic volumes (of 1 or both ventricles), biatrial enlargement, and normal ventricular wall thickness. {ECO:0000269|PubMed:26163040}.; DISEASE: Left ventricular non-compaction 10 (LVNC10) [MIM:615396]: A disease due to an arrest of myocardial morphogenesis. It is characterized by a hypertrophic left ventricle with deep trabeculations and with poor systolic function, with or without associated left ventricular dilation. In some cases, it is associated with other congenital heart anomalies. {ECO:0000269|PubMed:21551322}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.49203	0.21433	-0.534756622	20.54140127	1069.38163	6.26965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	188	chr11	47371400	chr11:47371400	C	T	.	PASS	AN=0;DP=188	GT	0/1
chr11	49010731	49010731	T	A	intergenic	OR4A47;TRIM49B	dist=499457;dist=42421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	130	chr11	49010731	chr11:49010731	T	A	.	PASS	AN=0;DP=130	GT	0/1
chr11	49859690	49859690	C	A	intergenic	LOC440040;OR4C13	dist=27721;dist=114253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	124	chr11	49859690	chr11:49859690	C	A	.	PASS	AN=0;DP=124	GT	0/1
chr11	55032505	55032505	C	A	exonic	TRIM48	.	nonsynonymous SNV	TRIM48:NM_024114:exon2:c.C174A:p.N58K	1.77E-14	0.000532837	0.999467163	.	0.05186	.	1.840996754	97.08657702	499.24357	4.58752	0.277	0.156	T	0.17	0.270	B	0.297	0.392	B	.	.	.	0.993	0.237	N	0.1	0.085	N	3.18	0.075	T	-1.66	0.397	N	0.163	0.196	-0.884	0.494	T	0.013	0.052	T	0.002	0.026	T	1.003	0.190	10.68	0.593	0.060	0.564	0.299	D	c	-0.813	-0.864	0.000	0.035	0.487	0.133	0	0.596	0.166	4.273	0.585	0.142	0.226	0.366	0.257	0.655	0.299	7.138	0.246	Zinc finger, RING/FYVE/PHD-type	.	.	0.5	111	140	chr11	55032505	chr11:55032505	C	A	111	PASS	AN=2;DP=140	GT	0/1
chr11	55059888	55059888	G	T	intergenic	TRIM48;TRIM51HP	dist=21293;dist=1291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	336	chr11	55059888	chr11:55059888	G	T	91	PASS	AN=2;DP=336	GT	0/1
chr11	60785733	60785733	G	C	intronic	CD6	.	.	.	0.004304658	0.98846706	0.007228281	.	0.24185	.	0.821252311	88.01604152	3740.49434	11.95458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	465	chr11	60785733	chr11:60785733	G	C	109	PASS	AN=2;DP=465	GT	0/1
chr11	61187363	61187363	C	-	intronic	CPSF7	.	.	.	0.991330175	0.008669408	4.17E-07	.	.	.	-0.626318434	17.03231894	16.33135	0.57846	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	483	chr11	61187362	chr11:61187362	AC	A	78	PASS	AN=2;DP=483	GT	0/1
chr11	61537709	61537709	C	T	intronic	MYRF	.	.	.	0.999847803	0.000152197	4.41E-12	.	0.22352	0.1057	-1.082044518	7.242274121	229.21291	3.27206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	374	chr11	61537709	chr11:61537709	C	T	112	PASS	AN=2;DP=374	GT	0/1
chr11	61734929	61734929	C	T	UTR5	FTH1	NM_002032:c.-32G>A	.	.	0.918437495	0.081030258	0.000532248	.	.	0.48545	0.103030231	61.2762444	8.70049	0.31993	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	672	chr11	61734929	chr11:61734929	C	T	74	PASS	AN=2;DP=672	GT	0/1
chr11	61908118	61908118	G	T	intronic	INCENP	.	.	.	0.996086665	0.003913333	2.44E-09	.	0.16577	0.12728	0.832189686	88.12809625	6919.01907	17.71496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	246	chr11	61908118	chr11:61908118	G	T	.	PASS	AN=0;DP=246	GT	0/1
chr11	62293635	62293635	C	A	exonic	AHNAK	.	nonsynonymous SNV	AHNAK:NM_001346445:exon5:c.G8254T:p.A2752S,AHNAK:NM_001346446:exon5:c.G8254T:p.A2752S,AHNAK:NM_001620:exon5:c.G8254T:p.A2752S	0.344567387	0.655432572	4.07E-08	.	0.19089	.	-2.834287974	0.613352206	5147.67106	14.73759	0.044	0.410	D	0.712	0.402	P	0.196	0.350	B	.	.	.	1	0.810	D	1.665	0.427	L	3.45	0.053	T	-1.26	0.318	N	0.099	0.101	-1.032	0.197	T	0.019	0.081	T	0.005	0.113	T	1.614	0.255	13.93	0.985	0.414	0.610	0.311	D	c	-0.402	-0.475	1.000	0.500	0.732	0.924	0	3.37	0.375	1.178	0.314	-0.086	0.118	0.000	0.063	0.001	0.043	12.170	0.533	.	.	.	0.5	98	350	chr11	62293635	chr11:62293635	C	A	98	PASS	AN=2;DP=350	GT	0/1
chr11	62378331	62378331	T	A	intronic	EML3	.	.	.	0.394340909	0.605658415	6.76E-07	.	0.25723	0.09936	-0.843147538	11.2762444	758.07118	5.45547	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	320	chr11	62378331	chr11:62378331	T	A	.	PASS	AN=0;DP=320	GT	0/1
chr11	62476390	62476390	C	A	ncRNA_intronic	HNRNPUL2-BSCL2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	482	chr11	62476390	chr11:62476390	C	A	97	PASS	AN=2;DP=482	GT	0/1
chr11	64457918	64457918	-	C	exonic	NRXN2	.	frameshift insertion	NRXN2:NM_015080:exon5:c.808dupG:p.A270Gfs*26	0.999895574	0.000104426	7.22E-14	.	0.24191	0.10189	-2.164449385	1.427223402	1296.88776	6.77694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	770	chr11	64457918	chr11:64457918	G	GC	99	PASS	AN=2;DP=770	GT	0/1
chr11	66623971	66623971	-	C	intronic	PC	.	.	.	0.71643567	0.283564107	2.23E-07	DISEASE: Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]: Leads to lactic acidosis, mental retardation and death. It occurs in three forms: mild or type A, severe neonatal or type B, and a very mild lacticacidemia. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.19381	0.81784	-1.74358502	2.394432649	138.12153	2.55935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	480	chr11	66623971	chr11:66623971	G	GC	97	PASS	AN=2;DP=480	GT	0/1
chr11	67250632	67250632	G	T	exonic	AIP	.	nonsynonymous SNV	AIP:NM_001302960:exon1:c.G3T:p.M1I,AIP:NM_003977:exon1:c.G3T:p.M1I	0.673915914	0.325081824	0.001002262	DISEASE: ACTH-secreting pituitary adenoma (ASPA) [MIM:219090]: A pituitary adenoma resulting in excessive production of adrenocorticotropic hormone. This leads to hypersecretion of cortisol by the adrenal glands and ACTH-dependent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:17360484}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Prolactin-secreting pituitary adenoma (PSPA) [MIM:600634]: Most common type of hormonally active pituitary adenoma. {ECO:0000269|PubMed:16728643, ECO:0000305|PubMed:17244780}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.51148	0.13318	-0.135838822	43.77211607	39.115	1.15958	0.0	0.912	D	0.963	0.537	D	0.447	0.442	P	0.000	0.843	D	1	0.810	D	.	.	.	-2.84	0.913	D	-1.35	0.375	N	0.876	0.864	0.550	0.912	D	0.713	0.901	D	0.851	0.989	D	6.836	0.927	33	0.996	0.765	0.958	0.660	D	c	0.424	0.468	1.0	0.983	0.442	0.072	0	5.16	0.704	3.410	0.522	1.048	0.713	1.000	0.715	1.000	0.888	14.006	0.638	.	.	.	0.5	105	694	chr11	67250632	chr11:67250632	G	T	105	PASS	AN=2;DP=694	GT	0/1
chr11	71822165	71822165	-	TGCTGGGGTCTCTGTCTA	intronic	ANAPC15	.	.	.	0.564413605	0.423423147	0.012163248	.	0.39459	0.11262	0.079165051	59.43029016	5.13875	0.19088	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	164	127	chr11	71822165	chr11:71822165	G	GTGCTGGGGTCTCTGTCTA	164	PASS	AN=2;DP=127	GT	1/0
chr11	73058016	73058016	G	T	intronic	ARHGEF17	.	.	.	0.995257099	0.004742901	5.43E-14	.	0.30241	0.104	-0.748045379	13.74734607	3511.2966	11.43648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	96	chr11	73058016	chr11:73058016	G	T	.	PASS	AN=0;DP=96	GT	0/1
chr11	74875100	74875100	C	A	exonic	SLCO2B1	.	nonsynonymous SNV	SLCO2B1:NM_001145211:exon3:c.C174A:p.F58L,SLCO2B1:NM_007256:exon3:c.C240A:p.F80L	0.003353563	0.996214752	0.000431685	.	0.12048	0.17779	-0.483123186	22.78249587	2109.9785	8.45565	0.001	0.784	D	0.945	0.513	P	0.667	0.512	P	0.000	0.460	D	0.989	0.810	D	4.135	0.976	H	-0.09	0.641	T	-5.13	0.832	D	0.543	0.580	-0.231	0.769	T	0.356	0.719	T	0.158	0.839	D	5.636	0.768	26.6	0.993	0.579	0.179	0.198	N	c	-0.187	-0.389	1.000	0.500	0.549	0.223	0	-3.11	0.049	-2.095	0.014	-1.093	0.019	0.000	0.063	0.935	0.408	10.527	0.440	Major facilitator superfamily domain	.	.	0.5	.	296	chr11	74875100	chr11:74875100	C	A	.	PASS	AN=0;DP=296	GT	0/1
chr11	74998428	74998428	G	C	intronic	ARRB1	.	.	.	0.986801821	0.013197011	1.17E-06	.	0.26736	0.17451	-0.844966979	11.1759849	138.55265	2.56415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	342	chr11	74998428	chr11:74998428	G	C	68	PASS	AN=2;DP=342	GT	0/1
chr11	85375173	85375173	C	T	exonic	CREBZF	.	synonymous SNV	CREBZF:NM_001039618:exon1:c.G747A:p.E249E	0.036661649	0.832377449	0.130960902	.	0.37422	0.47084	-0.139478553	43.29440906	117.84489	2.35984	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	1450	chr11	85375173	chr11:85375173	C	T	94	PASS	AN=2;DP=1450	GT	0/1
chr11	113668841	113668841	G	A	UTR3	USP28	NM_001301029:c.*1121C>T;NM_001346263:c.*1121C>T;NM_001346265:c.*1121C>T;NM_001346259:c.*1121C>T;NM_001346252:c.*1121C>T;NM_001346269:c.*1121C>T;NM_001346267:c.*1121C>T;NM_001346262:c.*1121C>T;NM_001346258:c.*1121C>T;NM_001346264:c.*1121C>T;NM_001346255:c.*1121C>T;NM_001346270:c.*1121C>T;NM_001346253:c.*1121C>T;NM_001346257:c.*1121C>T;NM_001346271:c.*1121C>T;NM_020886:c.*1121C>T;NM_001346272:c.*1121C>T;NM_001346261:c.*1121C>T;NM_001346268:c.*1121C>T;NM_001346254:c.*1121C>T;NM_001346260:c.*1121C>T	.	.	0.031657505	0.968342468	2.69E-08	.	0.60849	0.11751	-0.791786324	12.59731069	79.98741	1.89131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	252	chr11	113668841	chr11:113668841	G	A	126	PASS	AN=2;DP=252	GT	0/1
chr11	118888210	118888210	A	G	exonic	RPS25	.	synonymous SNV	RPS25:NM_001028:exon3:c.T145C:p.L49L	0.809686936	0.185516254	0.00479681	.	0.94325	0.1705	0.013025609	54.62962963	2.43389	0.08748	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	213	chr11	118888210	chr11:118888210	A	G	.	PASS	AN=0;DP=213	GT	0/1
chr11	119210088	119210088	C	A	exonic	C1QTNF5	.	stopgain	C1QTNF5:NM_001278431:exon3:c.G685T:p.G229X,C1QTNF5:NM_015645:exon15:c.G685T:p.G229X	0.830646789	0.165834575	0.003518635	DISEASE: Late-onset retinal degeneration (LORD) [MIM:605670]: Autosomal dominant disorder characterized by onset in the fifth to sixth decade with night blindness and punctate yellow-white deposits in the retinal fundus, progressing to severe central and peripheral degeneration, with choroidal neovascularization and chorioretinal atrophy. {ECO:0000269|PubMed:12944416, ECO:0000269|PubMed:22892318}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10641	.	.	.	17.68431	0.61873	.	.	.	.	.	.	.	.	.	0.000	0.843	U	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.748	0.998	47	0.992	0.559	0.990	0.894	D	c	1.116	0.938	1.0	0.983	0.628	0.401	0	4.48	0.538	6.054	0.705	0.852	0.362	1.000	0.715	0.998	0.697	17.366	0.872	C1q domain|Tumour necrosis factor-like domain	.	.	0.5	.	187	chr11	119210088	chr11:119210088	C	A	.	PASS	AN=0;DP=187	GT	0/1
chr11	123909490	123909490	A	T	exonic	OR10G7	.	synonymous SNV	OR10G7:NM_001004463:exon1:c.T219A:p.T73T	0.007122109	0.531402926	0.461474965	.	0.06744	0.08917	1.774838537	96.82118424	459.74042	4.44864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	317	chr11	123909490	chr11:123909490	A	T	88	PASS	AN=2;DP=317	GT	0/1
chr12	208258	208258	G	T	intronic	IQSEC3	.	.	.	0.925104239	0.074895032	7.29E-07	.	0.52569	.	-0.839512508	11.40009436	1171.33568	6.50545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	389	chr12	208258	chr12:208258	G	T	85	PASS	AN=2;DP=389	GT	0/1
chr12	2602441	2602441	C	A	exonic	CACNA1C	.	synonymous SNV	CACNA1C:NM_000719:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129827:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129829:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129830:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129831:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129832:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129833:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129834:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129835:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129836:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129837:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129838:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129839:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129840:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129841:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129842:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129843:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129844:exon7:c.C993A:p.P331P,CACNA1C:NM_001129846:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167623:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167624:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167625:exon7:c.C1002A:p.P334P,CACNA1C:NM_199460:exon7:c.C1002A:p.P334P	0.999998433	1.57E-06	4.37E-21	DISEASE: Timothy syndrome (TS) [MIM:601005]: Disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities and autism. {ECO:0000269|PubMed:15454078, ECO:0000269|PubMed:15863612, ECO:0000269|PubMed:25260352}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brugada syndrome 3 (BRGDA3) [MIM:611875]: A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66288	0.13071	-2.087541484	1.574663836	257.23512	3.4497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	263	chr12	2602441	chr12:2602441	C	A	.	PASS	AN=0;DP=263	GT	0/1
chr12	7639333	7639333	C	T	exonic	CD163	.	stopgain	CD163:NM_004244:exon10:c.G2220A:p.W740X,CD163:NM_203416:exon10:c.G2220A:p.W740X	0.015136904	0.984853339	9.76E-06	.	0.22744	0.23364	-0.106515707	45.60627506	949.73058	5.96719	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.683	0.997	47	0.997	0.835	0.978	0.768	D	c	0.944	0.834	1.000	0.747	0.487	0.133	0	5.54	0.828	4.951	0.631	0.935	0.490	1.000	0.715	1.000	0.888	17.343	0.871	SRCR domain|SRCR-like domain	.	.	0.5	63	100	chr12	7639333	chr12:7639333	C	T	63	PASS	AN=2;DP=100	GT	0/1
chr12	14650683	14650683	G	T	exonic	ATF7IP	.	nonsynonymous SNV	ATF7IP:NM_001286514:exon15:c.G3486T:p.K1162N,ATF7IP:NM_018179:exon15:c.G3489T:p.K1163N,ATF7IP:NM_181352:exon15:c.G3513T:p.K1171N	0.999741038	0.000258962	3.26E-12	.	0.67749	0.10619	0.473967469	78.86293937	7630.06967	18.76351	0.001	0.784	D	0.996	0.670	D	0.985	0.749	D	0.003	0.358	N	1.000	0.537	D	1.73	0.448	L	1.54	0.301	T	-3.3	0.658	D	0.451	0.504	-1.006	0.283	T	0.117	0.414	T	0.028	0.505	D	3.711	0.503	23.3	0.998	0.896	0.989	0.886	D	c	0.305	0.313	0.894	0.259	0.707	0.730	0	4.04	0.461	3.383	0.520	-0.197	0.102	1.000	0.715	0.998	0.697	9.328	0.370	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	.	155	chr12	14650683	chr12:14650683	G	T	.	PASS	AN=0;DP=155	GT	0/1
chr12	20602478	20602478	G	T	intronic	PDE3A	.	.	.	0.106612096	0.893376508	1.14E-05	DISEASE: Hypertension and brachydactyly syndrome (HTNB) [MIM:112410]: A syndrome characterized by brachydactyly type E, severe salt-independent but age-dependent hypertension, an increased fibroblast growth rate, neurovascular contact at the rostral-ventrolateral medulla, and altered baroreflex blood pressure regulation. It results in death from stroke before age 50 years when untreated. Brachydactyly type E is characterized by shortening of the fingers mainly in the metacarpals and metatarsals. {ECO:0000269|PubMed:25961942}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09476	0.14669	-1.104093597	6.894314697	1899.16799	8.01225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	297	chr12	20602478	chr12:20602478	G	T	71	PASS	AN=2;DP=297	GT	0/1
chr12	38363524	38363524	G	T	intergenic	NONE;ALG10B	dist=NONE;dist=347033	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	289	chr12	38363524	chr12:38363524	G	T	73	PASS	AN=2;DP=289	GT	0/1
chr12	52841168	52841168	T	A	exonic	KRT6B	.	nonsynonymous SNV	KRT6B:NM_005555:exon9:c.A1501T:p.S501C	0.004792655	0.966239227	0.028968117	.	0.12487	.	-0.304932527	32.24817174	532.75963	4.70795	0.229	0.183	T	0.002	0.090	B	0.001	0.040	B	0.330	0.141	N	1	0.090	N	2.25	0.640	M	-2.32	0.878	D	-1.9	0.443	N	0.277	0.335	-0.703	0.603	T	0.445	0.782	T	0.044	0.616	D	0.385	0.131	6.483	0.783	0.118	0.073	0.131	N	c	-1.088	-1.182	0.994	0.335	0.497	0.185	0	-2.21	0.065	0.009	0.130	-0.028	0.127	0.017	0.192	0.002	0.062	7.916	0.288	.	.	.	0.5	108	388	chr12	52841168	chr12:52841168	T	A	108	PASS	AN=2;DP=388	GT	0/1
chr12	53084970	53084970	G	T	exonic	KRT77	.	synonymous SNV	KRT77:NM_175078:exon9:c.C1716A:p.S572S	1.05E-06	0.785358392	0.214640555	.	0.11671	.	2.289361599	98.30738382	4908.5509	14.28597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	809	chr12	53084970	chr12:53084970	G	T	125	PASS	AN=2;DP=809	GT	0/1
chr12	53170958	53170958	C	T	exonic	KRT76	.	nonsynonymous SNV	KRT76:NM_015848:exon1:c.G118A:p.G40S	6.27E-07	0.443932489	0.556066884	.	0.15911	.	1.249272484	93.46543996	5036.73118	14.50591	0.639	0.050	T	0.001	0.067	B	0.004	0.093	B	0.130	0.187	N	1	0.090	N	1.26	0.320	L	-3.29	0.937	D	-2.02	0.465	N	0.089	0.086	-0.494	0.689	T	0.591	0.854	D	0.034	0.553	D	-0.545	0.053	0.170	0.411	0.029	0.047	0.102	N	c	-1.448	-1.516	0.000	0.046	0.497	0.185	0	-3.94	0.038	0.006	0.129	-0.008	0.133	0.000	0.063	0.320	0.241	13.368	0.600	Keratin type II head	.	.	0.5	.	252	chr12	53170958	chr12:53170958	C	T	.	PASS	AN=0;DP=252	GT	0/1
chr12	53207548	53207548	G	T	exonic	KRT4	.	nonsynonymous SNV	KRT4:NM_002272:exon1:c.C295A:p.P99T	0.000566043	0.993911632	0.005522325	DISEASE: White sponge nevus 1 (WSN1) [MIM:193900]: A rare disorder characterized by the presence of soft, white, and spongy plaques in the oral mucosa. The characteristic histopathologic features are epithelial thickening, parakeratosis, and vacuolization of the suprabasal layer of oral epithelial keratinocytes. Less frequently the mucous membranes of the nose, esophagus, genitalia and rectum are involved. {ECO:0000269|PubMed:10652003, ECO:0000269|PubMed:12828738}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3298	0.21875	0.336225928	73.67893371	3276.78109	10.92393	0.086	0.326	T	0.179	0.273	B	0.039	0.223	B	0.370	0.135	N	1.000	0.090	N	2.465	0.718	M	-1.98	0.853	D	-2.32	0.514	N	0.19	0.250	-0.595	0.651	T	0.490	0.806	T	0.156	0.837	D	-0.948	0.034	0.020	0.985	0.411	0.384	0.258	N	c	-0.854	-0.950	1.000	0.480	0.497	0.185	0	-5.76	0.022	-0.112	0.107	0.098	0.198	0.000	0.063	0.516	0.274	8.993	0.350	Keratin type II head	.	.	0.5	115	379	chr12	53207548	chr12:53207548	G	T	115	PASS	AN=2;DP=379	GT	0/1
chr12	53774021	53774021	C	-	UTR5	SP1	NM_138473:c.-55del-;NM_001251825:c.-55del-	.	.	0.997637149	0.002362764	8.61E-08	.	0.99998	0.76734	-0.933156985	9.54824251	50.01247	1.38791	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	984	chr12	53774020	chr12:53774020	GC	G	100	PASS	AN=2;DP=984	GT	0/1
chr12	56559113	56559113	G	-	exonic	SMARCC2	.	frameshift deletion	SMARCC2:NM_003075:exon26:c.3128delC:p.P1043Lfs*15,SMARCC2:NM_001130420:exon27:c.3221delC:p.P1074Lfs*15,SMARCC2:NM_001330288:exon27:c.3221delC:p.P1074Lfs*15,SMARCC2:NM_139067:exon27:c.3221delC:p.P1074Lfs*15	0.999999989	1.09E-08	8.71E-21	.	0.99223	0.13798	-1.660796428	2.707006369	91.03551	2.05285	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	481	chr12	56559112	chr12:56559112	AG	A	84	PASS	AN=2;DP=481	GT	0/1
chr12	57590798	57590798	G	C	exonic	LRP1	.	nonsynonymous SNV	LRP1:NM_002332:exon56:c.G8926C:p.D2976H	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	0.003	0.682	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1.000	0.588	D	2.96	0.854	M	-4.14	0.968	D	-4.8	0.806	D	0.867	0.854	1.079	0.989	D	0.946	0.982	D	0.296	0.908	D	6.956	0.935	33	0.991	0.528	0.991	0.911	D	c	0.905	0.854	1.000	0.747	0.672	0.522	0	5.34	0.759	8.018	0.890	1.048	0.713	1.000	0.715	0.975	0.474	17.970	0.890	Complement Clr-like EGF domain|EGF-like calcium-binding domain|EGF-like, conserved site|Growth factor receptor cysteine-rich domain	.	.	0.5	141	644	chr12	57590798	chr12:57590798	G	C	141	PASS	AN=2;DP=644	GT	0/1
chr12	57604120	57604120	G	A	exonic	LRP1	.	nonsynonymous SNV	LRP1:NM_002332:exon82:c.G12611A:p.C4204Y	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	0.0	0.912	D	0.998	0.715	D	0.991	0.782	D	0.000	0.843	D	1.000	0.588	D	4.215	0.979	H	1.6	0.286	T	-7.07	0.939	D	0.941	0.936	-0.201	0.777	T	0.288	0.660	T	0.036	0.571	D	6.395	0.883	29.6	0.991	0.528	0.923	0.551	D	c	0.905	0.797	1.000	0.747	0.672	0.522	0	4.44	0.530	7.637	0.823	1.048	0.713	1.000	0.715	1.000	0.888	16.366	0.831	EGF-like domain	.	.	0.5	81	210	chr12	57604120	chr12:57604120	G	A	81	PASS	AN=2;DP=210	GT	0/1
chr12	58125636	58125636	C	A	exonic	AGAP2	.	nonsynonymous SNV	AGAP2:NM_001122772:exon8:c.G1909T:p.G637W,AGAP2:NM_014770:exon8:c.G901T:p.G301W	0.999218902	0.000781098	9.71E-12	.	0.8169	0.23301	-0.176292081	40.56381222	265.49784	3.49614	0.011	0.614	D	0.998	0.715	D	0.908	0.759	P	0.865	0.089	N	0.998	0.445	D	0.895	0.225	L	1.51	0.352	T	-1.68	0.402	N	0.556	0.591	-1.042	0.168	T	0.108	0.393	T	0.024	0.474	T	6.460	0.891	29.9	0.996	0.748	0.854	0.442	D	c	0.101	0.187	1.000	0.408	0.707	0.730	0	4.63	0.570	2.299	0.430	0.852	0.362	0.153	0.235	0.998	0.697	7.136	0.245	.	.	.	0.5	95	733	chr12	58125636	chr12:58125636	C	A	95	PASS	AN=2;DP=733	GT	0/1
chr12	58127972	58127972	G	A	intronic	AGAP2	.	.	.	0.999218902	0.000781098	9.71E-12	.	0.8169	0.23301	-0.176292081	40.56381222	265.49784	3.49614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	86	chr12	58127972	chr12:58127972	G	A	64	PASS	AN=2;DP=86	GT	0/1
chr12	70049190	70049190	C	T	exonic	BEST3	.	nonsynonymous SNV	BEST3:NM_152439:exon6:c.G865A:p.E289K,BEST3:NM_001282613:exon8:c.G1186A:p.E396K,BEST3:NM_032735:exon10:c.G1504A:p.E502K	3.69E-17	0.001380606	0.998619394	.	0.14764	0.10434	0.134171522	63.57041755	1059.3782	6.24526	0.001	0.784	D	0.999	0.764	D	0.994	0.807	D	0.075	0.212	N	0.647	0.810	D	1.935	0.520	L	-5.28	0.990	D	-1.1	0.326	N	0.471	0.686	1.082	0.989	D	0.967	0.990	D	0.354	0.924	D	4.793	0.643	24.7	0.999	0.935	0.937	0.586	D	c	0.206	0.110	1.000	0.747	0.487	0.133	0	4.6	0.564	4.645	0.609	-0.004	0.134	0.997	0.399	0.002	0.062	14.301	0.658	.	.	.	0.5	.	135	chr12	70049190	chr12:70049190	C	T	.	PASS	AN=0;DP=135	GT	0/1
chr12	78362403	78362403	G	T	exonic	NAV3	.	stopgain	NAV3:NM_001024383:exon5:c.G592T:p.E198X,NAV3:NM_014903:exon5:c.G592T:p.E198X	0.999999399	6.01E-07	4.23E-22	DISEASE: Note=A chromosomal aberration disrupting NAV3 has been found in patients with Sezary syndrome (PubMed:16166283). Translocation t(12;18)(q21;q21.2) (PubMed:16166283). {ECO:0000269|PubMed:16166283}.; 	0.8009	0.11717	-2.045202892	1.645435244	577.63321	4.87321	.	.	.	.	.	.	.	.	.	0.002	0.383	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.938	0.987	40	0.998	0.894	0.995	0.965	D	c	1.164	1.017	1.000	0.747	0.563	0.310	0	5.53	0.825	7.051	0.762	0.943	0.531	1.000	0.715	0.987	0.523	19.453	0.948	Calponin homology domain	.	.	0.5	70	79	chr12	78362403	chr12:78362403	G	T	70	PASS	AN=2;DP=79	GT	0/1
chr12	94975543	94975543	G	T	exonic	TMCC3	.	nonsynonymous SNV	TMCC3:NM_001301036:exon2:c.C757A:p.Q253K,TMCC3:NM_020698:exon2:c.C850A:p.Q284K	0.000392184	0.845537036	0.15407078	.	0.0962	0.10967	0.178263593	66.12998349	211.70761	3.13738	0.175	0.235	T	0.285	0.304	B	0.131	0.313	B	0.004	0.340	N	0.983	0.422	D	1.355	0.339	L	1.03	0.405	T	-1.45	0.356	N	0.368	0.429	-1.061	0.114	T	0.101	0.375	T	0.009	0.227	T	2.161	0.321	17.25	0.982	0.386	0.988	0.865	D	c	0.215	0.400	0.936	0.272	0.707	0.730	0	5.93	0.959	7.384	0.789	0.974	0.594	1.000	0.715	0.989	0.536	20.344	0.988	.	.	.	0.5	123	215	chr12	94975543	chr12:94975543	G	T	123	PASS	AN=2;DP=215	GT	0/1
chr12	98909624	98909624	G	T	ncRNA_exonic	TMPO-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	762	chr12	98909624	chr12:98909624	G	T	125	PASS	AN=2;DP=762	GT	0/1
chr12	117461949	117461949	C	A	intronic	FBXW8	.	.	.	8.69E-13	0.037230433	0.962769567	.	0.19894	0.27411	-0.28470423	33.48667138	330.90072	3.86825	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	341	chr12	117461949	chr12:117461949	C	A	90	PASS	AN=2;DP=341	GT	0/1
chr13	100637893	100637893	G	T	exonic	ZIC2	.	nonsynonymous SNV	ZIC2:NM_007129:exon3:c.G1556T:p.G519V	.	.	.	DISEASE: Holoprosencephaly 5 (HPE5) [MIM:609637]: A structural anomaly of the brain, in which the developing forebrain fails to correctly separate into right and left hemispheres. Holoprosencephaly is genetically heterogeneous and associated with several distinct facies and phenotypic variability. {ECO:0000269|PubMed:11285244, ECO:0000269|PubMed:15221788, ECO:0000269|PubMed:19177455}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87813	0.23021	.	.	382.0785	4.12056	0.006	0.614	D	0.11	0.246	B	0.012	0.149	B	0.006	0.320	N	1.000	0.480	D	0.805	0.203	L	-1.22	0.788	T	-0.66	0.191	N	0.354	0.415	-0.658	0.624	T	0.265	0.636	T	0.850	0.988	D	3.223	0.447	22.7	0.981	0.380	0.790	0.388	D	c	-0.233	-0.118	1.000	0.517	0.543	0.218	0	2.81	0.318	4.421	0.594	0.779	0.314	1.000	0.715	0.991	0.552	10.976	0.465	.	.	.	0.5	88	234	chr13	100637893	chr13:100637893	G	T	88	PASS	AN=2;DP=234	GT	0/1
chr13	111371701	111371701	A	T	exonic	ING1	.	stopgain	ING1:NM_001267728:exon2:c.A211T:p.K71X,ING1:NM_005537:exon2:c.A691T:p.K231X,ING1:NM_198217:exon2:c.A130T:p.K44X,ING1:NM_198218:exon2:c.A55T:p.K19X,ING1:NM_198219:exon2:c.A262T:p.K88X	0.011435702	0.979963341	0.008600957	DISEASE: Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. {ECO:0000269|PubMed:10866301}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78935	0.17351	-0.512444034	21.55579146	154.20317	2.71419	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.978	0.988	40	0.995	0.707	0.991	0.918	D	c	0.884	0.760	1.000	0.747	0.632	0.406	0	5.14	0.699	8.731	0.912	1.053	0.755	1.000	0.715	1.000	0.888	14.967	0.707	Inhibitor of growth protein, N-terminal histone-binding	.	.	0.5	88	302	chr13	111371701	chr13:111371701	A	T	88	PASS	AN=2;DP=302	GT	0/1
chr13	111522059	111522059	G	T	ncRNA_exonic	LINC00346	.	.	.	.	.	.	.	.	.	.	.	328.50602	3.85367	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	338	chr13	111522059	chr13:111522059	G	T	83	PASS	AN=2;DP=338	GT	0/1
chr13	114762066	114762066	G	T	exonic	RASA3	.	synonymous SNV	RASA3:NM_001320822:exon21:c.C1986A:p.G662G,RASA3:NM_007368:exon21:c.C2082A:p.G694G,RASA3:NM_001320821:exon23:c.C933A:p.G311G	0.000433959	0.999498118	6.79E-05	.	0.20897	0.10415	-1.657176494	2.736494456	205.03169	3.0937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	229	chr13	114762066	chr13:114762066	G	T	.	PASS	AN=0;DP=229	GT	0/1
chr13	114806428	114806428	C	A	intronic	RASA3	.	.	.	0.000433959	0.999498118	6.79E-05	.	0.20897	0.10415	-1.657176494	2.736494456	205.03169	3.0937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	149	chr13	114806428	chr13:114806428	C	A	96	PASS	AN=2;DP=149	GT	0/1
chr14	21542838	21542838	G	A	exonic	ARHGEF40	.	nonsynonymous SNV	ARHGEF40:NM_018071:exon3:c.G949A:p.E317K	7.19E-05	0.999928131	1.25E-08	.	.	.	-0.226073511	37.1255013	1688.98262	7.57807	0.169	0.230	T	0.004	0.165	B	0.004	0.127	B	0.042	0.239	N	1	0.090	N	0	0.065	N	4.45	0.022	T	-0.36	0.221	N	0.126	0.290	-0.898	0.482	T	0.005	0.016	T	0.009	0.234	T	-0.348	0.065	0.516	0.816	0.133	0.137	0.178	N	c	-0.826	-0.745	0.997	0.355	0.632	0.406	0	4.23	0.492	2.765	0.471	1.048	0.713	0.115	0.229	0.034	0.151	11.400	0.489	.	.	.	0.5	84	447	chr14	21542838	chr14:21542838	G	A	84	PASS	AN=2;DP=447	GT	0/1
chr14	23315908	23315908	G	-	UTR3	MMP14	NM_004995:c.*660delG	.	.	0.987123657	0.01287612	2.23E-07	DISEASE: Winchester syndrome (WNCHRS) [MIM:277950]: A disease characterized by severe osteolysis in the hands and feet, generalized osteoporosis, bone thinning, and absence of subcutaneous nodules. Various additional features include coarse face, corneal opacities, gum hypertrophy, and EKG changes. {ECO:0000269|PubMed:22922033}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54891	0.55746	0.04598748	57.47817882	1317.7477	6.82691	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	90	chr14	23315907	chr14:23315907	AG	A	155	PASS	AN=2;DP=90	GT	0/1
chr14	23777193	23777193	G	T	exonic	BCL2L2;BCL2L2-PABPN1	.	nonsynonymous SNV	BCL2L2:NM_001199839:exon3:c.G217T:p.G73C,BCL2L2-PABPN1:NM_001199864:exon3:c.G217T:p.G73C,BCL2L2:NM_004050:exon3:c.G217T:p.G73C	.	.	.	.	.	.	.	.	.	.	0.052	0.682	T	0.592	0.556	P	0.281	0.677	B	0.000	0.473	D	0.562	0.461	N	2.095	0.583	M	2.66	0.126	T	-3.18	0.656	D	0.308	0.454	-0.824	0.537	T	0.136	0.452	T	0.031	0.535	D	4.130	0.554	23.8	0.996	0.724	0.971	0.723	D	c	0.021	0.101	1.000	0.747	0.660	0.490	0	4.94	0.645	4.022	0.567	1.048	0.713	1.000	0.715	1.000	0.888	12.745	0.565	.	.	.	0.5	126	652	chr14	23777193	chr14:23777193	G	T	126	PASS	AN=2;DP=652	GT	0/1
chr14	23829836	23829836	G	T	exonic	EFS	.	nonsynonymous SNV	EFS:NM_005864:exon2:c.C225A:p.S75R	2.45E-06	0.494202308	0.505795246	.	0.41116	0.14682	1.734373503	96.61476763	5246.98871	14.94057	0.358	0.120	T	0.004	0.112	B	0.002	0.063	B	0.117	0.192	N	1	0.810	D	2.005	0.547	M	1.95	0.225	T	-1.16	0.297	N	0.14	0.163	-1.066	0.103	T	0.032	0.138	T	0.003	0.077	T	0.906	0.180	10.11	0.950	0.253	0.321	0.243	N	c	-0.687	-0.628	1.000	0.747	0.632	0.408	0	3.16	0.353	0.726	0.255	1.048	0.713	0.002	0.151	0.950	0.426	5.295	0.150	SH3 domain	.	.	0.5	106	181	chr14	23829836	chr14:23829836	G	T	106	PASS	AN=2;DP=181	GT	0/1
chr14	31926571	31926571	G	C	exonic	DTD2	.	nonsynonymous SNV	DTD2:NM_080664:exon1:c.C29G:p.A10G	0.001708149	0.467463368	0.530828483	.	0.25961	0.07098	-0.053113545	49.38664779	6.20561	0.23402	0.079	0.344	T	0.476	0.348	P	0.132	0.314	B	0.008	0.310	N	1.000	0.548	D	2.24	0.636	M	0.27	0.592	T	-2.5	0.543	D	0.416	0.607	-0.768	0.570	T	0.181	0.528	T	0.045	0.617	D	3.890	0.524	23.5	0.996	0.726	0.947	0.619	D	c	-0.046	-0.001	1.0	0.983	0.442	0.072	0	4.09	0.469	6.242	0.721	0.079	0.188	1.000	0.715	0.362	0.248	12.504	0.551	D-Tyr tRNAtyr deacylase-like domain	.	.	0.5	152	1356	chr14	31926571	chr14:31926571	G	C	152	PASS	AN=2;DP=1356	GT	0/1
chr14	36988512	36988512	C	A	exonic	NKX2-1	.	nonsynonymous SNV	NKX2-1:NM_003317:exon1:c.G51T:p.L17F,NKX2-1:NM_001079668:exon2:c.G141T:p.L47F	0.081926486	0.871861122	0.046212392	DISEASE: Chorea, hereditary benign (BHC) [MIM:118700]: A rare autosomal dominant movement disorder, defined by early onset in childhood, a stable or non-progressive course of chorea, and no mental deterioration. Chorea is characterized by involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. {ECO:0000269|PubMed:11971878, ECO:0000269|PubMed:15955952}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction (CAHTP) [MIM:610978]: An autosomal dominant disorder that manifests in infancy with neurological disturbances, hypothyroidism, and respiratory problems. It is characterized by movement abnormalities beginning with muscular hypotonia followed by the development of chorea, athetosis, dystonia, ataxia, and dysarthria. {ECO:0000269|PubMed:11854318, ECO:0000269|PubMed:11854319, ECO:0000269|PubMed:15289765, ECO:0000269|PubMed:24714694}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.81487	0.52282	1.273147413	93.66595895	44.04874	1.26407	0.0	0.912	D	0.999	0.764	D	0.998	0.875	D	0.000	0.523	D	1	0.810	D	2.155	0.604	M	-0.95	0.754	T	-3.04	0.640	D	0.954	0.952	0.226	0.864	D	0.563	0.841	D	0.321	0.915	D	5.424	0.736	26.0	0.989	0.485	0.978	0.773	D	c	0.682	0.636	1.000	0.747	0.437	0.062	0	4.16	0.480	4.559	0.603	0.855	0.374	1.000	0.715	1.000	0.888	15.002	0.710	.	.	.	0.5	107	535	chr14	36988512	chr14:36988512	C	A	107	PASS	AN=2;DP=535	GT	0/1
chr14	45431332	45431332	T	C	upstream	KLHL28;TOGARAM1	dist=61	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	890	chr14	45431332	chr14:45431332	T	C	126	PASS	AN=2;DP=890	GT	0/1
chr14	59113339	59113339	G	C	exonic	DACT1	.	synonymous SNV	DACT1:NM_001079520:exon4:c.G1887C:p.V629V,DACT1:NM_016651:exon4:c.G1998C:p.V666V	0.816597553	0.183214244	0.000188203	DISEASE: Neural tube defects (NTD) [MIM:182940]: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components. {ECO:0000269|PubMed:22610794}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.15217	0.12544	0.202129237	67.42745931	2431.69074	9.16027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	592	chr14	59113339	chr14:59113339	G	C	.	PASS	AN=0;DP=592	GT	0/1
chr14	59931147	59931147	G	A	exonic	GPR135	.	synonymous SNV	GPR135:NM_022571:exon1:c.C798T:p.T266T	0.003932041	0.644923881	0.351144078	.	0.05073	.	.	.	520.54112	4.65898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	193	chr14	59931147	chr14:59931147	G	A	54	PASS	AN=2;DP=193	GT	0/1
chr14	75388240	75388240	C	A	exonic	RPS6KL1	.	nonsynonymous SNV	RPS6KL1:NM_031464:exon2:c.G5T:p.S2I	0.000674281	0.9788712	0.020454519	.	0.10194	.	0.04598748	57.47817882	4892.98014	14.2268	0.0	0.912	D	0.998	0.715	D	0.991	0.807	D	0.011	0.298	N	0.993	0.238	N	2.39	0.691	M	0.01	0.625	T	-3.15	0.895	D	0.458	0.510	-0.860	0.513	T	0.248	0.617	T	0.061	0.683	D	5.601	0.763	26.5	0.995	0.703	0.788	0.386	D	c	0.270	0.224	1.000	0.458	0.660	0.495	0	3.26	0.363	2.273	0.428	0.852	0.362	1.000	0.715	0.781	0.330	6.163	0.195	.	.	.	0.5	79	392	chr14	75388240	chr14:75388240	C	A	79	PASS	AN=2;DP=392	GT	0/1
chr14	86088953	86088953	C	A	exonic	FLRT2	.	synonymous SNV	FLRT2:NM_001346143:exon2:c.C1095A:p.P365P,FLRT2:NM_001346144:exon2:c.C1095A:p.P365P,FLRT2:NM_001346145:exon2:c.C1095A:p.P365P,FLRT2:NM_001346146:exon2:c.C1095A:p.P365P,FLRT2:NM_013231:exon2:c.C1095A:p.P365P	0.894038334	0.105747558	0.000214108	.	0.2241	0.11009	-0.044015879	50.44821892	1227.80506	6.62629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	320	chr14	86088953	chr14:86088953	C	A	115	PASS	AN=2;DP=320	GT	0/1
chr14	105412163	105412163	C	A	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.G9325T:p.V3109L,AHNAK2:NM_138420:exon7:c.G9625T:p.V3209L	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.393	0.107	T	0.008	0.135	B	0.007	0.121	B	.	.	.	1	0.090	N	1.435	0.361	L	5.31	0.011	T	-0.93	0.249	N	0.117	0.129	-0.900	0.481	T	0.003	0.010	T	0.003	0.078	T	0.444	0.137	6.990	0.806	0.128	0.020	0.060	N	c	-1.262	-1.364	0.000	0.059	0.476	0.093	0	-2.26	0.064	-5.015	0.002	-4.746	0.000	0.000	0.063	0.000	0.016	0.886	0.012	.	.	.	0.5	76	321	chr14	105412163	chr14:105412163	C	A	76	PASS	AN=2;DP=321	GT	0/1
chr14	106109683	106109683	C	T	intergenic	MIR8071-2;ELK2AP	dist=3114;dist=26231	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	263	chr14	106109683	chr14:106109683	C	T	.	PASS	AN=0;DP=263	GT	0/1
chr14	106452718	106452718	G	T	intergenic	ADAM6;LINC00226	dist=14360;dist=291551	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	344	chr14	106452718	chr14:106452718	G	T	85	PASS	AN=2;DP=344	GT	0/1
chr14	106494322	106494322	C	A	intergenic	ADAM6;LINC00226	dist=55964;dist=249947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	319	chr14	106494322	chr14:106494322	C	A	91	PASS	AN=2;DP=319	GT	0/1
chr14	106725332	106725332	C	T	intergenic	ADAM6;LINC00226	dist=286974;dist=18937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	288	chr14	106725332	chr14:106725332	C	T	98	PASS	AN=2;DP=288	GT	0/1
chr15	20453992	20453992	T	C	intergenic	NONE;CHEK2P2	dist=NONE;dist=34005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	346	chr15	20453992	chr15:20453992	T	C	.	PASS	AN=0;DP=346	GT	0/1
chr15	20495286	20495286	A	C	ncRNA_intronic	CHEK2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	234	chr15	20495286	chr15:20495286	A	C	148	PASS	AN=2;DP=234	GT	0/1
chr15	22743235	22743235	A	G	exonic	GOLGA6L1;GOLGA6L22	.	synonymous SNV	GOLGA6L1:NM_001001413:exon8:c.A1620G:p.R540R,GOLGA6L22:NM_001271664:exon10:c.A1584G:p.R528R	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	94	chr15	22743235	chr15:22743235	A	G	81	PASS	AN=2;DP=94	GT	0/1
chr15	23410615	23410615	T	C	intronic	GOLGA6L22	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	259	chr15	23410615	chr15:23410615	T	C	.	PASS	AN=0;DP=259	GT	0/1
chr15	35046595	35046595	T	A	intronic	GJD2	.	.	.	0.1177216	0.856017325	0.026261075	.	0.33289	0.19444	-0.271755481	34.31823543	43.42131	1.25398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	529	chr15	35046595	chr15:35046595	T	A	125	PASS	AN=2;DP=529	GT	0/1
chr15	43622483	43622483	C	A	exonic	LCMT2	.	nonsynonymous SNV	LCMT2:NM_014793:exon1:c.G205T:p.A69S	7.27E-08	0.268667513	0.731332415	.	0.07788	0.11769	-0.042196577	50.49539986	231.36801	3.28766	0.504	0.076	T	0.506	0.354	P	0.281	0.386	B	0.052	0.229	N	1	0.810	D	1.445	0.365	L	1.9	0.235	T	0.34	0.038	N	0.264	0.321	-1.123	0.022	T	0.047	0.201	T	0.024	0.472	T	2.050	0.307	16.53	0.832	0.141	0.946	0.614	D	c	-0.343	-0.246	1.000	0.747	0.006	0.001	3	4.63	0.570	3.175	0.503	0.049	0.161	1.000	0.715	0.311	0.239	12.395	0.545	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	95	515	chr15	43622483	chr15:43622483	C	A	95	PASS	AN=2;DP=515	GT	0/1
chr15	44085843	44085843	T	C	exonic	SERF2	.	synonymous SNV	SERF2:NM_001199875:exon3:c.T186C:p.H62H	0.138975962	0.779592802	0.081431235	.	0.24204	0.11262	.	.	2084.12462	8.40921	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	421	chr15	44085843	chr15:44085843	T	C	76	PASS	AN=2;DP=421	GT	0/1
chr15	45123755	45123755	-	C	ncRNA_exonic	SORD2P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	216	chr15	45123755	chr15:45123755	G	GC	97	PASS	AN=2;DP=216	GT	0/1
chr15	58985103	58985103	G	A	ncRNA_exonic	HSP90AB4P	.	.	.	.	.	.	.	0.20153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	156	chr15	58985103	chr15:58985103	G	A	81	PASS	AN=2;DP=156	GT	0/1
chr15	59981640	59981640	C	A	UTR5	BNIP2	NM_001320674:c.-1G>T;NM_004330:c.-1G>T	.	.	1.69E-05	0.671754446	0.328228624	.	0.59599	0.12477	-0.336073593	30.55555556	3900.56272	12.33278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	282	chr15	59981640	chr15:59981640	C	A	.	PASS	AN=0;DP=282	GT	0/1
chr15	73996200	73996200	G	T	exonic	CD276	.	nonsynonymous SNV	CD276:NM_001329629:exon4:c.G496T:p.A166S,CD276:NM_001024736:exon5:c.G934T:p.A312S	2.02E-05	0.709451017	0.290528763	.	0.09767	0.14799	0.450099045	78.01958009	6835.12654	17.61125	0.774	0.033	T	0.008	0.135	B	0.022	0.184	B	0.323	0.142	N	1	0.090	N	-0.52	0.025	N	-0.04	0.633	T	0.47	0.031	N	0.114	0.124	-1.002	0.294	T	0.060	0.250	T	0.018	0.401	T	-1.326	0.021	0.004	0.719	0.095	0.214	0.212	N	c	-1.310	-1.255	1.000	0.517	0.713	0.817	0	0.246	0.147	-0.062	0.115	0.905	0.419	0.000	0.063	0.162	0.208	4.847	0.128	Immunoglobulin V-set domain|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	269	chr15	73996200	chr15:73996200	G	T	.	PASS	AN=0;DP=269	GT	0/1
chr15	74327470	74327470	G	C	UTR3	PML	NM_033240:c.*473G>C	.	.	0.937511029	0.062486698	2.27E-06	DISEASE: Note=A chromosomal aberration involving PML may be a cause of acute promyelocytic leukemia (APL). Translocation t(15;17)(q21;q21) with RARA. The PML breakpoints (type A and type B) lie on either side of an alternatively spliced exon. {ECO:0000269|PubMed:1652369, ECO:0000269|PubMed:1720570}.; 	0.13603	0.57235	0.148734569	64.11889597	74.41273	1.8023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	576	chr15	74327470	chr15:74327470	G	C	92	PASS	AN=2;DP=576	GT	0/1
chr15	79025018	79025018	C	A	intergenic	CHRNB4;LOC646938	dist=91431;dist=19361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	200	chr15	79025018	chr15:79025018	C	A	.	PASS	AN=0;DP=200	GT	0/1
chr15	81627146	81627146	G	T	exonic	TMC3	.	nonsynonymous SNV	TMC3:NM_001080532:exon21:c.C2374A:p.P792T	9.78E-16	0.396541992	0.603458008	.	0.05595	0.12437	1.478915028	95.29370134	1882.26477	7.98006	0.109	0.295	T	0.001	0.067	B	0.002	0.063	B	0.738	0.098	N	1	0.090	N	1.19	0.302	L	-0.22	0.665	T	-2.89	0.606	D	0.059	0.043	-0.982	0.346	T	0.120	0.419	T	0.026	0.487	D	-0.170	0.078	1.266	0.935	0.228	0.098	0.153	N	c	-0.895	-0.938	1.000	0.480	0.497	0.185	0	-1.64	0.078	0.717	0.253	0.143	0.228	0.282	0.249	0.008	0.104	1.798	0.029	.	.	.	0.5	93	291	chr15	81627146	chr15:81627146	G	T	93	PASS	AN=2;DP=291	GT	0/1
chr15	102516373	102516373	C	T	ncRNA_exonic	WASH3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	171	1076	chr15	102516373	chr15:102516373	C	T	171	PASS	AN=2;DP=1076	GT	0/1
chr16	1402200	1402200	G	T	intronic	GNPTG	.	.	.	6.00E-08	0.243287932	0.756712008	DISEASE: Mucolipidosis type III complementation group C (MLIIIC) [MIM:252605]: Autosomal recessive disease of lysosomal hydrolase trafficking. Unlike the related diseases, mucolipidosis II and IIIA, the enzyme affected in mucolipidosis IIIC (GlcNAc- phosphotransferase) retains full transferase activity on synthetic substrates but lacks activity on lysosomal hydrolases. Typical clinical findings include stiffness of the hands and shoulders, claw-hand deformity, scoliosis, short stature, coarse facies, and mild mental retardation. Radiographically, severe dysostosis multiplex of the hip is characteristic and frequently disabling. The clinical diagnosis can be confirmed by finding elevated serum lysosomal enzyme levels and/or decreased lysosomal enzyme levels in cultured fibroblasts. {ECO:0000269|PubMed:10712439, ECO:0000269|PubMed:15532026, ECO:0000269|PubMed:24316125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTG have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.11006	0.14352	-0.334253673	30.70299599	52.40877	1.43216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	265	chr16	1402200	chr16:1402200	G	T	124	PASS	AN=2;DP=265	GT	0/1
chr16	1813737	1813737	G	A	exonic	MAPK8IP3	.	nonsynonymous SNV	MAPK8IP3:NM_001040439:exon16:c.G1957A:p.G653S,MAPK8IP3:NM_001318852:exon17:c.G1978A:p.G660S,MAPK8IP3:NM_015133:exon17:c.G1975A:p.G659S	0.999999971	2.91E-08	9.42E-20	.	0.31764	0.18911	-2.649793416	0.766690257	619.3755	5.02096	0.041	0.419	D	0.999	0.899	D	0.899	0.916	P	0.000	0.629	D	1	0.810	D	2.725	0.800	M	0.77	0.496	T	-5.19	0.836	D	0.538	0.576	-0.361	0.732	T	0.313	0.683	T	0.530	0.956	D	4.995	0.672	25.1	0.998	0.875	0.982	0.799	D	c	0.665	0.586	1.0	0.983	0.840	1.000	0	4.82	0.615	9.852	0.984	0.898	0.412	1.000	0.715	0.901	0.381	17.511	0.876	.	.	.	0.5	97	118	chr16	1813737	chr16:1813737	G	A	97	PASS	AN=2;DP=118	GT	0/1
chr16	2028523	2028523	C	-	intronic	TBL3	.	.	.	1.54E-06	0.998145068	0.001853396	.	0.16182	0.11544	-0.338129542	30.07784855	1241.80468	6.65189	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	539	chr16	2028522	chr16:2028522	AC	A	80	PASS	AN=2;DP=539	GT	0/1
chr16	2030628	2030628	C	T	intronic	NOXO1	.	.	.	3.17E-11	0.011808231	0.988191769	.	0.0626	0.1393	0.240763792	69.36777542	563.1205	4.81832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	743	chr16	2030628	chr16:2030628	C	T	76	PASS	AN=2;DP=743	GT	0/1
chr16	2837462	2837462	C	T	upstream	PRSS33	dist=754	.	.	0.000160244	0.439783392	0.560056365	.	0.05419	.	.	.	451.00798	4.41353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	233	chr16	2837462	chr16:2837462	C	T	119	PASS	AN=2;DP=233	GT	0/1
chr16	14976507	14976507	G	T	exonic	NOMO1	.	synonymous SNV	NOMO1:NM_014287:exon26:c.G3084T:p.R1028R	.	.	.	.	.	0.1005	.	.	534.93703	4.71517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	1099	chr16	14976507	chr16:14976507	G	T	133	PASS	AN=2;DP=1099	GT	0/1
chr16	18482153	18482153	G	T	ncRNA_exonic	PKD1P5-LOC105376752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	599	chr16	18482153	chr16:18482153	G	T	120	PASS	AN=2;DP=599	GT	0/1
chr16	18820575	18820575	G	A	UTR3	SMG1	NM_015092:c.*316C>T	.	.	1	4.40E-14	1.05E-36	.	.	.	-2.975494782	0.542580797	910.18577	5.86659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	201	chr16	18820575	chr16:18820575	G	A	74	PASS	AN=2;DP=201	GT	0/1
chr16	23702685	23702685	G	T	exonic	ERN2	.	nonsynonymous SNV	ERN2:NM_001308220:exon19:c.C2282A:p.A761E,ERN2:NM_033266:exon20:c.C2438A:p.A813E	1.79E-15	0.517166148	0.482833852	.	0.37292	0.11979	-1.697674421	2.583156405	1512.87602	7.22771	0.991	0.030	T	0.002	0.349	B	0.012	0.360	B	0.001	0.403	N	0.540	0.314	N	1.595	0.408	L	1.58	0.291	T	-0.93	0.249	N	0.264	0.321	-1.057	0.126	T	0.046	0.199	T	0.010	0.263	T	1.702	0.266	14.42	0.941	0.237	0.893	0.494	D	c	-0.441	-0.289	1.000	0.747	0.676	0.548	0	4.83	0.617	1.374	0.337	1.048	0.713	0.601	0.275	0.985	0.512	13.880	0.630	KEN domain;KEN domain|PUG domain	.	.	0.5	90	618	chr16	23702685	chr16:23702685	G	T	90	PASS	AN=2;DP=618	GT	0/1
chr16	29624821	29624821	C	T	ncRNA_exonic	SMG1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	903	chr16	29624821	chr16:29624821	C	T	110	PASS	AN=2;DP=903	GT	0/1
chr16	31008054	31008054	C	T	exonic	STX1B	.	nonsynonymous SNV	STX1B:NM_052874:exon7:c.G487A:p.E163K	0.944474733	0.05548414	4.11E-05	DISEASE: Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172]: An autosomal dominant neurologic disorder characterized by febrile and/or afebrile seizures manifesting in early childhood. Seizure are variable and include generalized tonic-clonic, atonic, myoclonic, complex partial, and absence types. Most patients have remission of seizures later in childhood with no residual neurologic deficits. Rarely, patients may show mild developmental delay or mild intellectual disabilities. {ECO:0000269|PubMed:25362483}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22761	0.14229	-0.163345027	41.24793583	5.61252	0.20995	0.001	0.784	D	0.613	0.418	P	0.319	0.399	B	0.000	0.629	D	1	0.810	D	2.33	0.670	M	0.28	0.591	T	-3.86	0.726	D	0.923	0.918	-0.219	0.772	T	0.297	0.669	T	0.085	0.745	D	5.918	0.812	27.5	0.999	0.983	0.992	0.920	D	c	0.605	0.609	1.0	0.983	0.789	0.998	0	4.76	0.600	7.867	0.854	0.870	0.379	1.000	0.715	0.995	0.604	16.694	0.851	Syntaxin, N-terminal domain|t-SNARE	.	.	0.5	85	556	chr16	31008054	chr16:31008054	C	T	85	PASS	AN=2;DP=556	GT	0/1
chr16	31196420	31196420	C	T	exonic	FUS	.	synonymous SNV	FUS:NM_001170634:exon6:c.C681T:p.G227G,FUS:NM_001170937:exon6:c.C672T:p.G224G,FUS:NM_004960:exon6:c.C684T:p.G228G	0.999963786	3.62E-05	3.26E-12	DISEASE: Note=A chromosomal aberration involving FUS is found in a patient with malignant myxoid liposarcoma. Translocation t(12;16)(q13;p11) with DDIT3. {ECO:0000269|PubMed:7503811}.; DISEASE: Note=A chromosomal aberration involving FUS is a cause of acute myeloid leukemia (AML). Translocation t(16;21)(p11;q22) with ERG. {ECO:0000269|PubMed:8187069}.; DISEASE: Angiomatoid fibrous histiocytoma (AFH) [MIM:612160]: A distinct variant of malignant fibrous histiocytoma that typically occurs in children and adolescents and is manifest by nodular subcutaneous growth. Characteristic microscopic features include lobulated sheets of histiocyte-like cells intimately associated with areas of hemorrhage and cystic pseudovascular spaces, as well as a striking cuffing of inflammatory cells, mimicking a lymph node metastasis. {ECO:0000269|PubMed:11063792}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving FUS is found in a patient with angiomatoid fibrous histiocytoma. Translocation t(12;16)(q13;p11.2) with ATF1 generates a chimeric FUS/ATF1 protein. {ECO:0000269|PubMed:11063792}.; DISEASE: Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:19251627, ECO:0000269|PubMed:19251628, ECO:0000269|PubMed:19861302, ECO:0000269|PubMed:20124201}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tremor, hereditary essential 4 (ETM4) [MIM:614782]: A common movement disorder mainly characterized by postural tremor of the arms. Head, legs, trunk, voice, jaw, and facial muscles also may be involved. The condition can be aggravated by emotions, hunger, fatigue and temperature extremes, and may cause a functional disability or even incapacitation. Inheritance is autosomal dominant. {ECO:0000269|PubMed:22863194}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42621	0.49093	-1.001120478	8.321538099	78.86065	1.87589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	550	chr16	31196420	chr16:31196420	C	T	.	PASS	AN=0;DP=550	GT	0/1
chr16	32007110	32007110	G	C	intergenic	ZNF267;LOC102723753	dist=78481;dist=156323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	575	chr16	32007110	chr16:32007110	G	C	.	PASS	AN=0;DP=575	GT	0/1
chr16	32133768	32133768	G	C	intergenic	ZNF267;LOC102723753	dist=205139;dist=29665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	166	547	chr16	32133768	chr16:32133768	G	C	166	PASS	AN=2;DP=547	GT	0/1
chr16	32170666	32170666	T	A	ncRNA_splicing	LOC102723753	NR_135178:exon19:c.3089-2A>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	523	chr16	32170666	chr16:32170666	T	A	93	PASS	AN=2;DP=523	GT	0/1
chr16	32859230	32859230	C	A	intergenic	TP53TG3;SLC6A10P	dist=171780;dist=29567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	1286	chr16	32859230	chr16:32859230	C	A	92	PASS	AN=2;DP=1286	GT	0/1
chr16	32883398	32883398	C	A	intergenic	TP53TG3;SLC6A10P	dist=195948;dist=5399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	772	chr16	32883398	chr16:32883398	C	A	92	PASS	AN=2;DP=772	GT	0/1
chr16	32890992	32890992	G	T	ncRNA_exonic	SLC6A10P	.	.	.	.	.	.	.	0.09544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	297	chr16	32890992	chr16:32890992	G	T	92	PASS	AN=2;DP=297	GT	0/1
chr16	32891453	32891453	G	T	ncRNA_intronic	SLC6A10P	.	.	.	.	.	.	.	0.09544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	1710	chr16	32891453	chr16:32891453	G	T	121	PASS	AN=2;DP=1710	GT	0/1
chr16	32916782	32916782	G	A	intergenic	SLC6A10P;TP53TG3B	dist=20319;dist=288801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	512	chr16	32916782	chr16:32916782	G	A	84	PASS	AN=2;DP=512	GT	0/1
chr16	33366720	33366720	A	G	intergenic	LOC390705;ENPP7P13	dist=68018;dist=205124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	469	chr16	33366720	chr16:33366720	A	G	159	PASS	AN=2;DP=469	GT	0/1
chr16	47117444	47117444	G	A	exonic	NETO2	.	synonymous SNV	NETO2:NM_001201477:exon9:c.C1245T:p.Y415Y,NETO2:NM_018092:exon9:c.C1266T:p.Y422Y	0.158399551	0.841464188	0.000136261	.	0.17156	0.11389	-0.404032746	26.53338051	133.98421	2.51752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	183	chr16	47117444	chr16:47117444	G	A	.	PASS	AN=0;DP=183	GT	0/1
chr16	47533805	47533805	G	T	exonic	PHKB	.	nonsynonymous SNV	PHKB:NM_000293:exon3:c.G305T:p.R102M,PHKB:NM_001031835:exon4:c.G284T:p.R95M	3.16E-10	0.999792045	0.000207954	DISEASE: Glycogen storage disease 9B (GSD9B) [MIM:261750]: A metabolic disorder characterized by hepatomegaly, only slightly elevated transaminases and plasma lipids, clinical improvement with increasing age, and remarkably no clinical muscle involvement. Biochemical observations suggest that this mild phenotype is caused by an incomplete holoenzyme that lacks the beta subunit, but that may possess residual activity. {ECO:0000269|PubMed:9402963}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.34561	0.21599	0.367380537	74.74050484	834.92029	5.65576	0.029	0.721	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	2.8	0.819	M	-2.88	0.915	D	-4.84	0.824	D	0.465	0.784	0.990	0.970	D	0.887	0.963	D	.	.	.	6.297	0.870	29.1	0.963	0.287	0.993	0.948	D	c	0.894	0.826	1.0	0.983	0.706	0.609	0	4.79	0.608	9.964	0.990	1.048	0.713	1.000	0.715	0.973	0.468	17.891	0.887	Six-hairpin glycosidase-like	.	.	0.5	92	264	chr16	47533805	chr16:47533805	G	T	92	PASS	AN=2;DP=264	GT	0/1
chr16	49671746	49671746	C	A	exonic	ZNF423	.	nonsynonymous SNV	ZNF423:NM_001330533:exon2:c.G966T:p.Q322H,ZNF423:NM_001271620:exon4:c.G1137T:p.Q379H,ZNF423:NM_015069:exon4:c.G1317T:p.Q439H	0.990468533	0.00953136	1.06E-07	DISEASE: Nephronophthisis 14 (NPHP14) [MIM:614844]: An autosomal recessive disorder manifesting as infantile-onset kidney disease, cerebellar vermis hypoplasia, and situs inversus. Nephronophthisis is a progressive tubulo-interstitial kidney disorder histologically characterized by modifications of the tubules with thickening of the basement membrane, interstitial fibrosis and, in the advanced stages, medullary cysts. {ECO:0000269|PubMed:22863007}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Joubert syndrome 19 (JBTS19) [MIM:614844]: A form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). JBTS19 patients have polycystic kidney disease, Leber congenital amaurosis, cerebellar vermis hypoplasia, and breathing abnormality. {ECO:0000269|PubMed:22863007}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.57996	0.12164	-2.203192877	1.362349611	308.99952	3.74292	0.029	0.457	D	0.026	0.181	B	0.02	0.179	B	0.000	0.843	D	0.998	0.445	D	0.55	0.145	N	2.91	0.100	T	-1.56	0.377	N	0.373	0.434	-0.970	0.373	T	0.016	0.067	T	0.013	0.326	T	2.081	0.311	16.73	0.984	0.403	0.934	0.580	D	c	-0.114	0.088	1.000	0.517	0.707	0.730	0	5.05	0.674	3.820	0.551	0.852	0.362	1.000	0.715	1.000	0.888	6.563	0.215	.	.	.	0.5	66	303	chr16	49671746	chr16:49671746	C	A	66	PASS	AN=2;DP=303	GT	0/1
chr16	54966439	54966439	G	T	exonic	IRX5	.	nonsynonymous SNV	IRX5:NM_001252197:exon2:c.G279T:p.M93I,IRX5:NM_005853:exon2:c.G279T:p.M93I	.	.	.	DISEASE: Hamamy syndrome (HMMS) [MIM:611174]: A syndrome characterized by severe hypertelorism, upslanting palpebral fissures, brachycephaly, abnormal ears, sloping shoulders, enamel hypoplasia, and osteopenia with repeated fractures. Additional features include myopia, mild to moderate sensorineural hearing loss, gonadal anomalies and borderline intelligence. {ECO:0000269|PubMed:22581230}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66381	0.13039	.	.	1652.69996	7.51371	0.154	0.309	T	0.063	0.219	B	0.168	0.335	B	0.000	0.843	D	1	0.810	D	0.82	0.209	L	0.34	0.592	T	-2.07	0.558	N	0.51	0.570	-0.820	0.539	T	0.188	0.540	T	0.019	0.410	T	2.204	0.326	17.54	0.992	0.553	0.895	0.497	D	c	0.119	0.267	1.000	0.747	0.598	0.340	0	4.68	0.582	6.624	0.739	0.953	0.551	1.000	0.715	0.994	0.587	16.332	0.828	.	.	.	0.5	99	241	chr16	54966439	chr16:54966439	G	T	99	PASS	AN=2;DP=241	GT	0/1
chr16	55824470	55824470	C	A	intergenic	CES1P1;CES1	dist=15644;dist=12294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	516	chr16	55824470	chr16:55824470	C	A	105	PASS	AN=2;DP=516	GT	0/1
chr16	67208152	67208152	C	A	exonic	NOL3	.	stopgain	NOL3:NM_001185057:exon2:c.C80A:p.S27X,NOL3:NM_001276309:exon2:c.C80A:p.S27X,NOL3:NM_001276311:exon2:c.C80A:p.S27X,NOL3:NM_003946:exon2:c.C80A:p.S27X,NOL3:NM_001276307:exon4:c.C80A:p.S27X,NOL3:NM_001276312:exon4:c.C80A:p.S27X,NOL3:NM_001276319:exon4:c.C266A:p.S89X	0.000536476	0.458633926	0.540829599	DISEASE: Myoclonus, familial cortical (FCM) [MIM:614937]: An autosomal dominant neurologic condition characterized by adult onset of cortical myoclonus manifest as involuntary jerks or movements affecting the face and limbs. Affected individuals can also experience falls without seizure activity or loss of consciousness. {ECO:0000269|PubMed:22926851}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08489	0.13982	0.125076652	62.7388535	82.97218	1.93512	.	.	.	.	.	.	.	.	.	0.000	0.469	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.485	0.963	35	0.990	0.507	0.577	0.302	D	c	0.635	0.447	1.0	0.983	0.726	0.872	0	4.95	0.648	2.836	0.476	0.925	0.434	0.990	0.367	0.765	0.326	13.69	0.619	CARD domain|Death-like domain	.	.	0.5	96	244	chr16	67208152	chr16:67208152	C	A	96	PASS	AN=2;DP=244	GT	0/1
chr16	69776180	69776180	C	T	UTR3	NOB1	NM_014062:c.*55G>A	.	.	8.61E-08	0.292883367	0.707116547	.	0.12273	.	-0.154246007	42.22694032	2859.41631	10.11657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	1009	chr16	69776180	chr16:69776180	C	T	149	PASS	AN=2;DP=1009	GT	0/1
chr16	75238153	75238153	C	A	exonic	CTRB2	.	nonsynonymous SNV	CTRB2:NM_001025200:exon7:c.G698T:p.W233L	0.283515253	0.630328734	0.086156013	.	0.02971	0.33983	.	.	23.4963	0.78152	0.005	0.654	D	1.0	0.899	D	0.992	0.790	D	0.000	0.629	U	1	0.810	D	2.71	0.795	M	-3.3	0.938	D	-10.4	0.992	D	0.929	0.923	1.010	0.974	D	0.893	0.964	D	0.522	0.955	D	5.375	0.728	25.9	0.987	0.438	0.975	0.748	D	c	0.684	0.600	1.000	0.747	0.554	0.283	0	4.33	0.509	6.100	0.709	0.803	0.325	1.000	0.715	0.973	0.468	16.809	0.855	Peptidase S1, PA clan|Serine proteases, trypsin domain	.	.	0.5	120	558	chr16	75238153	chr16:75238153	C	A	120	PASS	AN=2;DP=558	GT	0/1
chr16	84218459	84218459	C	A	exonic	TAF1C	.	stopgain	TAF1C:NM_001243156:exon2:c.G136T:p.E46X,TAF1C:NM_005679:exon2:c.G136T:p.E46X	3.23E-11	0.472377146	0.527622854	.	0.24194	0.0925	0.593325282	82.46048596	1956.88534	8.14058	.	.	.	.	.	.	.	.	.	0.173	0.031	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.443	0.472	23.0	0.894	0.182	0.010	0.037	N	c	-0.490	-0.957	1.000	0.747	0.731	0.878	0	-7.45	0.012	-2.252	0.013	-2.251	0.004	0.000	0.063	0.003	0.074	2.072	0.034	.	.	.	0.5	.	273	chr16	84218459	chr16:84218459	C	A	.	PASS	AN=0;DP=273	GT	0/1
chr16	86600947	86600947	G	T	exonic	FOXC2	.	nonsynonymous SNV	FOXC2:NM_005251:exon1:c.G6T:p.Q2H	.	.	.	DISEASE: Lymphedema-distichiasis (LYD) [MIM:153400]: A disorder characterized by primary limb lymphedema associated with distichiasis (double rows of eyelashes, with extra eyelashes growing from the Meibomian gland orifices). Swelling of the extremities, due to altered lymphatic flow, usually appears in late childhood or puberty. Most affected individuals have ocular findings including corneal irritation, recurrent conjunctivitis, and photophobia. Drooping of the upper eyelid (ptosis) is a variable feature of the lymphedema-distichiasis syndrome, occurring in about 30% of patients. {ECO:0000269|PubMed:11078474, ECO:0000269|PubMed:11371511, ECO:0000269|PubMed:11499682}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.38597	0.23829	.	.	50.82093	1.40445	0.0	0.912	D	0.999	0.764	D	0.99	0.774	D	0.615	0.057	U	0.994	0.422	D	2.015	0.552	M	-4.1	0.967	D	-3.49	0.680	D	0.725	0.724	0.608	0.920	D	0.914	0.972	D	0.585	0.963	D	5.864	0.804	27.3	0.996	0.740	0.975	0.751	D	c	0.453	0.349	1.000	0.747	0.623	0.393	0	1.4	0.213	6.207	0.719	0.952	0.539	1.000	0.715	1.000	0.888	8.527	0.323	.	.	.	0.5	103	527	chr16	86600947	chr16:86600947	G	T	103	PASS	AN=2;DP=527	GT	0/1
chr16	86612457	86612457	G	-	exonic	FOXL1	.	frameshift deletion	FOXL1:NM_005250:exon1:c.128delG:p.A44Pfs*219	0.063930237	0.726767174	0.209302589	.	0.73079	.	.	.	70.601	1.74883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	363	chr16	86612456	chr16:86612456	CG	C	124	PASS	AN=2;DP=363	GT	0/1
chr16	88123963	88123963	C	-	intergenic	BANP;LOC400553	dist=13039;dist=9052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	543	chr16	88123962	chr16:88123962	GC	G	96	PASS	AN=2;DP=543	GT	0/1
chr16	88499564	88499564	C	A	exonic	ZNF469	.	nonsynonymous SNV	ZNF469:NM_001127464:exon2:c.C5602A:p.P1868T	.	.	.	.	.	.	.	.	3862.54073	12.24999	0.0	0.912	D	0.767	0.418	P	0.344	0.408	B	.	.	.	1	0.090	N	1.7	0.440	L	2.21	0.184	T	-2.63	0.564	D	0.305	0.365	-1.052	0.139	T	0.025	0.107	T	0.411	0.936	D	3.911	0.527	23.5	0.952	0.257	0.044	0.098	N	c	-0.393	-0.436	0.443	0.205	0.646	0.450	0	3.49	0.389	0.033	0.135	0.807	0.329	0.000	0.063	0.045	0.161	2.867	0.052	.	.	.	0.5	.	222	chr16	88499564	chr16:88499564	C	A	.	PASS	AN=0;DP=222	GT	0/1
chr16	89017426	89017426	C	A	exonic	LOC100129697	.	nonsynonymous SNV	LOC100129697:NM_001290330:exon2:c.C900A:p.D300E	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	758	chr16	89017426	chr16:89017426	C	A	.	PASS	AN=0;DP=758	GT	0/1
chr16	89661967	89661967	C	T	exonic	CPNE7	.	nonsynonymous SNV	CPNE7:NM_153636:exon14:c.C1495T:p.L499F,CPNE7:NM_014427:exon16:c.C1720T:p.L574F	1.63E-13	0.026868774	0.973131226	.	0.10022	.	-1.343026423	4.647322482	1754.91457	7.73074	0.183	0.373	T	0.096	0.277	B	0.106	0.296	B	0.000	0.629	D	0.876	0.356	D	1.975	0.537	M	1.35	0.346	T	-2.13	0.483	N	0.469	0.519	-0.963	0.387	T	0.087	0.337	T	0.026	0.494	D	2.331	0.341	18.37	0.743	0.103	0.913	0.530	D	c	-0.475	-0.497	1.000	0.517	0.706	0.609	0	2.58	0.299	2.284	0.429	0.848	0.348	0.965	0.337	0.205	0.218	12.567	0.555	Copine|von Willebrand factor, type A	.	.	0.5	102	417	chr16	89661967	chr16:89661967	C	T	102	PASS	AN=2;DP=417	GT	0/1
chr17	3838567	3838567	G	A	exonic	ATP2A3	.	synonymous SNV	ATP2A3:NM_005173:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174953:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174954:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174955:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174956:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174957:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174958:exon17:c.C2529T:p.Y843Y	0.06445003	0.935544655	5.31E-06	.	0.12887	0.19795	-1.471735692	3.739089408	775.92328	5.51515	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	266	chr17	3838567	chr17:3838567	G	A	65	PASS	AN=2;DP=266	GT	0/1
chr17	7578179	7578179	C	A	exonic	TP53	.	stopgain	TP53:NM_001126115:exon2:c.G274T:p.E92X,TP53:NM_001126116:exon2:c.G274T:p.E92X,TP53:NM_001126117:exon2:c.G274T:p.E92X,TP53:NM_001276697:exon2:c.G193T:p.E65X,TP53:NM_001276698:exon2:c.G193T:p.E65X,TP53:NM_001276699:exon2:c.G193T:p.E65X,TP53:NM_001126118:exon5:c.G553T:p.E185X,TP53:NM_000546:exon6:c.G670T:p.E224X,TP53:NM_001126112:exon6:c.G670T:p.E224X,TP53:NM_001126113:exon6:c.G670T:p.E224X,TP53:NM_001126114:exon6:c.G670T:p.E224X,TP53:NM_001276695:exon6:c.G553T:p.E185X,TP53:NM_001276696:exon6:c.G553T:p.E185X,TP53:NM_001276760:exon6:c.G553T:p.E185X,TP53:NM_001276761:exon6:c.G553T:p.E185X	0.912222953	0.087750328	2.67E-05	DISEASE: Note=TP53 is found in increased amounts in a wide variety of transformed cells. TP53 is frequently mutated or inactivated in about 60% of cancers. TP53 defects are found in Barrett metaplasia a condition in which the normally stratified squamous epithelium of the lower esophagus is replaced by a metaplastic columnar epithelium. The condition develops as a complication in approximately 10% of patients with chronic gastroesophageal reflux disease and predisposes to the development of esophageal adenocarcinoma.; DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Li-Fraumeni syndrome (LFS) [MIM:151623]: Autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:10484981, ECO:0000269|PubMed:1565144, ECO:0000269|PubMed:1737852, ECO:0000269|PubMed:1933902, ECO:0000269|PubMed:1978757, ECO:0000269|PubMed:2259385, ECO:0000269|PubMed:7887414, ECO:0000269|PubMed:8825920, ECO:0000269|PubMed:9452042}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Papilloma of choroid plexus (CPP) [MIM:260500]: A benign tumor of neuroectodermal origin that generally occurs in childhood, but has also been reported in adults. Although generally found within the ventricular system, choroid plexus papillomas can arise ectopically in the brain parenchyma or disseminate throughout the neuraxis. Patients present with signs and symptoms of increased intracranial pressure including headache, hydrocephalus, papilledema, nausea, vomiting, cranial nerve deficits, gait impairment, and seizures. {ECO:0000269|PubMed:12085209}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Adrenocortical carcinoma (ADCC) [MIM:202300]: A malignant neoplasm of the adrenal cortex and a rare childhood tumor. It occurs with increased frequency in patients with Beckwith- Wiedemann syndrome and Li-Fraumeni syndrome. {ECO:0000269|PubMed:11481490}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Basal cell carcinoma 7 (BCC7) [MIM:614740]: A common malignant skin neoplasm that typically appears on hair-bearing skin, most commonly on sun-exposed areas. It is slow growing and rarely metastasizes, but has potentialities for local invasion and destruction. It usually develops as a flat, firm, pale area that is small, raised, pink or red, translucent, shiny, and waxy, and the area may bleed following minor injury. Tumor size can vary from a few millimeters to several centimeters in diameter. {ECO:0000269|PubMed:21946351}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.99999	0.9998	-0.247889024	35.98726115	15.3263	0.55115	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.787	0.978	38	0.997	0.804	0.970	0.719	D	c	0.919	0.728	0.695	0.226	0.732	0.924	0	3.13	0.349	4.159	0.577	0.852	0.362	1.000	0.715	0.992	0.562	12.988	0.578	p53, DNA-binding domain|p53-like transcription factor, DNA-binding|p53/RUNT-type transcription factor, DNA-binding domain	.	.	0.5	69	188	chr17	7578179	chr17:7578179	C	A	69	PASS	AN=2;DP=188	GT	0/1
chr17	10247303	10247303	G	T	exonic	MYH13	.	nonsynonymous SNV	MYH13:NM_003802:exon16:c.C1708A:p.P570T	1.89E-29	0.014239931	0.985760069	.	0.48597	0.1881	-0.635977455	16.74333569	5547.032	15.40045	0.048	0.400	D	0.003	0.102	B	0.22	0.361	B	.	.	.	0.985	0.247	N	1.465	0.370	L	-2.18	0.867	D	-2.52	0.547	D	0.197	0.306	0.032	0.829	D	0.676	0.888	D	0.068	0.705	D	1.967	0.297	16.00	0.957	0.270	0.235	0.219	N	c	-0.610	-0.697	0.000	0.012	0.487	0.133	0	-0.255	0.123	0.009	0.130	0.900	0.413	0.000	0.063	0.983	0.502	16.651	0.850	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	95	359	chr17	10247303	chr17:10247303	G	T	95	PASS	AN=2;DP=359	GT	0/1
chr17	10417160	10417160	C	A	exonic	MYH1	.	nonsynonymous SNV	MYH1:NM_005963:exon8:c.G719T:p.R240M	1.29E-29	0.041852309	0.958147691	.	0.69127	0.30625	-1.080656478	7.248171739	785.49267	5.53734	0.0	0.912	D	0.999	0.764	D	0.986	0.754	D	0.000	0.481	U	1	0.810	D	2.995	0.861	M	-2.47	0.890	D	-4.87	0.812	D	0.951	0.947	0.981	0.969	D	0.885	0.962	D	0.205	0.870	D	6.732	0.919	32	0.965	0.296	0.959	0.663	D	c	1.028	0.958	1.0	0.983	0.534	0.214	0	5.58	0.843	7.875	0.855	0.935	0.490	1.000	0.715	1.000	0.888	19.947	0.972	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	65	173	chr17	10417160	chr17:10417160	C	A	65	PASS	AN=2;DP=173	GT	0/1
chr17	17707151	17707151	G	A	exonic	RAI1	.	nonsynonymous SNV	RAI1:NM_030665:exon4:c.G5647A:p.A1883T	0.999136112	0.000863888	6.14E-11	DISEASE: Smith-Magenis syndrome (SMS) [MIM:182290]: Characterized by congenital mental retardation associated with development and growth delays. Affected persons have characteristic behavioral abnormalities, including self-injurious behaviors and sleep disturbance, and distinct craniofacial and skeletal anomalies. {ECO:0000269|PubMed:11404004, ECO:0000269|PubMed:12652298}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13693	0.11743	-3.683732498	0.253597547	223.68182	3.23449	0.0	0.912	D	0.999	0.764	D	0.995	0.818	D	.	.	.	1.000	0.810	D	4.17	0.977	H	-0.97	0.757	T	-3.46	0.677	D	0.668	0.791	0.488	0.904	D	0.663	0.883	D	0.358	0.925	D	7.132	0.943	34	0.965	0.295	0.994	0.953	D	c	0.983	0.925	1.000	0.747	0.707	0.730	0	5.46	0.799	9.735	0.980	1.048	0.713	1.000	0.715	0.997	0.653	18.908	0.924	Zinc finger, PHD-type	.	.	0.5	84	330	chr17	17707151	chr17:17707151	G	A	84	PASS	AN=2;DP=330	GT	0/1
chr17	20416895	20416895	A	C	intergenic	KRT16P3;CDRT15L2	dist=9084;dist=66142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	358	chr17	20416895	chr17:20416895	A	C	106	PASS	AN=2;DP=358	GT	0/1
chr17	25974223	25974223	G	-	intronic	LGALS9	.	.	.	0.00139054	0.964148727	0.034460733	.	0.13572	0.22025	0.797386419	87.53833451	2358.5758	9.00919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	164	chr17	25974222	chr17:25974222	AG	A	59	PASS	AN=2;DP=164	GT	0/1
chr17	28886747	28886747	G	T	intronic	TBC1D29	.	.	.	8.25E-05	0.321646341	0.678271175	.	0.07418	.	0.215080721	67.91696155	10.20934	0.37212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	398	chr17	28886747	chr17:28886747	G	T	.	PASS	AN=0;DP=398	GT	0/1
chr17	33769038	33769038	C	A	exonic	SLFN13	.	nonsynonymous SNV	SLFN13:NM_144682:exon5:c.G1466T:p.R489L	8.75E-15	0.004834494	0.995165506	.	0.05976	0.06727	2.763559657	98.99740505	1954.11134	8.1348	0.635	0.051	T	0.388	0.327	B	0.083	0.277	B	0.287	0.039	N	1	0.090	P	2.24	0.636	M	4.49	0.035	T	-2.15	0.486	N	0.188	0.241	-0.948	0.414	T	0.008	0.030	T	.	.	.	0.520	0.144	7.585	0.425	0.031	0.004	0.019	N	c	-1.448	-1.614	0.119	0.168	0.707	0.730	0	-6.09	0.020	-6.973	0.001	-2.795	0.002	0.000	0.063	0.000	0.016	5.552	0.163	.	.	.	0.5	170	599	chr17	33769038	chr17:33769038	C	A	170	PASS	AN=2;DP=599	GT	0/1
chr17	36861971	36861971	C	A	exonic	MLLT6	.	nonsynonymous SNV	MLLT6:NM_005937:exon1:c.C86A:p.A29E	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	0.448	0.342	B	0.115	0.316	B	0.005	0.332	N	0.716	0.299	N	0.625	0.159	N	.	.	.	.	.	.	0.262	0.323	-1.013	0.258	T	0.015	0.062	T	0.417	0.937	D	4.294	0.575	24.0	0.976	0.342	0.758	0.369	D	c	-0.418	-0.326	1.000	0.747	0.767	0.994	0	1.16	0.198	6.035	0.704	-0.077	0.119	1.000	0.715	0.996	0.625	11.099	0.472	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, PHD-type, conserved site|Zinc finger, RING/FYVE/PHD-type	.	.	0.5	129	1087	chr17	36861971	chr17:36861971	C	A	129	PASS	AN=2;DP=1087	GT	0/1
chr17	39412133	39412133	C	A	exonic	KRTAP9-9	.	nonsynonymous SNV	KRTAP9-9:NM_030975:exon1:c.C496A:p.P166T,KRTAP9-9:NM_001318227:exon2:c.C511A:p.P171T	0.007298706	0.536562679	0.456138614	.	.	0.10345	.	.	5752.9952	15.75321	0.037	0.430	D	0.975	0.561	D	0.763	0.547	P	.	.	.	0.999	0.220	N	.	.	.	4.67	0.018	T	-4.87	0.812	D	0.492	0.539	-0.980	0.350	T	0.013	0.050	T	0.004	0.112	T	4.329	0.580	24.0	0.993	0.575	0.117	0.166	N	c	-0.033	-0.185	0.004	0.103	0.447	0.083	0	1.48	0.218	0.044	0.138	0.718	0.303	0.000	0.063	0.957	0.436	4.831	0.127	.	.	.	0.5	.	321	chr17	39412133	chr17:39412133	C	A	.	PASS	AN=0;DP=321	GT	0/1
chr17	43324637	43324637	C	A	UTR3	FMNL1	NM_005892:c.*412C>A	.	.	0.999687036	0.000312964	5.17E-12	.	0.38561	0.13099	-1.063626766	7.484076433	3176.17327	10.74104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	410	chr17	43324637	chr17:43324637	C	A	105	PASS	AN=2;DP=410	GT	0/1
chr17	43626397	43626397	G	C	intergenic	LRRC37A4P;MAPK8IP1P2	dist=28508;dist=51072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	875	chr17	43626397	chr17:43626397	G	C	129	PASS	AN=2;DP=875	GT	0/1
chr17	46689879	46689879	A	G	UTR3	HOXB8	NM_024016:c.*685T>C	.	.	0.444768418	0.548716697	0.006514885	.	0.70662	0.1705	0.347360312	73.97381458	275.34627	3.55414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	168	chr17	46689879	chr17:46689879	A	G	124	PASS	AN=2;DP=168	GT	0/1
chr17	47583697	47583697	C	A	exonic	NGFR	.	nonsynonymous SNV	NGFR:NM_002507:exon3:c.C245A:p.P82Q	0.238222215	0.754753803	0.007023982	.	0.45788	0.74431	-0.203796826	38.81811748	290.02902	3.64468	0.415	0.100	T	0.213	0.284	B	0.049	0.237	B	0.014	0.286	N	0.998	0.448	D	1.33	0.334	L	-2.66	0.903	D	-1.28	0.322	N	0.167	0.202	-0.342	0.738	T	0.462	0.792	T	0.086	0.747	D	2.601	0.374	20.2	0.979	0.361	0.432	0.268	N	c	-0.427	-0.265	1.000	0.517	0.696	0.567	0	4.39	0.520	2.493	0.447	0.935	0.490	0.400	0.259	1.000	0.888	15.485	0.752	TNFR/NGFR cysteine-rich region	.	.	0.5	.	276	chr17	47583697	chr17:47583697	C	A	.	PASS	AN=0;DP=276	GT	0/1
chr17	48940281	48940281	-	A	UTR3	TOB1	NM_001243885:c.*59_*60insT;NM_001243877:c.*59_*60insT;NM_005749:c.*59_*60insT	.	.	0.798204384	0.196185003	0.005610612	.	0.78741	0.22085	-0.271755481	34.31823543	36.86645	1.10425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	299	chr17	48940281	chr17:48940281	G	GA	67	PASS	AN=2;DP=299	GT	0/1
chr17	60217010	60217010	G	T	intergenic	MED13;TBC1D3P2	dist=74367;dist=125057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	385	chr17	60217010	chr17:60217010	G	T	67	PASS	AN=2;DP=385	GT	0/1
chr17	60217713	60217713	G	T	intergenic	MED13;TBC1D3P2	dist=75070;dist=124354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	303	chr17	60217713	chr17:60217713	G	T	.	PASS	AN=0;DP=303	GT	0/1
chr17	60345044	60345044	A	T	ncRNA_intronic	TBC1D3P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	286	chr17	60345044	chr17:60345044	A	T	.	PASS	AN=0;DP=286	GT	0/1
chr17	62009640	62009640	G	T	UTR5	CD79B	NM_021602:c.-19C>A;NM_000626:c.-19C>A;NM_001329050:c.-19C>A;NM_001039933:c.-19C>A	.	.	0.950002657	0.049842119	0.000155224	DISEASE: Agammaglobulinemia 6, autosomal recessive (AGM6) [MIM:612692]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:17675462}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24113	0.3219	-0.449946534	24.00330267	9.1864	0.3355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	551	chr17	62009640	chr17:62009640	G	T	120	PASS	AN=2;DP=551	GT	0/1
chr17	62223403	62223403	G	T	ncRNA_intronic	SNHG25	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	679	chr17	62223403	chr17:62223403	G	T	138	PASS	AN=2;DP=679	GT	0/1
chr17	62817209	62817209	C	A	ncRNA_intronic	PLEKHM1P1	.	.	.	.	.	.	.	.	0.09794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	141	chr17	62817209	chr17:62817209	C	A	.	PASS	AN=0;DP=141	GT	0/1
chr17	71468207	71468207	C	A	intronic	SDK2	.	.	.	0.029034431	0.970965567	1.25E-09	.	0.41261	0.12096	-2.470675891	0.9849021	2484.07134	9.29974	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	510	chr17	71468207	chr17:71468207	C	A	127	PASS	AN=2;DP=510	GT	0/1
chr17	72736980	72736980	C	T	exonic	RAB37	.	nonsynonymous SNV	RAB37:NM_001006638:exon2:c.C167T:p.S56F,RAB37:NM_001163989:exon2:c.C182T:p.S61F,RAB37:NM_001330471:exon2:c.C86T:p.S29F	8.23E-05	0.76782021	0.23209752	.	0.08186	0.11813	0.040529541	57.15380986	48.09219	1.35018	0.003	0.721	D	0.884	0.473	P	0.816	0.571	P	0.000	0.449	D	0.999	0.810	D	2.03	0.557	M	-1.14	0.779	T	-3.79	0.724	D	0.38	0.440	0.185	0.857	D	0.556	0.838	D	0.226	0.881	D	5.061	0.682	25.2	0.998	0.867	0.990	0.891	D	c	0.476	0.436	1.000	0.747	0.706	0.609	0	5.1	0.688	4.832	0.622	0.921	0.432	1.000	0.715	0.999	0.750	17.296	0.870	P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	70	304	chr17	72736980	chr17:72736980	C	T	70	PASS	AN=2;DP=304	GT	0/1
chr17	77093795	77093795	A	T	exonic	RBFOX3	.	nonsynonymous SNV	RBFOX3:NM_001350453:exon8:c.T601A:p.Y201N,RBFOX3:NM_001350451:exon9:c.T601A:p.Y201N,RBFOX3:NM_001082575:exon10:c.T601A:p.Y201N	.	.	.	.	.	.	-0.141298762	42.87567823	36.57701	1.09709	.	.	.	0.094	0.238	B	0.062	0.255	B	0.000	0.629	D	1	0.810	D	1.845	0.488	L	1.73	0.264	T	.	.	.	0.813	0.831	-1.080	0.073	T	0.053	0.223	T	0.057	0.669	D	3.998	0.538	23.6	0.956	0.267	0.996	0.978	D	c	-0.032	0.109	1.000	0.747	0.742	0.980	0	4.27	0.498	8.780	0.914	1.168	0.901	1.000	0.715	0.984	0.507	13.219	0.591	.	.	.	0.5	.	206	chr17	77093795	chr17:77093795	A	T	.	PASS	AN=0;DP=206	GT	0/1
chr17	78083795	78083795	G	T	exonic	GAA	.	stopgain	GAA:NM_000152:exon9:c.G1378T:p.E460X,GAA:NM_001079804:exon9:c.G1378T:p.E460X,GAA:NM_001079803:exon10:c.G1378T:p.E460X	4.62E-11	0.781839838	0.218160162	DISEASE: Glycogen storage disease 2 (GSD2) [MIM:232300]: A metabolic disorder with a broad clinical spectrum. The severe infantile form, or Pompe disease, presents at birth with massive accumulation of glycogen in muscle, heart and liver. Cardiomyopathy and muscular hypotonia are the cardinal features of this form whose life expectancy is less than two years. The juvenile and adult forms present as limb-girdle muscular dystrophy beginning in the lower limbs. Final outcome depends on respiratory muscle failure. Patients with the adult form can be free of clinical symptoms for most of their life but finally develop a slowly progressive myopathy. {ECO:0000269|PubMed:10189220, ECO:0000269|PubMed:10206684, ECO:0000269|PubMed:10338092, ECO:0000269|PubMed:10737124, ECO:0000269|PubMed:11071489, ECO:0000269|PubMed:11738358, ECO:0000269|PubMed:12601120, ECO:0000269|PubMed:12923862, ECO:0000269|PubMed:14643388, ECO:0000269|PubMed:14695532, ECO:0000269|PubMed:14972326, ECO:0000269|PubMed:15145338, ECO:0000269|PubMed:15668445, ECO:0000269|PubMed:16433701, ECO:0000269|PubMed:1652892, ECO:0000269|PubMed:16782080, ECO:0000269|PubMed:1684505, ECO:0000269|PubMed:16917947, ECO:0000269|PubMed:17643989, ECO:0000269|PubMed:18425781, ECO:0000269|PubMed:18429042, ECO:0000269|PubMed:1898413, ECO:0000269|PubMed:19588081, ECO:0000269|PubMed:20080426, ECO:0000269|PubMed:20350966, ECO:0000269|PubMed:21109266, ECO:0000269|PubMed:22644586, ECO:0000269|PubMed:22676651, ECO:0000269|PubMed:25681614, ECO:0000269|PubMed:7695647, ECO:0000269|PubMed:7717400, ECO:0000269|PubMed:7866409, ECO:0000269|PubMed:7881422, ECO:0000269|PubMed:7981676, ECO:0000269|PubMed:8094613, ECO:0000269|PubMed:8401535, ECO:0000269|PubMed:8834250, ECO:0000269|PubMed:9521422, ECO:0000269|PubMed:9535769, ECO:0000269|PubMed:9660056, ECO:0000269|Ref.5}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11717	0.93517	-1.159397299	6.098136353	1841.49194	7.915	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.180	0.989	41	0.998	0.844	0.927	0.561	D	c	1.008	0.829	1.000	0.747	0.718	0.821	0	5.41	0.782	9.349	0.964	0.953	0.551	1.000	0.715	0.784	0.331	13.497	0.607	Glycoside hydrolase superfamily	.	.	0.5	137	953	chr17	78083795	chr17:78083795	G	T	137	PASS	AN=2;DP=953	GT	0/1
chr17	79683805	79683805	G	A	intronic	SLC25A10	.	.	.	0.002439368	0.928274848	0.069285784	.	0.18311	0.12721	-0.448125345	24.19202642	41.5856	1.21268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	406	chr17	79683805	chr17:79683805	G	A	85	PASS	AN=2;DP=406	GT	0/1
chr18	13824036	13824036	C	T	intergenic	RNMT;MC5R	dist=59481;dist=1507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	693	chr18	13824036	chr18:13824036	C	T	131	PASS	AN=2;DP=693	GT	0/1
chr18	14173952	14173952	A	G	intergenic	ZNF519;ANKRD20A5P	dist=41463;dist=5144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	130	chr18	14173952	chr18:14173952	A	G	100	PASS	AN=2;DP=130	GT	0/1
chr18	24035449	24035449	T	-	UTR3	KCTD1	NM_198991:c.*258delA;NM_001258221:c.*258delA;NM_001142730:c.*258delA;NM_001136205:c.*258delA;NM_001351443:c.*258delA;NM_001258222:c.*258delA	.	.	0.934855731	0.064842753	0.000301517	DISEASE: Scalp-ear-nipple syndrome (SENS) [MIM:181270]: A disease characterized by aplasia cutis congenita of the scalp, breast anomalies that range from hypothelia or athelia to amastia, and minor anomalies of the external ears. Less frequent clinical characteristics include nail dystrophy, dental anomalies, cutaneous syndactyly of the digits, and renal malformations. Penetrance appears to be high, although there is substantial variable expressivity within families. {ECO:0000269|PubMed:23541344}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20055	0.11262	-0.405853867	26.23260203	261.92903	3.47336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	156	348	chr18	24035448	chr18:24035448	CT	C	156	PASS	AN=2;DP=348	GT	0/1
chr18	77464792	77464792	G	T	exonic	CTDP1	.	nonsynonymous SNV	CTDP1:NM_001202504:exon5:c.G290T:p.R97L,CTDP1:NM_001318511:exon5:c.G647T:p.R216L,CTDP1:NM_004715:exon5:c.G647T:p.R216L,CTDP1:NM_048368:exon5:c.G647T:p.R216L	0.924155319	0.075843928	7.53E-07	DISEASE: Congenital cataracts, facial dysmorphism, and neuropathy (CCFDN) [MIM:604168]: An autosomal recessive developmental disorder characterized by a complex clinical phenotype with seemingly unrelated features involving multiple organs and systems. Developmental abnormalities include congenital cataracts and microcorneae, hypomyelination of the peripheral nervous system, impaired physical growth, delayed early motor and intellectual development, facial dysmorphism and hypogonadism. Central nervous system involvement, with cerebral and spinal cord atrophy, may be the result of disrupted development with superimposed degenerative changes. Affected individuals are prone to severe rhabdomyolysis after viral infections and to serious complications related to general anesthesia (such as pulmonary edema and epileptic seizures). {ECO:0000269|PubMed:14517542}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11827	0.23034	-0.835882558	11.47676339	993.37938	6.07377	0.113	0.287	T	1.0	0.899	D	0.997	0.971	D	0.000	0.843	D	1	0.810	D	0.57	0.153	N	2.3	0.170	T	-4.51	0.782	D	0.897	0.886	-1.066	0.104	T	0.067	0.274	T	0.015	0.352	T	6.266	0.865	29.0	0.998	0.924	0.976	0.757	D	c	0.549	0.585	1.000	0.747	0.707	0.730	0	4.96	0.650	7.350	0.785	0.953	0.551	1.000	0.715	0.993	0.574	18.560	0.910	FCP1 homology domain|FCP1-like phosphatase, phosphatase domain|HAD-like domain	.	.	0.5	124	216	chr18	77464792	chr18:77464792	G	T	124	PASS	AN=2;DP=216	GT	0/1
chr19	313545	313545	C	A	exonic	MIER2	.	stopgain	MIER2:NM_001346105:exon7:c.G646T:p.E216X,MIER2:NM_017550:exon8:c.G754T:p.E252X	0.977262863	0.022736235	9.02E-07	.	0.24964	.	-1.148192153	6.316348195	267.17865	3.50509	.	.	.	.	.	.	.	.	.	0.000	0.473	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.488	0.963	35	0.996	0.761	0.912	0.527	D	c	0.514	0.225	0.133	0.171	0.672	0.522	0	2.75	0.313	2.526	0.450	0.890	0.394	0.986	0.359	0.067	0.174	7.591	0.270	ELM2 domain	.	.	0.5	.	238	chr19	313545	chr19:313545	C	A	.	PASS	AN=0;DP=238	GT	0/1
chr19	806606	806606	G	T	intronic	PTBP1	.	.	.	0.9987392	0.001260782	1.86E-08	.	0.88766	0.24759	-1.217968826	5.638122199	29.53361	0.94402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	366	chr19	806606	chr19:806606	G	T	.	PASS	AN=0;DP=366	GT	0/1
chr19	2038185	2038185	C	T	UTR3	MKNK2	NM_199054:c.*1427G>A	.	.	9.34E-06	0.777281387	0.222709276	.	0.18067	0.14759	-0.576764155	18.7839113	742.98614	5.41125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	385	chr19	2038185	chr19:2038185	C	T	86	PASS	AN=2;DP=385	GT	0/1
chr19	2476487	2476487	G	T	intronic	GADD45B	.	.	.	0.185427442	0.763426872	0.051145686	.	0.43236	0.38305	-0.031067188	51.03798066	5224.38363	14.87867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	900	chr19	2476487	chr19:2476487	G	T	138	PASS	AN=2;DP=900	GT	0/1
chr19	4508855	4508855	G	T	exonic	PLIN4	.	nonsynonymous SNV	PLIN4:NM_001080400:exon4:c.C3585A:p.H1195Q	1.66E-12	0.007710433	0.992289567	.	0.16259	0.102	5.994578529	99.85845718	9818.87991	21.57786	0.01	0.564	D	1.0	0.899	D	0.983	0.742	D	0.000	0.473	D	1.000	0.191	N	3.06	0.872	M	2.22	0.182	T	-6.83	0.930	D	0.705	0.708	-1.075	0.083	T	0.075	0.301	T	0.045	0.617	D	4.476	0.599	24.2	0.990	0.492	0.078	0.136	N	c	-0.392	-0.605	0.001	0.078	0.581	0.326	0	-1.18	0.091	-1.209	0.031	-1.161	0.017	0.004	0.165	0.040	0.157	7.974	0.291	.	.	.	0.5	82	476	chr19	4508855	chr19:4508855	G	T	82	PASS	AN=2;DP=476	GT	0/1
chr19	6414075	6414075	-	A	UTR3	KHSRP	NM_003685:c.*47_*48insT	.	.	0.999711222	0.000288778	5.13E-10	.	0.45176	0.15486	-0.690637458	15.12149092	19.12445	0.65912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	234	chr19	6414075	chr19:6414075	G	GA	73	PASS	AN=2;DP=234	GT	0/1
chr19	8591377	8591377	G	T	exonic	MYO1F	.	synonymous SNV	MYO1F:NM_001348355:exon24:c.C2718A:p.T906T,MYO1F:NM_012335:exon24:c.C2730A:p.T910T	0.158022191	0.841977807	1.90E-09	.	0.37121	0.20079	-1.828205761	2.123142251	209.12294	3.12186	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	458	chr19	8591377	chr19:8591377	G	T	114	PASS	AN=2;DP=458	GT	0/1
chr19	8931965	8931965	C	A	exonic	ZNF558	.	nonsynonymous SNV	ZNF558:NM_144693:exon7:c.G138T:p.E46D	0.000767127	0.768778657	0.230454216	.	0.15725	0.09863	0.330767508	73.53739089	79.11796	1.87794	0.014	0.531	D	0.015	0.158	B	0.097	0.288	B	.	.	.	1	0.810	D	2.55	0.747	M	4.38	0.023	T	-1.53	0.372	N	0.158	0.189	-0.903	0.477	T	0.008	0.028	T	0.004	0.083	T	3.538	0.483	23.1	0.993	0.588	0.471	0.277	N	c	-0.523	-0.466	0.000	0.056	0.707	0.730	0	1.98	0.252	-0.373	0.075	-0.005	0.134	0.007	0.175	0.983	0.502	7.989	0.292	Krueppel-associated box	.	.	0.5	.	202	chr19	8931965	chr19:8931965	C	A	.	PASS	AN=0;DP=202	GT	0/1
chr19	9120973	9120973	G	T	intergenic	MUC16;OR1M1	dist=28955;dist=82948	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	429	chr19	9120973	chr19:9120973	G	T	113	PASS	AN=2;DP=429	GT	0/1
chr19	11661058	11661058	G	C	UTR3	CNN1	NM_001308342:c.*448G>C;NM_001308341:c.*448G>C;NM_001299:c.*448G>C	.	.	0.861520643	0.138047141	0.000432216	.	0.31953	0.14336	-0.336073593	30.55555556	38.63481	1.14452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	273	chr19	11661058	chr19:11661058	G	C	96	PASS	AN=2;DP=273	GT	0/1
chr19	15794498	15794498	G	T	exonic	CYP4F12	.	nonsynonymous SNV	CYP4F12:NM_023944:exon7:c.G843T:p.Q281H	1.18E-09	0.317322174	0.682677824	.	0.12638	0.13897	3.741799815	99.5930644	493.21153	4.56649	0.067	0.359	T	0.015	0.158	B	0.114	0.302	B	0.137	0.184	U	1	0.090	N	1.555	0.395	L	-0.42	0.695	T	-3.34	0.663	D	0.053	0.112	-0.890	0.490	T	0.184	0.533	T	0.033	0.549	D	-0.572	0.051	0.146	0.908	0.195	0.179	0.198	N	c	-1.031	-1.135	0.000	0.071	0.487	0.133	0	-1.35	0.086	-1.551	0.023	-3.501	0.001	0.000	0.063	0.000	0.016	2.707	0.048	.	.	.	0.5	100	297	chr19	15794498	chr19:15794498	G	T	100	PASS	AN=2;DP=297	GT	0/1
chr19	16653215	16653215	C	G	UTR5	CHERP	NM_006387:c.-26G>C	.	.	0.999988396	1.16E-05	2.04E-13	.	0.24899	0.1174	-1.087493118	7.106628922	30.28923	0.96588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	231	chr19	16653215	chr19:16653215	C	G	76	PASS	AN=2;DP=231	GT	0/1
chr19	18650239	18650239	C	T	exonic	FKBP8	.	nonsynonymous SNV	FKBP8:NM_001308373:exon4:c.G493A:p.V165M,FKBP8:NM_012181:exon4:c.G493A:p.V165M	0.978738099	0.021243272	1.86E-05	.	0.14814	0.16202	-0.578583623	18.71903751	316.31545	3.77722	0.261	0.165	T	0.068	0.468	B	0.009	0.337	B	0.000	0.497	D	0.988	0.810	D	0.835	0.211	L	0.29	0.589	T	-0.12	0.088	N	0.241	0.364	-0.844	0.524	T	0.139	0.458	T	0.022	0.453	T	2.702	0.386	20.8	0.980	0.367	0.211	0.211	N	c	-0.271	-0.271	0.012	0.122	0.707	0.730	0	3.71	0.416	0.405	0.206	0.841	0.343	0.004	0.165	0.530	0.276	13.033	0.581	FKBP-type peptidyl-prolyl cis-trans isomerase domain	.	.	0.5	108	192	chr19	18650239	chr19:18650239	C	T	108	PASS	AN=2;DP=192	GT	0/1
chr19	19431733	19431733	C	T	exonic	MAU2	.	nonsynonymous SNV	MAU2:NM_015329:exon1:c.C65T:p.A22V	0.999717755	0.000282245	9.82E-11	.	0.26949	.	-0.758599262	13.32861524	16.10564	0.57035	0.519	0.073	T	0.028	0.184	B	0.015	0.162	B	0.037	0.244	U	0.795	0.344	D	0.14	0.088	N	-1.34	0.800	T	-0.16	0.095	N	0.21	0.258	-0.674	0.617	T	0.228	0.593	T	0.108	0.785	D	3.361	0.462	22.9	0.996	0.711	0.949	0.624	D	c	-0.170	0.087	1.0	0.983	0.442	0.072	0	5.31	0.750	4.788	0.619	0.935	0.490	1.000	0.715	0.983	0.502	16.478	0.839	Tetratricopeptide-like helical domain	.	.	0.5	121	851	chr19	19431733	chr19:19431733	C	T	121	PASS	AN=2;DP=851	GT	0/1
chr19	35486903	35486903	A	G	UTR5	GRAMD1A	NM_001320036:c.-24A>G	.	.	0.568380699	0.431615022	4.28E-06	.	0.11858	0.11551	-1.017713296	8.103326256	1134.30997	6.42672	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	411	chr19	35486903	chr19:35486903	A	G	116	PASS	AN=2;DP=411	GT	0/1
chr19	35502371	35502371	C	T	intronic	GRAMD1A	.	.	.	0.568380699	0.431615022	4.28E-06	.	0.11858	0.11551	-1.017713296	8.103326256	1134.30997	6.42672	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	206	chr19	35502371	chr19:35502371	C	T	.	PASS	AN=0;DP=206	GT	0/1
chr19	36122319	36122319	G	T	intronic	RBM42	.	.	.	0.759889531	0.239708836	0.000401633	.	0.204	0.11141	-0.293801652	32.93819297	28.6708	0.91789	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	263	chr19	36122319	chr19:36122319	G	T	75	PASS	AN=2;DP=263	GT	0/1
chr19	36487002	36487002	G	T	UTR3	SDHAF1	NM_001042631:c.*478G>T	.	.	0.106593834	0.5920706	0.301335566	.	.	.	.	.	13.08923	0.47642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	115	chr19	36487002	chr19:36487002	G	T	83	PASS	AN=2;DP=115	GT	0/1
chr19	36821265	36821265	-	T	ncRNA_exonic	LINC00665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	750	chr19	36821265	chr19:36821265	A	AT	82	PASS	AN=2;DP=750	GT	0/1
chr19	38850231	38850231	C	T	intronic	CATSPERG	.	.	.	1.31E-11	0.754237373	0.245762627	.	0.21807	.	-0.657684922	16.09459778	542.61244	4.74222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	418	chr19	38850231	chr19:38850231	C	T	106	PASS	AN=2;DP=418	GT	0/1
chr19	39423227	39423227	C	A	exonic	MRPS12	.	nonsynonymous SNV	MRPS12:NM_021107:exon2:c.C304A:p.L102M,MRPS12:NM_033362:exon3:c.C304A:p.L102M,MRPS12:NM_033363:exon3:c.C304A:p.L102M	0.010426267	0.612392219	0.377181514	.	0.31923	0.17492	-0.139478553	43.29440906	162.82289	2.78572	0.001	0.784	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.08	0.973	H	0.56	0.546	T	-2.0	0.461	N	0.687	0.729	0.351	0.884	D	0.526	0.824	D	0.054	0.658	D	5.459	0.741	26.1	0.996	0.736	0.944	0.609	D	c	0.909	0.778	1.0	0.983	0.719	0.830	0	5.85	0.936	5.987	0.700	0.925	0.434	1.000	0.715	0.977	0.480	17.651	0.880	Nucleic acid-binding, OB-fold	.	.	0.5	111	635	chr19	39423227	chr19:39423227	C	A	111	PASS	AN=2;DP=635	GT	0/1
chr19	40747818	40747818	C	A	intronic	AKT2	.	.	.	0.997816207	0.002183722	7.10E-08	DISEASE: Note=Defects in AKT2 are a cause of susceptibility to breast cancer (BC). AKT2 promotes metastasis of tumor cells without affecting the latency of tumor development. With AKT3, plays also a pivotal role in the biology of glioblastoma.; DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:15166380, ECO:0000269|PubMed:19164855}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hypoinsulinemic hypoglycemia with hemihypertrophy (HIHGHH) [MIM:240900]: A disorder characterized by hypoglycemia, low insulin levels, low serum levels of ketone bodies and branched-chain amino acids, left-sided hemihypertrophy, neonatal macrosomia, reduced consciousness and hypoglycemic seizures. {ECO:0000269|PubMed:21979934}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.91994	0.55644	-0.648365105	16.35999056	17.52078	0.61489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	624	chr19	40747818	chr19:40747818	C	A	124	PASS	AN=2;DP=624	GT	0/1
chr19	41074106	41074106	C	T	exonic	SPTBN4	.	nonsynonymous SNV	SPTBN4:NM_020971:exon31:c.C6874T:p.R2292W	.	.	.	.	0.16131	0.15197	-1.824619408	2.129039868	5101.64368	14.64602	0.0	0.912	D	0.997	0.764	D	0.551	0.575	P	0.000	0.473	U	0.965	0.385	D	0	0.065	N	-1.43	0.807	T	-1.74	0.412	N	0.457	0.509	-0.090	0.803	T	0.452	0.786	T	0.271	0.899	D	7.746	0.955	35	0.999	0.951	0.825	0.414	D	c	0.066	0.080	1.000	0.747	0.598	0.340	0	3.64	0.407	1.957	0.398	0.004	0.136	1.000	0.715	0.117	0.195	13.106	0.585	.	.	.	0.5	94	650	chr19	41074106	chr19:41074106	C	T	94	PASS	AN=2;DP=650	GT	0/1
chr19	41633855	41633855	G	T	exonic	CYP2F1	.	synonymous SNV	CYP2F1:NM_000774:exon10:c.G1344T:p.L448L	2.76E-05	0.771523766	0.228448673	.	.	.	1.003094668	90.77022883	5472.61938	15.24169	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	295	chr19	41633855	chr19:41633855	G	T	.	PASS	AN=0;DP=295	GT	0/1
chr19	42351672	42351672	G	A	exonic	DMRTC2	.	nonsynonymous SNV	DMRTC2:NM_001040283:exon2:c.G176A:p.R59H	0.726527694	0.272884882	0.000587423	.	.	0.0851	-0.514264485	21.41424864	37.06083	1.1074	0.318	0.136	T	0.637	0.899	P	0.142	0.875	B	0.020	0.272	N	0.994	0.421	D	0.52	0.136	N	.	.	.	-3.31	0.659	D	0.904	0.894	-0.716	0.597	T	0.274	0.646	T	0.005	0.125	T	4.402	0.589	24.1	0.916	0.203	0.885	0.481	D	c	0.292	0.328	0.827	0.246	0.497	0.185	0	4.29	0.502	2.205	0.422	1.045	0.669	1.000	0.715	1.000	0.888	12.978	0.578	DM DNA-binding domain	.	.	0.5	.	151	chr19	42351672	chr19:42351672	G	A	.	PASS	AN=0;DP=151	GT	0/1
chr19	42752834	42752834	C	T	exonic	ERF	.	nonsynonymous SNV	ERF:NM_001301035:exon4:c.G1205A:p.C402Y,ERF:NM_001308402:exon4:c.G1205A:p.C402Y,ERF:NM_001312656:exon4:c.G1205A:p.C402Y,ERF:NM_006494:exon4:c.G1430A:p.C477Y	0.807144401	0.19263935	0.000216249	DISEASE: Craniosynostosis 4 (CRS4) [MIM:600775]: A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability. {ECO:0000269|PubMed:23354439}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.63786	0.13887	-0.424258538	25.56027365	41.74458	1.21591	0.002	0.721	D	0.969	0.548	D	0.895	0.617	P	0.003	0.356	U	1.000	0.588	D	1.87	0.498	L	1.8	0.263	T	-3.06	0.630	D	0.85	0.837	-1.033	0.196	T	0.108	0.393	T	0.019	0.413	T	4.988	0.671	25.1	0.994	0.637	0.949	0.625	D	c	0.546	0.521	1.000	0.448	0.672	0.522	0	4.25	0.495	3.419	0.522	0.837	0.341	1.000	0.715	0.995	0.604	12.374	0.544	.	.	.	0.5	71	310	chr19	42752834	chr19:42752834	C	T	71	PASS	AN=2;DP=310	GT	0/1
chr19	43439858	43439858	G	T	exonic	PSG7	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	0.723	0.405	P	0.739	0.538	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.097	0.207	.	.	.	.	.	.	.	.	.	0.665	0.157	8.593	0.606	0.063	0.002	0.013	N	n	-0.375	-0.222	0.007	0.115	0.054	0.004	0	-1.38	0.085	-2.555	0.010	-1.058	0.020	0.000	0.063	0.000	0.016	2.002	0.032	Immunoglobulin V-set domain|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	87	297	chr19	43439858	chr19:43439858	G	T	87	PASS	AN=2;DP=297	GT	0/1
chr19	43593534	43593534	G	C	intergenic	PSG2;PSG5	dist=6641;dist=78361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	388	chr19	43593534	chr19:43593534	G	C	108	PASS	AN=2;DP=388	GT	0/1
chr19	49468728	49468728	A	T	UTR5	FTL	NM_000146:c.-37A>T	.	.	0.000458653	0.427809813	0.571731534	DISEASE: Hereditary hyperferritinemia-cataract syndrome (HHCS) [MIM:600886]: An autosomal dominant disease characterized by elevated level of ferritin in serum and tissues, and early-onset bilateral cataract. {ECO:0000269|PubMed:19176363}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurodegeneration with brain iron accumulation 3 (NBIA3) [MIM:606159]: A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. It is characterized by a variety of neurological signs including parkinsonism, ataxia, corticospinal signs, mild non-progressive cognitive deficit and episodic psychosis. It is linked with decreased serum ferritin levels. {ECO:0000269|PubMed:16116125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: L-ferritin deficiency (LFTD) [MIM:615604]: A condition characterized by low levels of ferritin in serum and tissues in the absence of other hematological symptoms. Seizures and mild neuropsychologic impairment may manifest in individuals with complete ferritin deficiency. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08288	0.64843	-0.163345027	41.24793583	10.88019	0.39394	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	803	chr19	49468728	chr19:49468728	A	T	125	PASS	AN=2;DP=803	GT	0/1
chr19	49552005	49552005	T	C	UTR5	CGB8	NM_033183:c.-9A>G	.	.	0.091777955	0.569050721	0.339171324	.	.	0.0808	.	.	2.44485	0.08929	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	461	chr19	49552005	chr19:49552005	T	C	91	PASS	AN=2;DP=461	GT	0/1
chr19	49558667	49558667	T	C	UTR5	CGB7	NM_033142:c.-35A>G	.	.	0.013101838	0.660375879	0.326522282	.	0.13856	0.10426	.	.	1267.08809	6.70772	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	327	chr19	49558667	chr19:49558667	T	C	152	PASS	AN=2;DP=327	GT	0/1
chr19	49558678	49558678	T	G	UTR5	CGB7	NM_033142:c.-46A>C	.	.	0.013101838	0.660375879	0.326522282	.	0.13856	0.10426	.	.	1267.08809	6.70772	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	298	chr19	49558678	chr19:49558678	T	G	135	PASS	AN=2;DP=298	GT	0/1
chr19	50216195	50216195	G	T	intronic	CPT1C	.	.	.	0.000284628	0.999590886	0.000124486	.	0.20362	.	-0.705410796	14.77942911	101.01814	2.17533	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	167	chr19	50216195	chr19:50216195	G	T	92	PASS	AN=2;DP=167	GT	0/1
chr19	50838423	50838423	A	T	ncRNA_exonic	NAPSB	.	.	.	.	.	.	.	0.02668	0.05504	-0.073340031	48.11866006	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	222	chr19	50838423	chr19:50838423	A	T	.	PASS	AN=0;DP=222	GT	0/1
chr19	52000670	52000670	G	T	exonic	SIGLEC12	.	nonsynonymous SNV	SIGLEC12:NM_033329:exon5:c.C1081A:p.L361I,SIGLEC12:NM_053003:exon6:c.C1435A:p.L479I	1.54E-10	0.197090502	0.802909498	.	0.06344	.	2.337125365	98.40174569	3066.99793	10.53027	0.177	0.222	T	0.706	0.472	P	0.33	0.480	B	0.306	0.040	U	1	0.090	N	2.785	0.815	M	3.43	0.055	T	-0.98	0.260	N	0.096	0.097	-1.025	0.221	T	0.033	0.142	T	0.002	0.046	T	0.807	0.171	9.507	0.765	0.111	0.005	0.023	N	c	-0.930	-1.201	0.006	0.112	0.487	0.133	0	-1.22	0.090	-0.683	0.052	-0.201	0.102	0.000	0.063	0.001	0.043	2.514	0.043	Immunoglobulin-like fold	.	.	0.5	81	218	chr19	52000670	chr19:52000670	G	T	81	PASS	AN=2;DP=218	GT	0/1
chr19	53014793	53014793	G	T	exonic	ZNF578	.	nonsynonymous SNV	ZNF578:NM_001099694:exon6:c.G1159T:p.V387L	8.81E-14	0.002639121	0.997360879	.	.	.	1.047190339	91.34229771	336.42783	3.89648	.	.	.	0.002	0.090	B	0.001	0.040	B	.	.	.	1	0.090	N	0.01	0.080	N	2.49	0.145	T	.	.	.	0.078	0.097	-1.016	0.249	T	0.036	0.157	T	0.001	0.004	T	-0.021	0.092	2.389	0.760	0.109	0.014	0.047	N	c	-1.326	-1.434	0.000	0.029	0.487	0.133	0	-2.57	0.059	-3.182	0.006	-2.389	0.003	0.000	0.063	0.000	0.016	3.497	0.072	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	71	92	chr19	53014793	chr19:53014793	G	T	71	PASS	AN=2;DP=92	GT	0/1
chr19	54649671	54649671	T	-	exonic	CNOT3	.	frameshift deletion	CNOT3:NM_014516:exon9:c.729delT:p.S245Afs*89	0.999967222	3.28E-05	2.56E-12	.	0.73088	0.10155	-0.598810865	18.13517339	98.27185	2.1432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	382	chr19	54649670	chr19:54649670	CT	C	87	PASS	AN=2;DP=382	GT	0/1
chr19	54745682	54745682	C	T	exonic	LILRA6;LILRB3	.	nonsynonymous SNV	LILRB3:NM_001081450:exon4:c.G428A:p.R143Q,LILRB3:NM_001320960:exon4:c.G428A:p.R143Q,LILRB3:NM_006864:exon4:c.G428A:p.R143Q,LILRA6:NM_024318:exon4:c.G419A:p.R140Q	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	205	chr19	54745682	chr19:54745682	C	T	.	PASS	AN=0;DP=205	GT	0/1
chr19	54778505	54778505	C	G	UTR3	LILRB2	NM_001278403:c.*32G>C;NM_001278404:c.*32G>C;NM_005874:c.*32G>C;NM_001080978:c.*32G>C;NM_001278405:c.*220G>C	.	.	7.83E-06	0.979376847	0.020615324	.	0.31832	.	2.831581484	99.08586931	3895.89182	12.31761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	433	chr19	54778505	chr19:54778505	C	G	110	PASS	AN=2;DP=433	GT	0/1
chr19	54782405	54782405	C	G	exonic	LILRB2	.	nonsynonymous SNV	LILRB2:NM_001278404:exon6:c.G619C:p.G207R,LILRB2:NM_001278405:exon6:c.G967C:p.G323R,LILRB2:NM_001278406:exon6:c.G967C:p.G323R,LILRB2:NM_001080978:exon7:c.G967C:p.G323R,LILRB2:NM_001278403:exon7:c.G967C:p.G323R,LILRB2:NM_005874:exon7:c.G967C:p.G323R	7.83E-06	0.979376847	0.020615324	.	0.31832	.	2.831581484	99.08586931	3895.89182	12.31761	0.254	0.203	T	0.709	0.401	P	0.439	0.439	B	0.114	0.027	N	1	0.090	N	0.08	0.083	N	5.79	0.007	T	-1.54	0.373	N	0.152	0.276	-0.988	0.331	T	0.003	0.009	T	0.003	0.057	T	-0.286	0.069	0.714	0.677	0.082	0.002	0.010	N	c	-1.095	-1.318	0.999	0.381	0.447	0.083	0	-3.77	0.040	-1.813	0.018	-1.204	0.016	0.000	0.063	0.000	0.016	0.771	0.009	Immunoglobulin-like domain;Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	115	409	chr19	54782405	chr19:54782405	C	G	115	PASS	AN=2;DP=409	GT	0/1
chr19	55341459	55341459	C	G	intronic	KIR3DL1	.	.	.	9.78E-06	0.552285382	0.447704835	.	0.05806	.	3.335364374	99.43382873	2335.80145	8.95125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	701	chr19	55341459	chr19:55341459	C	G	140	PASS	AN=2;DP=701	GT	0/1
chr19	55795460	55795460	G	-	upstream	BRSK1	dist=74	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	604	chr19	55795459	chr19:55795459	CG	C	58	PASS	AN=2;DP=604	GT	0/1
chr19	55828098	55828098	G	A	intronic	TMEM150B	.	.	.	4.55E-06	0.22830469	0.771690758	.	.	.	-0.093566408	46.7386176	27.38398	0.88237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	146	chr19	55828098	chr19:55828098	G	A	87	PASS	AN=2;DP=146	GT	0/1
chr19	56736012	56736012	A	G	intronic	ZSCAN5A	.	.	.	0.081218246	0.90832008	0.010461674	.	0.0921	.	-0.088107893	47.06298655	564.39042	4.82371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	444	chr19	56736012	chr19:56736012	A	G	127	PASS	AN=2;DP=444	GT	0/1
chr20	2124496	2124496	G	T	UTR3	STK35	NM_080836:c.*104G>T	.	.	0.918199526	0.081264275	0.000536199	.	0.19968	0.11306	.	.	1408.18303	7.0104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	355	chr20	2124496	chr20:2124496	G	T	84	PASS	AN=2;DP=355	GT	0/1
chr20	4158180	4158180	A	T	exonic	SMOX	.	nonsynonymous SNV	SMOX:NM_001270691:exon3:c.A391T:p.I131F,SMOX:NM_175839:exon3:c.A391T:p.I131F,SMOX:NM_175840:exon3:c.A391T:p.I131F,SMOX:NM_175841:exon3:c.A391T:p.I131F,SMOX:NM_175842:exon3:c.A391T:p.I131F	0.837563766	0.162301151	0.000135083	.	0.6224	0.41186	-1.153638777	6.233781552	43.62644	1.25665	0.004	0.682	D	0.999	0.899	D	0.966	0.875	D	0.000	0.843	D	1.000	0.588	D	2.455	0.715	M	-3.0	0.922	D	-3.25	0.655	D	0.597	0.623	0.571	0.915	D	0.803	0.934	D	0.171	0.849	D	4.809	0.645	24.8	0.989	0.484	0.923	0.551	D	c	0.156	0.178	1.000	0.517	0.706	0.609	0	3.0	0.336	3.496	0.528	1.194	0.916	1.000	0.715	0.993	0.574	8.313	0.311	Amine oxidase|FAD/NAD(P)-binding domain	.	.	0.5	93	237	chr20	4158180	chr20:4158180	A	T	93	PASS	AN=2;DP=237	GT	0/1
chr20	23066469	23066469	C	-	exonic	CD93	.	frameshift deletion	CD93:NM_012072:exon1:c.361delG:p.E121Rfs*78	7.82E-10	0.075948416	0.924051584	.	0.15486	0.28768	-0.148789446	42.29771172	256.90385	3.44823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	586	chr20	23066468	chr20:23066468	TC	T	95	PASS	AN=2;DP=586	GT	0/1
chr20	29449550	29449550	T	C	intergenic	NONE;LINC01597	dist=NONE;dist=64034	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	398	chr20	29449550	chr20:29449550	T	C	93	PASS	AN=2;DP=398	GT	0/1
chr20	29449597	29449597	G	A	intergenic	NONE;LINC01597	dist=NONE;dist=63987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	440	chr20	29449597	chr20:29449597	G	A	109	PASS	AN=2;DP=440	GT	0/1
chr20	29516584	29516584	G	T	ncRNA_exonic	LINC01597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	310	chr20	29516584	chr20:29516584	G	T	.	PASS	AN=0;DP=310	GT	0/1
chr20	29628229	29628229	-	A	ncRNA_exonic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	515	chr20	29628229	chr20:29628229	G	GA	124	PASS	AN=2;DP=515	GT	0/1
chr20	29628263	29628263	A	G	ncRNA_exonic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	0.307	0.141	T	0.0	0.067	B	0.018	0.206	B	0.000	0.843	D	0.634	0.328	D	.	.	.	.	.	.	-0.57	0.172	N	0.489	0.536	-1.056	0.127	T	0.055	0.231	T	0.001	0.003	T	1.583	0.252	13.76	0.942	0.239	0.631	0.317	D	c	-0.318	-0.243	1.000	0.489	0.752	0.988	0	2.08	0.260	4.712	0.613	0.666	0.294	1.000	0.715	0.993	0.574	3.866	0.085	Actin cross-linking	.	.	0.5	155	752	chr20	29628263	chr20:29628263	A	G	155	PASS	AN=2;DP=752	GT	0/1
chr20	29628335	29628335	A	T	ncRNA_intronic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	180	233	chr20	29628335	chr20:29628335	A	T	180	PASS	AN=2;DP=233	GT	0/1
chr20	37590929	37590929	T	C	upstream	DHX35	dist=52	.	.	9.69E-11	0.973981761	0.026018239	.	0.27324	0.09942	-0.328796968	30.86223166	2233.3121	8.70874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	590	chr20	37590929	chr20:37590929	T	C	121	PASS	AN=2;DP=590	GT	0/1
chr20	43384782	43384782	C	A	exonic	RIMS4	.	nonsynonymous SNV	RIMS4:NM_001205317:exon6:c.G806T:p.R269L,RIMS4:NM_182970:exon6:c.G803T:p.R268L	0.952765435	0.047099891	0.000134674	.	0.27845	0.11729	-0.339715008	30.06605331	3.85321	0.1438	0.0	0.912	D	0.621	0.380	P	0.523	0.465	P	0.000	0.629	D	1.000	0.588	D	1.845	0.488	L	1.58	0.291	T	-6.09	0.899	D	0.674	0.683	-1.017	0.248	T	0.097	0.363	T	0.028	0.511	D	4.818	0.647	24.8	0.998	0.893	0.962	0.680	D	c	0.258	0.297	1.000	0.747	0.696	0.567	0	4.0	0.455	6.086	0.708	0.935	0.490	1.000	0.715	0.995	0.604	13.251	0.593	.	.	.	0.5	69	417	chr20	43384782	chr20:43384782	C	A	69	PASS	AN=2;DP=417	GT	0/1
chr20	44539841	44539841	G	A	exonic	PLTP	.	synonymous SNV	PLTP:NM_001242920:exon3:c.C150T:p.T50T,PLTP:NM_006227:exon3:c.C150T:p.T50T,PLTP:NM_182676:exon3:c.C150T:p.T50T	0.000142042	0.962665909	0.037192049	.	0.36337	0.21599	-0.440847477	24.59896202	193.00501	3.01119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	762	chr20	44539841	chr20:44539841	G	A	125	PASS	AN=2;DP=762	GT	0/1
chr20	50721372	50721372	C	T	intronic	ZFP64	.	.	.	0.005189853	0.968804042	0.026006106	.	0.60912	0.11612	0.45192103	78.03727294	242.73747	3.36359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	193	chr20	50721372	chr20:50721372	C	T	.	PASS	AN=0;DP=193	GT	0/1
chr20	55984073	55984073	T	C	UTR3	RBM38	NM_017495:c.*1171T>C;NM_001291780:c.*1171T>C;NM_183425:c.*1470T>C	.	.	0.859282996	0.138553757	0.002163247	.	0.16014	0.11106	0.43736446	77.56546355	461.24812	4.45359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	249	chr20	55984073	chr20:55984073	T	C	.	PASS	AN=0;DP=249	GT	0/1
chr20	60901732	60901732	C	A	splicing	LAMA5	NM_005560:exon40:c.5298+1G>T	.	.	0.943037981	0.056962019	9.75E-22	.	0.70971	.	3.125188892	99.28049068	9086.1435	20.60876	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.602	0.763	26.5	0.995	0.692	0.985	0.832	D	c	1.082	0.912	1.000	0.747	0.156	0.027	0	5.12	0.693	7.047	0.761	0.855	0.374	1.000	0.715	0.902	0.382	18.601	0.912	.	.	.	0.5	.	244	chr20	60901732	chr20:60901732	C	A	.	PASS	AN=0;DP=244	GT	0/1
chr20	61461737	61461737	C	A	exonic	COL9A3	.	nonsynonymous SNV	COL9A3:NM_001853:exon23:c.C1187A:p.P396H	3.25E-05	0.999944225	2.33E-05	DISEASE: Multiple epiphyseal dysplasia 3 (EDM3) [MIM:600969]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:10090888}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:11308397, ECO:0000269|PubMed:25381065}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Susceptibility to intervertebral disk disease is conferred by variant p.Arg103Trp (PubMed:11308397). {ECO:0000269|PubMed:11308397}.; 	0.4977	.	0.611719262	82.96768106	2646.06911	9.64989	0.137	0.259	T	0.975	0.561	D	0.815	0.570	P	0.048	0.233	N	0.958	0.262	N	2.825	0.825	M	-2.79	0.910	D	-1.32	0.330	N	0.231	0.283	0.164	0.853	D	0.780	0.925	D	0.330	0.918	D	4.813	0.646	24.8	0.987	0.441	0.340	0.247	N	c	0.232	0.102	0.997	0.351	0.696	0.567	0	3.04	0.340	0.071	0.143	0.852	0.362	0.000	0.063	0.557	0.281	4.047	0.092	.	.	.	0.5	.	328	chr20	61461737	chr20:61461737	C	A	.	PASS	AN=0;DP=328	GT	0/1
chr20	61942764	61942764	G	T	exonic	COL20A1	.	nonsynonymous SNV	COL20A1:NM_020882:exon12:c.G1412T:p.R471L	1.27E-24	0.001031378	0.998968622	.	0.0925	0.08222	-0.374974929	28.11983958	1065.33487	6.25837	0.354	0.127	T	0.657	0.400	P	0.171	0.378	B	0.943	0.083	N	1	0.090	N	2.105	0.586	M	0.34	0.582	T	-2.6	0.559	D	0.123	0.138	-0.998	0.306	T	0.124	0.429	T	0.035	0.560	D	0.445	0.137	6.998	0.909	0.196	0.097	0.152	N	c	-0.865	-1.012	0.001	0.075	0.581	0.326	0	-0.893	0.100	0.837	0.270	-0.450	0.056	0.000	0.063	0.004	0.083	8.845	0.341	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	.	251	chr20	61942764	chr20:61942764	G	T	.	PASS	AN=0;DP=251	GT	0/1
chr20	62551351	62551351	G	C	intronic	DNAJC5	.	.	.	0.858492459	0.139312429	0.002195113	DISEASE: Ceroid lipofuscinosis, neuronal, 4B (CLN4B) [MIM:162350]: An adult-onset neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. CLN4B has no visual involvement and is characterized by seizures and other neurologic symptoms. {ECO:0000269|PubMed:21820099, ECO:0000269|PubMed:22073189, ECO:0000269|PubMed:22235333, ECO:0000269|PubMed:22978711}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17855	0.11262	-0.339715008	30.06605331	3.7021	0.13784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	342	chr20	62551351	chr20:62551351	G	C	124	PASS	AN=2;DP=342	GT	0/1
chr21	9865857	9865857	A	G	intergenic	MIR3687-2;TEKT4P2	dist=39594;dist=41332	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	384	chr21	9865857	chr21:9865857	A	G	144	PASS	AN=2;DP=384	GT	0/1
chr21	10862749	10862749	A	T	intergenic	TEKT4P2;TPTE	dist=894155;dist=43438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	936	chr21	10862749	chr21:10862749	A	T	93	PASS	AN=2;DP=936	GT	0/1
chr21	10906989	10906989	C	T	exonic	TPTE	.	synonymous SNV	TPTE:NM_001290224:exon19:c.G1158A:p.R386R,TPTE:NM_199260:exon22:c.G1458A:p.R486R,TPTE:NM_199259:exon23:c.G1518A:p.R506R,TPTE:NM_199261:exon24:c.G1572A:p.R524R	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	511	chr21	10906989	chr21:10906989	C	T	148	PASS	AN=2;DP=511	GT	0/1
chr21	10935044	10935044	T	C	intronic	TPTE	.	.	.	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	225	chr21	10935044	chr21:10935044	T	C	110	PASS	AN=2;DP=225	GT	0/1
chr21	11049621	11049621	G	A	exonic	BAGE2;BAGE3	.	stopgain	BAGE3:NM_182481:exon4:c.C280T:p.R94X,BAGE2:NM_182482:exon4:c.C280T:p.R94X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	291	chr21	11049621	chr21:11049621	G	A	104	PASS	AN=2;DP=291	GT	0/1
chr21	11049623	11049623	T	C	splicing	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:exon4:c.280-2A>G;NM_182481:exon4:c.280-2A>G;NM_181704:exon4:c.285-2A>G;NM_181704:exon4:UTR3;NM_182484:exon4:c.284-2A>G;NM_182484:exon4:UTR3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	289	chr21	11049623	chr21:11049623	T	C	121	PASS	AN=2;DP=289	GT	0/1
chr21	11058353	11058353	T	C	intronic	BAGE;BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	299	chr21	11058353	chr21:11058353	T	C	123	PASS	AN=2;DP=299	GT	0/1
chr21	14485395	14485395	C	T	ncRNA_intronic	ANKRD30BP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	171	344	chr21	14485395	chr21:14485395	C	T	171	PASS	AN=2;DP=344	GT	0/1
chr21	14722780	14722780	A	G	intergenic	ANKRD30BP2;MIR3156-3	dist=232209;dist=55925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	133	chr21	14722780	chr21:14722780	A	G	72	PASS	AN=2;DP=133	GT	0/1
chr21	26979725	26979725	C	A	exonic	MRPL39	.	synonymous SNV	MRPL39:NM_017446:exon1:c.G63T:p.G21G,MRPL39:NM_080794:exon1:c.G63T:p.G21G	0.000718692	0.980539319	0.01874199	.	0.14902	0.11367	0.222355725	68.44184949	95.66892	2.11384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	544	chr21	26979725	chr21:26979725	C	A	.	PASS	AN=0;DP=544	GT	0/1
chr21	32508223	32508223	C	A	intronic	TIAM1	.	.	.	0.999932006	6.80E-05	1.04E-15	.	0.48136	0.33272	-0.913225292	9.843123378	5001.55165	14.43752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	298	chr21	32508223	chr21:32508223	C	A	72	PASS	AN=2;DP=298	GT	0/1
chr21	46306770	46306770	C	T	exonic	ITGB2	.	nonsynonymous SNV	ITGB2:NM_000211:exon15:c.G2128A:p.A710T,ITGB2:NM_001127491:exon15:c.G2128A:p.A710T,ITGB2:NM_001303238:exon15:c.G1921A:p.A641T	3.88E-05	0.997791391	0.002169845	DISEASE: Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]: LAD1 patients have recurrent bacterial infections and their leukocytes are deficient in a wide range of adhesion-dependent functions. {ECO:0000269|PubMed:1346613, ECO:0000269|PubMed:1347532, ECO:0000269|PubMed:1352501, ECO:0000269|PubMed:1590804, ECO:0000269|PubMed:1694220, ECO:0000269|PubMed:1968911, ECO:0000269|PubMed:20529581, ECO:0000269|PubMed:20549317, ECO:0000269|PubMed:7509236, ECO:0000269|PubMed:7686755, ECO:0000269|PubMed:9884339}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2445	0.53069	-1.03070223	7.861523944	113.69861	2.32291	0.003	0.682	D	0.857	0.453	P	0.461	0.446	P	.	.	.	1.000	0.588	D	3.045	0.869	M	-2.83	0.913	D	-2.28	0.516	N	0.234	0.415	0.710	0.933	D	0.759	0.918	D	0.100	0.773	D	5.324	0.720	25.8	0.995	0.706	0.895	0.498	D	c	0.250	0.152	1.000	0.747	0.672	0.522	0	4.83	0.617	3.667	0.540	0.036	0.152	0.991	0.370	0.002	0.062	15.399	0.744	.	.	.	0.5	88	458	chr21	46306770	chr21:46306770	C	T	88	PASS	AN=2;DP=458	GT	0/1
chr21	46842366	46842366	T	A	ncRNA_exonic	COL18A1-AS1	.	.	.	.	.	.	.	0.1043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	630	chr21	46842366	chr21:46842366	T	A	133	PASS	AN=2;DP=630	GT	0/1
chr22	17073410	17073410	G	C	exonic	CCT8L2	.	nonsynonymous SNV	CCT8L2:NM_014406:exon1:c.C31G:p.L11V	0.001833343	0.720145372	0.278021284	.	0.44923	.	0.314179756	72.75300778	163.41963	2.7912	0.264	0.163	T	0.98	0.574	D	0.91	0.629	D	0.180	0.171	U	1	0.090	N	1.1	0.281	L	0.49	0.558	T	-0.34	0.127	N	0.24	0.294	-1.012	0.262	T	0.120	0.420	T	0.007	0.174	T	2.263	0.333	17.92	0.991	0.522	0.094	0.150	N	c	-0.383	-0.510	0.002	0.091	0.487	0.133	0	2.0	0.254	0.694	0.250	0.569	0.285	0.483	0.266	0.026	0.142	7.483	0.264	.	.	.	0.5	95	514	chr22	17073410	chr22:17073410	G	C	95	PASS	AN=2;DP=514	GT	0/1
chr22	17395212	17395212	G	T	intergenic	HSFY1P1;GAB4	dist=84987;dist=47615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	324	chr22	17395212	chr22:17395212	G	T	95	PASS	AN=2;DP=324	GT	0/1
chr22	19841975	19841975	C	A	UTR5	GNB1L;RTL10	NM_053004:c.-33097G>T;NM_024627:c.-2191G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	176	1207	chr22	19841975	chr22:19841975	C	A	176	PASS	AN=2;DP=1207	GT	0/1
chr22	20295384	20295384	C	-	intergenic	RTN4R;DGCR6L	dist=39568;dist=6377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	493	chr22	20295383	chr22:20295383	GC	G	92	PASS	AN=2;DP=493	GT	0/1
chr22	21057355	21057355	T	C	ncRNA_exonic	TMEM191A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	1138	chr22	21057355	chr22:21057355	T	C	135	PASS	AN=2;DP=1138	GT	0/1
chr22	21354970	21354970	C	G	exonic	THAP7	.	nonsynonymous SNV	THAP7:NM_030573:exon3:c.G343C:p.A115P,THAP7:NM_001008695:exon4:c.G343C:p.A115P	0.029327855	0.923633046	0.047039099	.	0.37131	0.10994	.	.	76.37465	1.83233	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.888	0.087	N	1	0.090	P	-0.345	0.033	N	-3.75	0.955	D	0.94	0.015	N	0.024	0.007	-0.977	0.357	T	0.000	0.000	T	.	.	.	-0.669	0.046	0.085	0.483	0.040	0.009	0.036	N	c	-1.868	-1.808	1.000	0.747	0.628	0.401	0	0.539	0.163	0.097	0.149	-0.760	0.034	0.004	0.165	0.000	0.016	3.205	0.062	.	.	.	0.5	188	177	chr22	21354970	chr22:21354970	C	G	188	PASS	AN=2;DP=177	GT	0/1
chr22	21356777	21356777	G	A	ncRNA_exonic	THAP7-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	531	chr22	21356777	chr22:21356777	G	A	.	PASS	AN=0;DP=531	GT	0/1
chr22	21363454	21363454	G	C	ncRNA_exonic	THAP7-AS1;TUBA3FP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	219	chr22	21363454	chr22:21363454	G	C	.	PASS	AN=0;DP=219	GT	0/1
chr22	21532831	21532831	C	A	ncRNA_intronic	FAM230B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	944	chr22	21532831	chr22:21532831	C	A	99	PASS	AN=2;DP=944	GT	0/1
chr22	22664079	22664079	T	G	ncRNA_intronic	BMS1P20	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	342	chr22	22664079	chr22:22664079	T	G	123	PASS	AN=2;DP=342	GT	0/1
chr22	22664091	22664091	G	A	ncRNA_intronic	BMS1P20	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	381	chr22	22664091	chr22:22664091	G	A	116	PASS	AN=2;DP=381	GT	0/1
chr22	23982696	23982696	-	C	ncRNA_intronic	GUSBP11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	314	chr22	23982696	chr22:23982696	T	TC	76	PASS	AN=2;DP=314	GT	0/1
chr22	25715733	25715733	G	C	ncRNA_splicing	IGLL3P	NR_029395:exon3:c.216-1G>C	.	.	.	.	.	.	0.05956	0.07001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	170	chr22	25715733	chr22:25715733	G	C	.	PASS	AN=0;DP=170	GT	0/1
chr22	26747134	26747134	G	T	exonic	SEZ6L	.	nonsynonymous SNV	SEZ6L:NM_001184773:exon12:c.G2524T:p.G842W,SEZ6L:NM_001184774:exon12:c.G2524T:p.G842W,SEZ6L:NM_001184775:exon12:c.G2524T:p.G842W,SEZ6L:NM_001184777:exon12:c.G2524T:p.G842W,SEZ6L:NM_021115:exon12:c.G2524T:p.G842W	0.928831047	0.071168823	1.30E-07	.	0.30074	0.11342	-2.032105599	1.686718566	1299.61065	6.78117	0.0	0.912	D	0.998	0.899	D	0.995	0.916	D	0.000	0.537	D	1	0.810	D	3.54	0.933	H	-0.75	0.733	T	-6.85	0.940	D	0.925	0.938	0.692	0.931	D	0.701	0.897	D	0.358	0.925	D	6.576	0.904	31	0.996	0.753	0.983	0.813	D	c	0.936	0.817	1.000	0.747	0.554	0.246	0	4.54	0.551	9.459	0.968	1.024	0.645	1.000	0.715	0.997	0.653	16.502	0.840	Sushi/SCR/CCP domain	.	.	0.5	91	305	chr22	26747134	chr22:26747134	G	T	91	PASS	AN=2;DP=305	GT	0/1
chr22	31524444	31524444	C	A	intronic	INPP5J	.	.	.	6.43E-12	0.062187285	0.937812715	.	0.4443	0.14051	-0.224023033	37.4321774	1180.94022	6.52336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	425	chr22	31524444	chr22:31524444	C	A	84	PASS	AN=2;DP=425	GT	0/1
chr22	37334329	37334329	G	T	exonic	CSF2RB	.	nonsynonymous SNV	CSF2RB:NM_000395:exon14:c.G2479T:p.G827C	0.001866652	0.997129945	0.001003402	DISEASE: Pulmonary surfactant metabolism dysfunction 5 (SMDP5) [MIM:614370]: A rare lung disorder due to impaired surfactant homeostasis. It is characterized by alveolar filling with floccular material that stains positive using the periodic acid- Schiff method and is derived from surfactant phospholipids and protein components. Excessive lipoproteins accumulation in the alveoli results in severe respiratory distress. {ECO:0000269|PubMed:21075760}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3108	0.24942	-1.076610636	7.324840764	1096.75329	6.34077	0.002	0.721	D	1.0	0.899	D	0.991	0.782	D	0.158	0.177	N	1.000	0.090	N	1.79	0.469	L	-2.8	0.939	D	-3.26	0.665	D	0.466	0.532	0.141	0.849	D	0.807	0.935	D	0.066	0.700	D	5.638	0.768	26.6	0.997	0.821	0.586	0.304	D	c	0.136	-0.026	0.975	0.295	0.732	0.924	0	1.96	0.251	2.718	0.467	0.141	0.225	0.937	0.323	0.435	0.260	6.269	0.200	.	.	.	0.5	95	635	chr22	37334329	chr22:37334329	G	T	95	PASS	AN=2;DP=635	GT	0/1
chr22	37462130	37462130	A	T	exonic	TMPRSS6	.	nonsynonymous SNV	TMPRSS6:NM_001289001:exon18:c.T2399A:p.V800E,TMPRSS6:NM_153609:exon18:c.T2426A:p.V809E,TMPRSS6:NM_001289000:exon19:c.T2465A:p.V822E	3.34E-06	0.99700676	0.002989896	DISEASE: Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]: Key features include congenital hypochromic microcytic anemia, very low mean corpuscular erythrocyte volume, low transferrin saturation, abnormal iron absorption characterized by no hematologic improvement following treatment with oral iron, and abnormal iron utilization characterized by a sluggish, incomplete response to parenteral iron. {ECO:0000269|PubMed:18408718, ECO:0000269|PubMed:18603562, ECO:0000269|PubMed:19357398, ECO:0000269|PubMed:19592582, ECO:0000269|PubMed:19708871, ECO:0000269|PubMed:19747362, ECO:0000269|PubMed:20232450, ECO:0000269|PubMed:20704562, ECO:0000269|PubMed:21618415, ECO:0000269|PubMed:22581667, ECO:0000269|PubMed:25156943, ECO:0000269|PubMed:25588876}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations leading to abrogation of TMPRSS6 activity are associated with IRIDA due to elevated levels of hepcidin, a negative regulator of plasma iron pool (PubMed:20232450). {ECO:0000269|PubMed:20232450}.; 	0.11488	0.1454	0.589672374	82.36022647	395.53283	4.17829	0.083	0.342	T	0.041	0.200	B	0.011	0.145	B	0.944	0.076	N	0.691	0.302	N	0.93	0.236	L	-3.26	0.936	D	-0.17	0.096	N	0.317	0.409	-0.276	0.757	T	0.555	0.838	D	0.242	0.888	D	2.647	0.379	20.5	0.958	0.272	0.751	0.365	D	c	-0.722	-0.588	0.607	0.218	0.615	0.372	0	2.31	0.277	0.890	0.277	0.119	0.209	0.939	0.324	0.945	0.419	3.410	0.069	Peptidase S1, PA clan|Serine proteases, trypsin domain	.	.	0.5	119	182	chr22	37462130	chr22:37462130	A	T	119	PASS	AN=2;DP=182	GT	0/1
chr22	42898666	42898666	C	-	ncRNA_intronic	SERHL	.	.	.	.	.	.	.	0.10684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	193	chr22	42898665	chr22:42898665	GC	G	105	PASS	AN=2;DP=193	GT	0/1
chr22	44696688	44696688	C	A	intronic	KIAA1644	.	.	.	0.676861238	0.318457206	0.004681556	.	.	.	-0.139478553	43.29440906	142.92745	2.60644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	109	chr22	44696688	chr22:44696688	C	A	94	PASS	AN=2;DP=109	GT	0/1
chr22	46685382	46685382	G	T	exonic	TTC38	.	nonsynonymous SNV	TTC38:NM_017931:exon12:c.G1166T:p.G389V	5.70E-10	0.382156005	0.617843995	.	.	0.09803	0.913082291	89.54352442	574.23128	4.86368	0.037	0.430	D	0.999	0.764	D	0.975	0.717	D	0.000	0.843	D	1	0.810	D	3.295	0.906	M	0.61	0.535	T	-5.81	0.882	D	0.664	0.675	-0.203	0.776	T	0.346	0.711	T	0.033	0.549	D	4.886	0.656	24.9	0.997	0.825	0.939	0.592	D	c	0.652	0.520	1.000	0.747	0.635	0.413	0	4.77	0.603	6.884	0.752	1.048	0.713	1.000	0.715	0.103	0.190	15.297	0.735	.	.	.	0.5	148	582	chr22	46685382	chr22:46685382	G	T	148	PASS	AN=2;DP=582	GT	0/1
chr22	51193209	51193209	T	G	intergenic	ACR;RPL23AP82	dist=9482;dist=2305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	146	chr22	51193209	chr22:51193209	T	G	106	PASS	AN=2;DP=146	GT	0/1
chrX	37028770	37028770	C	A	exonic	FAM47C	.	nonsynonymous SNV	FAM47C:NM_001013736:exon1:c.C2287A:p.R763S	0.057797311	0.86697678	0.075225909	.	0.03714	.	1.76190403	96.75041283	797.36508	5.56605	0.602	0.056	T	0.048	0.207	B	0.011	0.145	B	.	.	.	1	0.090	N	1.32	0.331	L	2.06	0.205	T	-1.64	0.393	N	0.058	0.041	-0.957	0.398	T	0.029	0.123	T	0.001	0.005	T	-1.075	0.029	0.011	0.164	0.004	0.004	0.020	N	.	.	.	0.001	0.077	.	.	.	-1.85	0.073	0.201	0.169	-3.068	0.001	0.000	0.063	0.000	0.016	6.232	0.198	.	.	.	0.5	84	483	chrX	37028770	chrX:37028770	C	A	84	PASS	AN=2;DP=483	GT	0/1
chrX	37028880	37028880	C	A	exonic	FAM47C	.	synonymous SNV	FAM47C:NM_001013736:exon1:c.C2397A:p.L799L	0.057797311	0.86697678	0.075225909	.	0.03714	.	1.76190403	96.75041283	797.36508	5.56605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	436	chrX	37028880	chrX:37028880	C	A	125	PASS	AN=2;DP=436	GT	0/1
chrX	44494322	44494322	C	T	intergenic	FUNDC1;DUSP21	dist=92101;dist=208927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	395	chrX	44494322	chrX:44494322	C	T	85	PASS	AN=2;DP=395	GT	0/1
chrX	47494976	47494976	-	A	UTR3	ELK1	NM_001114123:c.*1251_*1252insT;NM_001257168:c.*1372_*1373insT;NM_005229:c.*1251_*1252insT	.	.	0.756057874	0.234569302	0.009372824	.	0.99996	0.15613	0.327131069	73.27199811	572.0593	4.85348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	162	chrX	47494976	chrX:47494976	G	GA	88	PASS	AN=2;DP=162	GT	0/1
chrX	48136935	48136935	G	T	intergenic	SSX1;SSX9	dist=10056;dist=24050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	168	chrX	48136935	chrX:48136935	G	T	.	PASS	AN=0;DP=168	GT	0/1
chrX	101095525	101095525	C	A	exonic	NXF5	.	nonsynonymous SNV	NXF5:NM_032946:exon10:c.G644T:p.W215L	0.004207845	0.961305373	0.034486781	DISEASE: Note=A chromosomal aberration involving NXF5 has been observed in one patient with a syndromic form of mental retardation and short stature. Pericentric inversion inv(X)(p21.1;q22) that interrupts NXF5. {ECO:0000269|PubMed:11566096}.; 	0.1981	.	1.929210393	97.45812692	107.8307	2.25521	0.115	0.285	T	1.0	0.899	D	0.954	0.677	D	0.000	0.629	U	0.998	0.441	D	3.165	0.888	M	0.42	0.570	T	-11.95	0.996	D	0.405	0.476	-0.774	0.567	T	0.233	0.599	T	0.022	0.447	T	5.034	0.678	25.2	0.985	0.421	0.903	0.511	D	.	.	.	0.000	0.046	.	.	.	1.86	0.244	5.252	0.650	0.691	0.297	1.000	0.715	0.512	0.273	9.331	0.370	Leucine-rich repeat domain, L domain-like	.	.	0.5	.	126	chrX	101095525	chrX:101095525	C	A	.	PASS	AN=0;DP=126	GT	0/1
chrX	107408103	107408103	G	C	intronic	COL4A6	.	.	.	0.990988266	0.009011734	6.37E-12	DISEASE: Note=Deletions covering the N-terminal regions of COL4A5 and COL4A6, which are localized in a head-to-head manner, are found in the chromosome Xq22.3 centromeric deletion syndrome. This results in a phenotype with features of diffuse leiomyomatosis and Alport syndrome (DL-ATS).; DISEASE: Deafness, X-linked, 6 (DFNX6) [MIM:300914]: A non- syndromic form of sensorineural hearing loss with prelingual onset. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:23714752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14684	0.07461	0.36555769	74.7287096	361.2174	4.02247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	184	chrX	107408103	chrX:107408103	G	C	.	PASS	AN=0;DP=184	GT	0/1
chrX	122648526	122648526	G	T	intergenic	GRIA3;THOC2	dist=23760;dist=85886	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	158	chrX	122648526	chrX:122648526	G	T	90	PASS	AN=2;DP=158	GT	0/1
chrX	135960119	135960119	C	T	exonic	RBMX	.	nonsynonymous SNV	RBMX:NM_002139:exon4:c.G343A:p.G115R	0.948299697	0.051665932	3.44E-05	DISEASE: Mental retardation, X-linked, syndromic, 11 (MRXS11) [MIM:300238]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS11 patients manifest moderate intellectual disability and craniofacial dysmorphism. {ECO:0000269|PubMed:25256757}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26116	.	0.325313577	73.11276244	16.97983	0.59829	0.089	0.342	T	0.991	0.899	D	0.86	0.832	P	0.000	0.559	U	0.000	0.810	P	2.015	0.552	M	-1.02	0.763	T	-3.62	0.703	D	0.791	0.782	0.130	0.847	D	0.585	0.851	D	.	.	.	5.659	0.771	26.7	0.999	0.995	0.968	0.710	D	.	.	.	1.000	0.747	.	.	.	5.65	0.868	5.492	0.664	0.931	0.441	1.000	0.715	1.000	0.888	16.982	0.861	Nucleotide-binding alpha-beta plait domain	.	.	0.5	107	159	chrX	135960119	chrX:135960119	C	T	107	PASS	AN=2;DP=159	GT	0/1
chrX	135960146	135960146	-	AA	exonic	RBMX	.	frameshift insertion	RBMX:NM_002139:exon4:c.315_316insTT:p.P106Ffs*31	0.948299697	0.051665932	3.44E-05	DISEASE: Mental retardation, X-linked, syndromic, 11 (MRXS11) [MIM:300238]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS11 patients manifest moderate intellectual disability and craniofacial dysmorphism. {ECO:0000269|PubMed:25256757}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26116	.	0.325313577	73.11276244	16.97983	0.59829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	155	chrX	135960146	chrX:135960146	G	GAA	104	PASS	AN=2;DP=155	GT	0/1
